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The global impact of malaria 
Transmitted by Anopheles mosquitoes, unicellular parasites of the genus Plasmodium 
yearly infect millions of people who consequently fall sick with a disease that has a potential 
fatal outcome: Malaria. 
Widespread in tropical and subtropical countries, malaria jeopardizes nearly half of the 
world’s population. In 2016 alone, 216 million people suffered and an estimated 445.000 
people died from malaria, despite the painstakingly achieved decline in global incidences 
(21%) and mortality rates (29%) since 2010 [1]. Children under five years of age accounted 
for more than 70% of all malaria mortalities, and, together with pregnant women, HIV 
patients, and travellers from non-endemic or low-transmission countries are most 
susceptible due to insufficient immunity against the parasite [1]. Malaria also has a huge 
economic burden on these countries. Costs due to healthcare can reach up to 40% of all 
public health expenses in high-burden countries and together with the costs due to lost 
productivity sum up to millions of dollars. In (Sub-Saharan) Africa alone, where nine out of 
ten disease cases occur, yearly malaria related costs have been estimated to be at least US$ 
12 billion [1]. Current strategies to fight malaria encompass diagnosis and treatment of 
patients as well as preventive treatment of pregnant women and infants, usage of 
insecticide-treated (bed) nets, indoor residual spraying and occasional larval control or 
other vector control interventions [1, 2]. To date, a vaccine against malaria is not 
commercially available, and the most advanced vaccine candidate RTS, S/AS01 provides, 
unfortunately, only partial and transient protection amongst young children and infants [3]. 
Furthermore, resistance of parasites to nearly all currently available antimalarial drugs 
emerges. Even to artemisinin, a compound of the herb Artemisia annua, which has been 
used to treat malaria for more than 1,000 years [4]. Additionally, insecticide resistance in 
Anopheles mosquitos spreads rapidly, and has been reported in 60 countries since 2010 
[1, 5]. 
Thus, the alarming development of drug-resistant malaria parasites and insecticide-
resistant mosquitoes, together with the lack of an effective and long-term protective 
malaria vaccine, poses a tremendous threat to current malaria control interventions and 
demands better understanding of the biology of this malaria causing parasite and novel 
intervention strategies. 
 
The genus Plasmodium  
Malaria parasites are obligate intracellular parasites, which depend on female blood-
sucking mosquitoes for sexual reproduction and transmission, and vertebrate hosts for 
asexual proliferation. They have been traditionally distinguished by basic features such as 
morphology, host specificity and geographic location and belong to the genus Plasmodium, 
the family Plasmodiidae, the order haemosporoida, the class haematozoa and the phylum 
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Apicomplexa [6, 7]. The existence of Plasmodium parasites can be traced back to the 
Cretaceous period (~66-145 million years ago) [6] and until now, approximately 200 
different Plasmodium species have been discovered. Most of them infect reptiles and birds, 
but also a variety of mammals such as ungulates, bats, rodents and primates [7, 8]. Reptile- 
and bird-infecting Plasmodium parasites are transmitted by a wide range of culicine and 
anopheline mosquitoes from the family Culicidae and the order Diptera [9]. Mammal-
infecting Plasmodium parasites, by contrast, seem to be solely transmitted by anopheline 
mosquitoes [10], suggesting a link between vector specialization and parasite radiation in 
mammals [11].  
Most Plasmodium species are rather host specific [12]. But some of them, such as certain 
avian malaria species, infect hosts from different families and orders [13, 14] and under 
experimental conditions even adapted to erythrocytes of phylogenetically distant hosts, for 
example, of the mammalian class [15, 16]. Interestingly, a phylogenetically early host switch 
from birds to bats has previously been identified as the evolutionary key event that lead to 
the radiation of Plasmodium parasites together with their respective mammalian hosts [17, 
18], also giving rise to the current human-infecting Plasmodium species [18-20]. 
 
Table 1: Human-infecting Plasmodium species and their typical features (reviewed in [21-25]). 
 
Species 
Pre-
erythrocytic 
infection 
Hypnozoite 
formation 
Asexual 
cycle*/ 
RBC or 
RC# 
Severity of 
the disease Endemic areas 
P. falciparum  5-10 days no 2 days / 
both 
Most severe, 
cerebral 
malaria, 
highest 
mortality 
Predominantly in 
Africa 
P. vivax 6-12 days yes 2 days / 
only RC 
Moderate to 
severe 
Predominantly in 
South-East Asia 
P. malariae 14-16 days no 3 days / 
prefers 
RBC 
Mild to 
moderate 
Found worldwide 
in endemic 
countries 
P. ovale curtisi,  
P. ovale 
wallikeri 
9 days yes 2 days / 
only RC 
Mild Found in Africa, 
western Pacific 
islands 
P. knowlesi 
(Macaque 
monkeys and 
humans) 
6-8 days no 1 day / 
RBC 
Severe Frequent 
zoonosis in 
Southeast Asia 
*approximate duration, # reticulocyte 
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Human-infecting Plasmodium species and their pathogenesis 
Five Plasmodium species parasitize humans as their natural hosts (P. falciparum, P. vivax, 
P. malariae, P. ovale curtisi and P. ovale wallikeri [26]) and the Macaque monkey-infecting 
species P. knowlesi infects humans frequently [27] (Table 1). Zoonosis (the disease 
transmission from animals to humans) with other primate-infecting Plasmodium species has 
been documented, but just diagnosed for few individual cases [23]. The vast majority of 
human malaria cases is caused by P. falciparum and P. vivax: in Sub-Saharan Africa primarily 
by P. falciparum, in South America primarily by P. vivax and in South-East Asia and western 
Pacific by both [24, 28]. P.  o. curtis, P. o. wallikeri and P. malariae infections are 
widespread, but much less abundant, and mostly occur as co-infection with 
P. falciparum [20, 24]. P. knowlesi infections are also less common and only occur in certain 
forested areas of South-East Asia. However, they might be underrated due to misdiagnoses 
by microscopy [25, 27]. 
After being infected, malaria symptoms appear when the parasites asexually proliferate 
within the human blood. The course of the disease varies depending on the infecting 
Plasmodium species. At the onset of disease, all species cause rather unspecific symptoms 
such as headache, slight fever, muscle pain and nausea. With increasing parasite load, these 
are followed by the characteristic periodic fever attacks with chills (cold stage), feeling of 
intense heat, burning skin and severe headache (hot stage) and profuse sweating and 
exhaustion (sweating stage). At the same time, additional symptoms can occur such as 
enlargement of the spleen and liver, slight jaundice and hemolytic anemia. The periodicity 
of the fever attacks occurs every 24 hours for P. knowlesi, every 48 hours for P. vivax, 
P. o. curtisi and P. o. wallikeri, and every 72 hours for P. malariae. P. falciparum causes 
rather irregular attacks with a 36-48-hour periodicity. Even daily attacks or continuous fever 
are possible [21, 25, 29, 30] (Table 1).  
P. falciparum causes the most life-threatening form of malaria and evolved an exceptional 
strategy to evade the host’s immune system. Specific proteins anchored at the surface of 
infected erythrocytes mediate adherence to endothelial cells of blood vessels and 
aggregation with other infected and uninfected erythrocytes. In this way, the parasites can 
escape the clearance by the spleen. However, it also leads to reduced blood flow causing 
dysfunction of vital organs such as kidneys, lung and liver, and the brain (cerebral malaria) 
resulting in severe malaria with acute anemia, respiratory distress and coma. Untreated 
severe P. falciparum infections are often lethal and account for the vast majority of malaria 
mortalities worldwide [21, 29, 30] (Table 1).  
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The life cycle of P. falciparum parasites 
A single bite of an infected mosquito can be sufficient to cause malaria. While the mosquito 
probes for blood, saliva and parasites residing in the mosquito’s salivary glands, so-called  
sporozoites, are injected into the skin of the human host (Figure 1). Within the skin the 
sporozoites randomly migrate until they reach a blood vessel and after invading it rapidly 
home to the liver. In the liver, just a couple of hours after the mosquito bite, they infect 
hepatocytes by invagination and grow into mature liver schizonts within the next ten days. 
Each mature liver schizont gives rise to tens of thousands infectious merozoites which are 
shed as vesicles, the merosomes, into the bloodstream. This pre-erythrocytic phase of the 
infection remains clinically asymptomatic [21]. In the pulmonary capillaries, the merozoites 
are released from the merosomes and within seconds recognize, attach and enter 
erythrocytes by invagination through specific ligand-receptor interactions. Once 
intracellular again, the parasite immediately turns into a ring stage and remodels the host  
cell for about 24 hours, before it enters the metabolically very active trophozoite stages. In 
the trophozoite stage, the parasite grows tremendously digesting hemoglobin as a primary 
source of nutrition. After roughly 12 hours the parasite enters the schizont stage and 
undergoes asynchronous rounds of endoreplication within the next 12 hours, while forming 
a multinucleated schizont. The mature schizont ruptures and releases up to 32 invasive 
merozoites as well as fever-causing endotoxins into the bloodstream. Within seconds fresh 
erythrocytes are invaded and a new cycle of asexual replication starts. Importantly, all 
malaria-related symptoms occur due to asexual proliferation and as mentioned before 
P. falciparum trophozoite and schizont stages additionally adhere to the vascular 
endothelium reducing the blood circulation in vital organs. Merozoites descending from a 
low number of sexually committed schizonts, undergo sexual differentiation and within 
two weeks they develop into mature male and female gametocytes, which might become 
part of a mosquito’s blood meal [21]. In the mosquito midgut, male gametocytes produce 
eight flagellated microgametes and female gametocytes mature into macrogametes. Male 
and female gametes fuse and form a diploid zygote which differentiates into a motile 
ookinete. The ookinete traverses the midgut wall and forms an oocyst, which undergoes 
several cycles of replication producing thousands of sporozoites. After approximately 17 
days these are released into the hemocoel and migrate to the salivary glands where they 
become infectious and reside until the female mosquito takes its next blood meal, thereby 
closing the cycle. [21, 31] (Figure 1). 
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Figure1: Life cycle of P. falciparum parasites. 
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Chromatin and gene expression regulation in eukaryotic organisms 
All information needed for an organism to develop, survive and to reproduce is encoded in 
its DNA. In eukaryotes – to which malaria parasites also belong – the DNA is packaged into 
a highly organized structure, the chromatin, and stored in a special compartment, the 
nucleus. To convert the information encoded by the DNA into various functional products, 
sections of the DNA, the genes, are transcribed into RNA, which are subsequently translated 
into proteins. By expressing different sets of genes, cells carrying identical DNA can give rise 
to very different phenotypes with strikingly distinct morphologies and functions. 
Accordingly, the expression of genes needs to be tightly regulated. This is accomplished 
through mechanisms which regulate the accessibility of the DNA (epigenetic mechanisms), 
the transcription of the DNA (transcriptional mechanisms), the stability and translation of 
the RNA (post-transcriptional mechanisms) as well as further processing of the proteins 
(post-translational mechanisms). In this thesis, I mainly discuss transcriptional and 
epigenetic mechanisms.  
 
Transcriptional gene regulation 
In eukaryotes, most protein coding genes are transcribed by the DNA-dependent RNA 
polymerase II (Pol II). The activity of this multi-protein complex is regulated both at the level 
of transcriptional initiation and elongation [32-34].  
The transcriptional initiation occurs at the promoter, which is located upstream of the gene 
body and contains the so-called core (or minimal) promoter. The core promoter consists of 
the transcription start site (TSS) and diverse regulatory elements (e.g. the TFIIB recognition 
element (BRE) and/or the TATA box), which are essential for the binding of general 
transcription factors (GTFs) and their assembly into the so-called pre-initiation complex 
(PIC) [35]. The PIC is crucial for the positioning of Pol II at the TSS and its advance to the 
pause site from where, after additional signaling events and recruitment of further factors, 
Pol II is released (‘promoter clearance’) and progresses into a phase of productive 
elongation [32, 33]. The promoter sequence upstream of the core promoter contains 
further DNA elements, the so-called proximal cis-regulatory elements (cis = acting on the 
same DNA molecule) [36]. These contain distinct DNA sequences, so-called motifs, which 
can be unique for individual genes or subsets of genes and are recognized and bound by the 
DNA-binding domain of specific transcription factors (TFs) [37]. Through their trans-
activating domain (trans = acting on a different molecule) specific TFs interact with co-
factors and/or directly with the PIC, which in turn alter the local chromatin structure and/or 
influence the assembly and/or the activity of the PIC. Depending on the respective activity, 
specific TFs can promote (activators) or inhibit (repressors) the transcription of their target 
genes [38].  In addition, TF binding sites can be located outside of the gene promoter and 
are able to influence gene transcriptions over large distances, for instance, by local DNA 
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looping or broader DNA reorganizations within the nucleus [39]. In mammals, long-range 
interactions between distant regulatory elements and promoters even occur over several 
thousands of base pairs. Distant regulatory sequences, which activate their target genes 
independent of their orientation in cis or in trans are often referred to as enhancers 
whereas distant regulatory elements which repress gene transcription as silencers. 
Silencers which restrict gene transcription to specific chromatin domains are often 
described as insulators [39]. The complex interplay between the above regulatory DNA 
elements and GTFs as well as specific TFs orchestrates the regulation of gene transcription, 
which is further fine-tuned by epigenetic mechanisms. 
 
Epigenetics 
In 1942, Conrad Waddington defined the term epigenetics as “the branch of biology which 
studies the causal interactions between genes and their products, which bring the 
phenotype into being” [40]. Since then, many refined definitions have been suggested [41, 
42], including the definition of an epigenetic trait as “a stably heritable phenotype resulting 
from changes in a chromosome without alterations in the DNA sequence” [43]. Nowadays, 
however, the term epigenetics often refers to any chromatin-based regulatory processes, 
ranging from the methylation of the DNA to the localization of chromatin domains within 
the nucleus, whereas the term epigenetic memory often refers to the stable propagation of 
an altered gene expression pattern, potentially induced by cell internal or external stimuli 
[44]. 
 
Epigenetic regulatory mechanisms  
Nucleosomes and their modifications  
In eukaryotes, the basic unit of the chromatin is the nucleosome which consists of 145- 147 
base pairs (bp) of DNA wrapped around a core particle composed of eight canonical 
histones (2x H2A, 2x H2B, 2x H3 and 2x H4) (Figure 2). Additionally, in many eukaryotes, a 
linker histone (H1) binds the histone octamer at the entry and exit sites of the DNA and 
stabilizes the chromatin structure [45]. Together, the nucleosomes form a continuous array 
across the chromatin fiber. Their density (nucleosome occupancy) and their location in 
relation to DNA elements or other nucleosomes (nucleosome positioning) influence and/or 
regulate the accessibility of the underlying DNA. For instance, by masking or exposing TF 
binding sites. ATP-dependent chromatin remodelers contribute to these mechanisms and 
actively remove nucleosomes (nucleosome eviction) or slide the histone octamers along 
the DNA (nucleosome repositioning). Furthermore, the continuous exchange of 
nucleosome core particles (nucleosome turnover) leads to a transient exposure of the 
underlying DNA to DNA-binding proteins. [45-48] (Figure 2). 
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Figure 2: Examples of epigenetic mechanisms.  
Importantly, epigenetic mechanisms act together to orchestrate chromatin regulating processes and 
should not be seen as separate entities. For instance, histone variant incorporation could enable 
distinct post-translational histone modifications (PTMs), which recruit effector proteins regulating 
nucleosome repositioning. This in turn could lead to TF binding, which results in the recruitment of 
other effector proteins, which in turn write or erase PTMs. 
 
The synthesis of the canonical histones (and of several H1 variants) is commonly coupled to 
DNA replication, and their assembly into nucleosomes typically occurs behind the 
replication fork. Special histone chaperones participate in nucleosome assembly and 
disassembly and ensure proper histone folding as well as escort and deposition of histones 
into the chromatin [45]. The histone chaperone Caf-1, for instance, binds to the DNA 
replication complex (‘replisome’) where it is thought to assemble and deposit (H3–H4)x2 
tetramers onto freshly replicated DNA [45].  
Canonical histones can be replaced by a wide array of histone variants, mainly on a 
replication independent manner (Figure 2 and Table 2). Their incorporation can alter the 
biophysical properties of the nucleosome and/or provide distinct sites for post-translational 
modifications, thereby giving rise to nucleosomes with unique structural and functional 
characteristics [45, 49, 50]. The incorporation of the H3-variant CenH3 (also known as 
CENPA or Cse4), for instance, is essential for the formation and functionality of the 
centromeres [51, 52] (Table 2). Furthermore, nucleosomes contain distinct sites for post-
translational histone modifications (PTMs), which can alter the structure and function of 
the nucleosomes and the surrounding chromatin alike (Figure 2, Table 3). Histone PTMs can 
directly influence histone-DNA and histone-histone interactions and thus, for instance, alter 
the stability of the nucleosome and affect the pace of histone exchange (turnover rate), or 
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Table 2: Canonical histones and their variants as well as their function/properties and chaperones 
(reviewed in [45, 46, 53-56]) 
 
Histone Function and/or properties Chaperone 
H2A Canonical histone FACT, NAP1, Nucleolin (H2A-
H2B) 
H2A.Z/H2AV Transcription initiation, DNA 
repair 
CHZ1 (yeast), ANP32E 
(mammals) (H2A.Z-H2B) 
H2A.X DNA repair, genome stability, 
meiotic remodeling of sex 
chromosomes 
FACT (H2A.X-H2B) 
macroH2A  Gene silencing, X chromosome 
inactivation 
APLF (core 
histones/macroH2A-H2B) 
H2A.B/H2A.Bbd Transcription initiation, testis and 
brain 
NAP1 
H2B Canonical histone FACT (H2A-H2B) 
TSH2B.1/H2B1A Testis-specific Not known 
H2B.W/H2BFWT Testis-specific SWI-SNF(remodeler) 
H3 Canonical histone Caf-1, NAP1, FACT, Asf1 (H3-
H4) 
CenH3 (i. a. plants) 
/CENP-A (vertebrates) 
/Cse4 (yeast) 
Kinetochore attachment, 
chromosome segregation 
Scm3 (yeast), HJURP 
(mammals) CenH3-H4 
H3.3 Transcription, Transcriptional 
memory, genome integrity, 
establishment of 
heterochromatin 
HIRA (deposition at active 
genes, DNA damage sites), 
ATRX-DAXX (deposition at 
heterochromatic regions), 
additional chaperones 
H3.Z/H3.Y.2 testis, brain and tumors 
(euchromatin) 
Not known 
H3.Y/H3.Y.1 testis, brain and tumors (not 
known) 
Not known 
H4 Canonical histone Caf-1, FACT, Asf1 (H3-H4) 
H4V Trypanosomes (protozoan 
parasite) [56] 
? 
 
can recruit non-histone proteins to chromatin [46]. PTMs occur at histone tails and at the 
lateral surface of nucleosomes and primarily affect lysine, serine, arginine and tyrosine 
residues [58]. Common histone PTMs are modifications with chemical groups such as acetyl, 
methyl- and phosphate or small proteins such as ubiquitin and SUMO. They are placed, 
removed and recognized by special classes of proteins, commonly referred to as ‘writers’, 
‘erasers’ and ‘readers’. Acetyl groups, for instance, are placed by histone acetyltransferases 
(HATs), removed by histone deacetylases (HDACs) and recognized by proteins with unique 
structural motifs such as the bromodomain that binds acetylated lysine. Methyl groups, on 
the other hand, are placed by histone methyltransferases (HMTs), removed by histone 
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demethylases (HDMs) and recognized by, for instance, chromodomain (H3K9me2/me3, 
H3K27me2/me3), Tudor domain (H3K36me3, H3Rme2, H4Rme2), or PHD finger containing 
proteins (H3K4me2/me3, H3K9me3) [59, 60].  
Besides histone PTMs, chemical modifications of the DNA, such as methylation and 
hydroxymethylation play important roles for gene regulation and chromatin organization 
in many eukaryotic organisms (Figure 2). In mammals, the most abundant modification is 
the methylation of the carbon-5 of cytosine (5mC) at sites where a cytosine (C) is followed 
 
Table 3: The most prominent histone posttranslational modifications, their function, location and 
associated readers (reviewed in [58-62]) 
 
Histone PTM Function and/or location Reader protein/domain 
H2AK119ub 
(mammals) 
Transcriptional inhibition at 
(facultative) heterochromatin 
? 
H2BK123ub (yeast)/ 
H2B120ub (mammals) 
Transcriptional activation, gene 
bodies 
Cps35 (H3K4 methylation) 
H3K4me3 Active euchromatin (promoters), 
transcriptional activation; bivalent 
genes/gene poising 
CHD1 (remodeler) via 
chromodomain, and others  
H3K9me2/3 (Constitutive) heterochromatin 
formation, transcriptional silencing; 
imprinting 
HP1 via chromodomain. EED 
(PRC mediated repression) via 
WD40 domain 
H3K27me3 (Facultative) heterochromatin 
formation, transcriptional silencing; 
X-inactivation; bivalent genes/gene 
poising 
PCR1 via chromodomain. EED 
(PRC mediated repression) via 
WD40 domain 
H3K36me3 Transcriptional elongation (coding 
region) 
Tudor domain 
H3K9ac Histone deposition; transcriptional 
activation 
Bromodomain 
H3K14ac Transcriptional activation; DNA repair Rsc4 (remodeler) via 
bromodomain, double PHD 
finger (DPF) containing 
proteins 
H3K27ac Gene activation, active enhancers by NURD complex 
H3K56ac Cell cycle progression, 
heterochromatin function 
Bromodomain-, double 
pleckstrin homology (DPH) 
domain-containing proteins 
H3K79me2/3 Active chromatin, telomeric silencing Tudor domain 
H3Rme2 Mitosis Tudor domain 
H3S10p Mitosis, meiosis, transcriptional 
activation 
GCN5 (histone acetylation), 
Bmh1/2 (yeast) via 14-3-3 
domain 
H4K20me3 Transcription activation TDRD3 via Tudor domain 
H4K16ac Transcriptional activation; DNA repair Bromodomain 
H4Rme2 Transcription activation TDRD3 via Tudor domain 
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by a guanine (G) forming a CpG dinucleotide [63]. 5mC is involved in processes such genomic 
imprinting and X-chromosome inactivation, transposon ‘control’ and regulation of gene 
expression by recruiting proteins such as members of the methyl-CpG-binding domain 
(MBD) protein family or influencing the binding of transcriptional regulators. MBDs, in turn, 
recruit chromatin modifier complexes, which act as transcriptional repressors [63, 64]. 
Methylation of the carbon-5 of cytosine is ‘written' by DNA methyltransferases (DNMTs) 
and ‘erased’ by methylcytosine dioxygenases (Tet proteins) or passively by through DNA 
replication (dilution) [63, 64].  Besides PTMs and DNA modifications non-coding RNAs 
(ncRNAs) are also involved in regulating gene expression. In particular, long ncRNA 
(lncRNAs, >200 nucleotides) acting in cis such as XIST (involved in X-chromosome 
inactivation) or in trans such as HOTAIR (involved in HOX gene silencing) have been shown 
to promote gene inactivation by recruiting repressive chromatin modifiers [65]. Together, 
all these components of the epigenetic machineries orchestrate the composition, the 
structure and the dynamics of the chromatin. 
 
Chromatin domains and higher order organization 
‘Writer’, ‘eraser’ and ‘reader’ proteins as well as chromatin remodeling enzymes often 
reside in multi-protein complexes and collectively give rise to chromatin regions, often 
referred to as chromatin domains, with distinct physicochemical properties. The two most 
distinctive examples of chromatin organization are the highly compact and transcriptionally 
silent heterochromatin and the transcriptionally permissive euchromatin (Figure 3). 
Remarkably, during the interphase, euchromatic and heterochromatic domains are 
differently distributed within the nucleus: actively transcribed euchromatic domains locate 
more towards the center whereas transcriptional silent heterochromatic domains locate to 
the periphery of the nucleus where they often associate with the nuclear lamina [66, 67].  
 
Figure 3: Heterochromatin and 
euchromatin are distinctly 
distributed within the nucleus. 
Densely packaged and 
transcriptional silent hetero-
chromatin locates towards the 
periphery of the nucleus. More 
loosely packaged and 
transcriptional active eu-
chromatin locates closer to the 
center of the nucleus. Orange 
bar represents the coding 
sequence of a gene. TF: 
Transcription factor, Pol II: 
Polymerase II. 
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In addition, intra- and inter-chromosomal interactions can further contribute to the higher 
order organization of the chromatin. For instance, in metazoans, chromatin is organized 
into sharply defined genomic regions (e.g. in vertebrates partly through the insulator CTCF 
and the cohesion complex), which are isolated from the neighboring regions and 
preferentially self-interact [68]. These so called topologically associated domains (TADs) 
range in size from hundreds of kilobases to several megabases and are either in a 
heterochromatic or euchromatic state, depending on the transcriptional activity of the 
underlying genes, and hence contribute to gene expression regulation [67-69]. 
 
Heterochromatin and euchromatin  
Heterochromatin is formed by the combination of repressive epigenetic marks and effectors 
proteins that lead to chromatin compaction and typically spans multiple adjacent genes.  A 
well investigated effector protein is the heterochromatin protein 1 (HP1) that binds di- and 
tri-methylated lysine 9 of histone 3 (H3K9me2/me3) directly through its chromodomain 
(Table 3). HP1 molecules on nearby nucleosomes oligomerize and mediate chromatin 
condensation, which results in a compact chromatin structure in which the underlying genes 
are silenced. Remarkably, HP1 dimers/oligomers also serve as a scaffold to recruit the 
enzyme SU(VAR)39, a histone lysine methyltransferases (HKMT), that adds the H3K9me3 
modification to adjacent nucleosomes and hence propagates chromatin condensation [70, 
71]. In mammals, H3K9me3 typically marks constitutive heterochromatin, which remains 
condensed in all cells at the same regions such as telomeres and pericentromeric regions 
[72].  
Next to constitutive heterochromatin, long term repression of genes can be established 
through Polycomb group (PcG) proteins, which are core components of two major protein 
complexes: Polycomb repressive complex 2 (PRC2), which ‘writes’ the heterochromatic 
mark H3K27me3, and PRC1, which is able to bind H3K27me3 and mediates mono-
ubiquitination of H2A (e.g. H2AK119 in mammal), hence likely restricting Pol II elongation. 
The resulting facultative heterochromatin silences genes on a cell type specific manner and 
restricts the gene-expression program of differentiated cells [73-76]. In contrast to these 
repressive epigenetic marks, tri-methylation of H3K4 at promoters and H3K36 at coding 
regions mediated by Thrithroax group (TrxG) proteins is closely linked to gene activation 
and often counteracts PcG activity. H3K4me3, for instance, likely provides a physical 
impediment for PCR2 but also recruits complexes involved in H3K27 acetylation. However, 
bivalent domains marked with H3K4me3 and H3K27me3 (same nucleosome, different H3 
tail) allow an ‘intermediate’ chromatin state in which genes are primed for expression but 
kept silent [62, 77]. Together with abundant histone acetylation (e.g. H3ac mediated by 
GCN5), H3K4me3 and H3K36me3 are linked the more ‘open’ (accessible) euchromatin 
which facilitates binding of transcriptional activators and transcription of the underlying 
genes. 
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Overview of the thesis 
During their life cycle Plasmodium parasites develop into various morphologically and 
functionally distinct forms without altering the sequence of their DNA. As in other 
eukaryotic organisms, these phenotypic changes are based on the expression of distinct sets 
of genes. The expression of these genes is regulated by a wide range of mechanisms, which 
tightly interact with each other. In this thesis, I describe and discuss aspects of the 
epigenetic landscape of malaria parasites and the contribution of epigenetic and 
transcriptional mechanisms to gene expression regulation.  
Chapter 2 reviews the chromatin landscape in P. falciparum and illustrates the complex 
interplay of epigenetic mechanisms and their contribution to gene expression regulation on 
the basis of two examples: the process of antigenic variation, which is critical for the evasion 
of the human immune system and the process of commitment to gametocytogenesis, which 
is central to parasite transmission.  
In Chapter 3 I explored the chromatin landscape of P. falciparum and characterize the 
genome-wide localization of the histone variant PfH3.3. We revealed that PfH3.3 is 
incorporated in GC-rich coding and subtelomeric repeat regions on a base composition-
dependent manner, and that incorporation of PfH3.3 to the active var locus might 
contribute to the regulation of antigenic variation.  
In Chapter 4 we performed genome-wide profiling of the heterochromatic mark, HP1 and 
provide a detailed catalog of heritably silenced genes for different Plasmodium species, 
strains and stages. We unveiled conserved and specialized features of HP1-mediated gene 
silencing across the genus Plasmodium, explored variantly silenced genes across different 
strains and unraveled a major role for HP1-mediated gene silencing in the process of sexual 
differentiation. 
Chapter 5 provides initial mechanistic insights to the regulatory events that lead to 
derepression of the master transcription factor of gametocyte commitment in 
P. falciparum. Here, we demonstrate that binding of the nuclear protein PfGDV1 to the 
heterochromatic mark PfHP1 at the pfap2-g locus counteracts HP1-mediated silencing and 
enables expression of PfAP2-G, which in turn triggers gametocyte conversion. Our study 
also revealed that the expression of PfGDV1 itself is regulated by its own antisense RNA.  
In Chapter 6 we explored the transcriptional regulatory network in P. falciparum during 
blood stage development. Using the Assay for Transposase Accessible Chromatin-
sequencing (ATAC-seq) we identified cis-regulatory elements in a genome-wide scale and 
investigated their role in relation to transcription. Additionally, we identified ‘stage-specific’ 
de novo and previously identified (Plasmodium) motifs and uncovered yet unknown cis-
trans regulatory interactions. 
In Chapter 7, I discuss our findings, place them into the context of the state-of-the-art and 
discuss how they contribute to a better understanding of the biology of malaria parasites.  
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Abstract 
Malaria parasites exhibit a very complex, multi-stage life cycle that requires extensive and 
accurate regulation of gene expression. Over the last decade, it has become increasingly 
clear that epigenetic mechanisms are a prerequisite for tightly controlled gene expression 
regulation by orchestrating chromatin composition, structure and dynamics; and hence play 
a key role in development and survival of the human malaria parasite Plasmodium 
falciparum. This chapter provides an overview of P. falciparum’s epigenetic machinery and 
its role in various biological processes. It summarizes the current knowledge on 
P. falciparum’s chromatin landscape and illustrates the complexity and importance of 
epigenetic regulation of gene expression in P. falciparum by means of two examples: the 
pathogenic process of antigenic variation and the transmission-ensuring process of 
gametocyte conversion. Although, up until now, the precise involvement of epigenetic 
mechanisms in these processes remains to be unraveled, it becomes evident that 
deciphering these mechanisms will contribute to understanding parasite pathogenicity and 
could help to find new strategies to fight this challenging parasite. 
 
Introduction 
Plasmodium is the unicellular parasite that causes malaria. It has a complex life cycle 
involving two hosts: the mosquito vector and a vertebrate host. Within both hosts, 
Plasmodium undergoes rapid transitions into several morphologically and functionally 
distinct forms. Unlike in multicellular eukaryotes, where the majority of cells differentiate 
into certain cell types with stable patterns of gene expression, Plasmodium constantly re-
establishes its gene expression pattern for every single form within its life cycle. However, 
Plasmodium is also capable to maintain expression patterns of certain genes over several 
generations; for instance, the expression of a single antigenic variation gene is conserved 
during multiplication of asexual blood stage parasites. To achieve this, Plasmodium not only 
needs to control its gene expression in a perfectly timed manner, but also needs to 
“remember” patterns of gene expression over generations of parasites.  
Over the last decades, scientists investigated the role of epigenetic mechanisms in 
controlling the regulation and memory of gene expression of this perplexing eukaryote. In 
this chapter, we provide an overview of the various epigenetic mechanisms and discuss why 
they are key to parasite survival. We mostly refer to findings obtained from the intra-
erythrocytic cycle of the human malaria parasite P. falciparum, unless indicated otherwise. 
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Epigenetics – an overview 
“Epigenetics” in its classical term refers to “causal interactions between genes and their 
products, which bring the phenotype into being” [1]. In other words, cells with an identical 
genome are able to transmit different phenotypic traits to their descendants. Nowadays, 
the term “epigenetics” is more commonly used to refer to any chromatin-based regulatory 
processes, for example, post-translational modifications of histones (PTMs) or DNA-
methylation. Therefore, the classical definition is often paraphrased as “epigenetic 
memory”, meaning that genetically identical cells give rise to different phenotypes that are 
propagated over several generations. 
The epigenetic machinery includes a wide-range of components, including DNA, non-coding 
RNA and numerous proteins. The well-known histones form the building block of chromatin, 
the nucleosome. A single nucleosome consists of a histone octamer composed of two of 
each canonical histone (H2A, H2B, H3 and H4) and ~147bp of DNA wrapped around it. 
Canonical histones can be exchanged by histone variants, which may alter the biophysical 
properties of nucleosomes and provide distinct sites for PTMs. All histones and their 
variants can be modified post-translationally with different chemical groups (e.g. 
acetylation, mono-, di-, or tri-methylation, phosphorylation), or they can be conjugated to 
small proteins (ubiquitination, sumoylation). Particularly, lysine, serine, arginine and 
tyrosine residues located in the N-terminal histone tail, protruding from the octamer core, 
are subject to these modifications. In addition, DNA itself can be modified with chemical 
groups (e.g. methylation or hydroxymethylation) [2]. Proteins that place (“writers”), remove 
(“erasers”), or bind to (“readers”) modifications, are also considered prime components of 
the epigenetic machinery and have key functions in dynamic modifications and 
interpretation of the epigenetic code [3]. “Writers”, for instance, attach acetyl groups to 
lysine residues (histone acetyltransferases – HATs) or methyl groups to lysine (histone lysine 
methyltransferases – HKMT) or arginine residues (histone arginine methyltransferase – 
HRMT). “Erasers” reverse these modifications by removing acetyl (histone deacetylases – 
HDACs) or methyl groups (histone demethylases). “Readers” contain domains that 
recognize and bind to specific modifications. These proteins often reside in multi-protein 
complexes or contain multiple distinct domains themselves, thereby exhibiting 
combinations of “reader”, “writer” or “eraser” activities. One well investigated “reader”, for 
example, is heterochromatin protein 1 (HP1) that binds tri-methylated lysine 9 of histone 3 
(H3K9me3) directly through its chromodomain. Interestingly, HP1 also recruits the enzyme 
SU(VAR)39, a HKMT, that “writes” the H3K9me3 modification providing a prime example of 
how epigenetic processes are often interconnected [2].  
All components of the epigenetic machinery together orchestrate the composition, the 
structure and the dynamics of chromatin. This in turn contributes to the regulation of 
chromatin structure dependent processes like chromosome segregation and transcriptional 
regulation of gene expression. For instance, “open” chromatin can facilitate the binding of 
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transcriptional activators and thus transcription of the underlying gene (loosely packed and 
active chromatin state = euchromatin) whereas denser “closed” chromatin has the opposite 
effect and silences gene expression (compact and inactive chromatin state = 
heterochromatin). Chromatin is also subjected to a “higher order”, 3D organization within 
the nucleus. Heterochromatic regions, for instance, often cluster and are localized close to 
the nuclear periphery (e.g., lamina) while euchromatin is more commonly associated with 
the nuclear lumen. 
 
The unique genome and chromatin landscape of Plasmodium falciparum 
P. falciparum has a haploid genome organized into 14 chromosomes consisting of 
approximately 23 million bp. More than half of the genome is covered by coding sequences 
that encode about 5300 proteins, and almost 80% of the genome is transcriptionally active 
during blood stage development [4, 5]. Remarkably, the P. falciparum genome is extremely 
AT-rich with an overall A+T content of 80.6%. Interestingly, the base composition differs in 
different chromosome regions. The centromeres are most A+T-rich (~97%), followed by 
intergenic regions (~86%) and coding sequences (~76%). Telomeric and subtelomeric 
regions, on the other hand, contain the most GC-rich sequences (~73% A+T) [5].  
The “chromatome” of P. falciparum is composed of the four canonical histones (H2A, H2B, 
H3 and H4), four histone variants (H2A.Z, H2B.Z, H3.3 and CenH3), at least 70 different PTMs 
including methylation, acetylation, phosphorylation, sumoylation and ubiquitinylation of 
certain amino acid residues [6-10], and numerous “reader”, “writer” and “eraser” proteins 
of which very little is known. Nonetheless, 4 HATs, 10 HKMTs, 3 HRMTs, 1 DNA (cytosine-
5)-methyltransferase (DNMT), 5 HDACs, 3 lysine demethylases and at least 18 “readers” 
have been predicted based on domain and homology searches (Table 1) [11, 12]. Specific 
combinations of (variant) histones and their modifications “divide” the genome into 
functionally distinct chromatin domains (centromere, telomere, eu- and heterochromatin) 
[13-15]. The epigenetic makeup of these domains will be discussed in the in the following 
sections.  
 
Centromeres 
The smallest and most AT-rich chromatin domains, the centromeres, are essential for the 
proper segregation of the chromosomes during cell division. They are demarcated by the 
histone variant PfCenH3 throughout the entire intra-erythrocytic cycle [16] (Figure 1). On 
each chromosome, PfCenH3 covers a single region of 4-4.5 kb that encompasses a 2-2.5 kb 
repeat-rich core with an A+T content of ~97%. In addition to PfCenH3, centromeric 
nucleosomes may also contain the histone variants PfH2A.Z and PfH2B.Z [16]. Next to these 
histone variants, small non-coding RNAs transcribed from bidirectional promoters flanking 
the AT-rich centromere cores associate with centromeric DNA [17, 18] and were suggested 
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to play an important role in centromeric chromatin formation, for instance, as a tether to 
recruit PfCenH3 [13, 17, 18]. Interestingly, while centromeres are delineated by 
pericentromeric heterochromatin in many – including evolutionary-related – organisms 
[19], heterochromatic marks are apparently absent near P. falciparum centromeres [16]. 
 
Telomeres 
P. falciparum’s GC-richest sequences are the telomeres, consisting of degenerated G-rich 
repeats of which GGGTT(T/C)A is most frequent [20].  Their primary function is to protect 
the chromosome ends, and they are organized into two parts: an internal region associated 
with three to four nucleosomes and an outer nucleosome free region [20]. Telomeres of 
different chromosomes usually cluster together at the nuclear periphery forming four to 
seven heterologous chromosome end clusters [21]. Furthermore, several findings support 
the idea that the outer nucleosome free region in P. falciparum is similarly organized as in 
yeast. In yeast, the nucleosome free region of the telomere, the telosome, is occupied by 
multi-protein complexes, which protect the ends of linear chromosomes from degradation 
by exonucleases and play a role in anchoring telomeres to the nuclear periphery [22]. 
Orthologue proteins of these telosome complexes in P. falciparum are for instance PfSir2A, 
a member of the NAD+-dependent/class III HDACs family [23], “P. falciparum origin 
recognition complex 1 protein” (PfORC1) [24] and “P. falciparum telomerase reverse-
transcriptase” (PfTERT) [25]. What the exact composition of this complex is, how it is 
recruited to the telomere and whether it plays a role in subtelomeric heterochromatin 
formation in P. falciparum remains to be investigated. 
 
Table 1: The "writers", "erasers" and "readers" of P. falciparum's epigenetic machinery [11]. 
 
 Enzyme or Domain/PTM mark Gene ID/Annotation/PTM mark* 
‘writers‘ Histone acetyltransferase (HAT) PF3D7_0823300/PfGCN5 
  PF3D7_1118600/PfMYST 
  PF3D7_1227800/PfElp3? 
  PF3D7_0416400/PfHAT1 
   
 Histone lysine methyltransferase (HKMT) PF3D7_0629700/PfSET1 
  PF3D7_1322100/PfSET2 
  PF3D7_0827800/PfSET3 
  PF3D7_0910000/PfSET4 
  PF3D7_1214200/PfSET5 
  PF3D7_1355300/PfSET6 
  PF3D7_1115200/PfSET7 
  PF3D7_0403900/PfSET8 
  PF3D7_0508100/PfSET9 
  PF3D7_1221000/PfSET10 
   
 Histone arginine methyltransferase (HRMT) PF3D7_1426200/PfPRMT1 
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  PF3D7_1361000/PfPRMT5 
  PF3D7_0811500/PfCARM1 
   
 DNA (cytosine-5) methyltransferase (DNMT) PF3D7_0727300/PfDNMT 
   
‘erasers’ Histone deacetylase (HDAC) PF3D7_0925700/PfHDAC1 
  PF3D7_1472200/PfHDA1 
  PF3D7_1008000/PfHDA2 
  PF3D7_1328800/PfSir2A 
  PF3D7_1451400/PfSir2B 
   
 Lysine demethylase PF3D7_0809900/PfJHDM1 
  PF3D7_0602800/PfJHDM2 
  PF3D7_1211600/PfLSD1 
   
‘readers’ Bromodomain/Kac PF3D7_0823300/PfGCN5 
  PF3D7_0629700/PfSET1 
  PF3D7_0110500 
  PF3D7_1212900 
  PF3D7_1234100 
  PF3D7_1033700 
  PF3D7_1475600 
   
 Chromodomain/Kme PF3D7_1220900/PfHP1/H3K9me
3 
  PF3D7_1118600/PfMYST 
  PF3D7_1140700 
   
 Double chromodomain/Kme PF3D7_1023900 
   
 Tudor domain/Kme PF3D7_1136300/PfTSN 
  PF3D7_0323500 
   
 PHD fingers/Kme PF3D7_0629700/PfSET1 
  PF3D7_1322100/PfSET2 
  PF3D7_1221000/PfSET10/H3/ 
H3K4me 
  PF3D7_1360700/SUMO ligase 
  PF3D7_1211600/PfLSD1 
  PF3D7_0310200 
  PF3D7_1008100 
  PF3D7_1141800 
  PF3D7_1433400 
   
 14-3-3 proteins/Sph PF3D7_0818200/H3S28ph/ 
H3S28pS32h 
  PF3D7_1362100 
  PF3D7_1422900 
* Only for “readers”, if known. 
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Euchromatin 
The largest part of P. falciparum’s epigenome is found in an open and transcriptional 
permissive euchromatic state. Throughout the intraerythrocytic cycle, AT-richer 
euchromatic intergenic regions are demarcated by PfH2A.Z/PfH2B.Z double-variant 
nucleosomes [26-28] and the classical “active” marks H3K4me3 and H3K9ac [26, 29-31] 
(Figure 1). H3K4me3 marks euchromatic intergenic regions in a stage-specific manner: early 
blood stages show only minor enrichment of H3K4me3 whereas at later stages intergenic 
regions of active genes are clearly marked [26]. H3K9ac, however, follows the expression 
pattern of most genes and seems to be placed in a transcription-coupled manner [26, 29]. 
Furthermore, the following marks were found to associate with euchromatic regions: 
H3K14ac, H3K56ac, H3K79me3, H4K5ac, H4K8ac, H4K12ac, H4K16ac, H4K20me and 
H4R3me2 [29, 30, 32, 33]. Intriguingly, “readers”, “writers” or “erasers” of these 
modifications are still poorly investigated. However, two HATs, PfGCN5 and PfMYST and 
one HKMT, PfSET8, have been characterized to some extent [34-37] (Table 1). PfGCN5 
preferentially acetylates H3 in vitro, particularly on H3K9 and H3K14, and interacts with the 
adaptor protein PfADA2; probably within the context of a large multi-protein complex 
similar to other eukaroytes [35, 38-40]. Its inhibition reduced H3K9ac and H3K14ac – but 
not H4ac levels – and negatively affected parasite growth, suggesting an important role in 
genome-wide gene activation [41-43]. PfMYST, in contrast, preferentially acetylates H4 
in vitro, especially H4K5ac, H4K8ac, H4K12ac and H4K16ac and likely plays a role in 
transcriptional regulation of gene expression, cell cycle progression and DNA damage repair 
[34]. Finally, PfSET8, which is highly homologous to Toxoplasma gondii’s TgSET8, may mono-
, di- and tri-methylate H4K20 in P. falciparum [36, 37].  
 
Heterochromatin: Subtelomeric regions and intrachromosomal islands  
Heterochromatin in P. falciparum can be found on all subtelomeric regions, some 
chromosome internal islands, as well as few singular genes, and encompasses 
approximately 400 genes, which account for approximately 8% of the parasite's coding 
genome [30, 31, 44-46]. The heterochromatic subtelomeres can be subdivided into two 
regions: (i) non-coding repeat-rich regions directly bordering the telomere, and (ii) protein-
coding regions. The non-coding region is composed of a mosaic of six diﬀerent blocks of 
repetitive sequences, the “telomere associated repetitive elements” (TAREs 1-6). These are 
positioned in the same order on all chromosomes and span around 20–40 kb [20, 47]. 
Interestingly, TAREs 1-6 give rise to long non-coding RNAs (lncRNAs) with yet unknown 
function, which were proposed to be involved in heterochromatin establishment [24, 48-
50] (see below). Strikingly, both the protein-coding subtelomeres and the 
intrachromosomal heterochromatic islands encode primarily for Plasmodium-specific 
multigene families, e.g. var, rifin, stevor and pfmc-2tm, which are partly involved in 
antigenic variation and subject to mutually exclusive gene expression [51] (see 4.1). 
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Heterochromatic regions are defined by hypoacetylation of histones and reduced 
accessibility to MNase digestion, suggesting more compact nucleosomal packaging [30, 31, 
45]. As a result, genes underlying heterochromatic regions are generally silenced. Other 
hallmarks of (constitutive) heterochromatin are H3K9me3 [30, 31] and heterochromatin 
protein PfHP1 [44, 45] (Figure 1). Orthologues of PfHP1 in Schizosaccharomyces pombe, 
Drosophila melanogaster and human contain a chromodomain that mediates H3K9me2 and 
H3K9me3 binding and a chromo shadow domain that enables oligomerization of HP1 
proteins leading to nucleosome aggregation and hence the formation of densely packed 
heterochromatin [52, 53]. PfHP1 also contains both domains and localizes to H3K9me3-
marked heterochromatin. Furthermore, a recombinant PfHP1 chromodomain binds both 
H3K9me2 and H3K9me3 in vitro, and PfHP1 depletion results in reduced H3K9me3 levels in 
blood-stage parasites. Hence, it is likely that PfHP1 and H3K9me3 may have a similar role in 
heterochromatin formation as shown for other organisms [44, 50, 54] (see the following 
text). A functional homolog of SU(VAR)39, the enzyme that places H3K9me3 in most 
organisms, could not be confirmed in P. falciparum. However, based on homology searches, 
PfSet3 (the only Plasmodium protein with a pre-SET domain), appears to be the most likely 
candidate to deposit this mark [30, 37, 55].  Recently, also unexpected enrichment of 
H3K36me3 was observed in heterochromatic subtelomeres and intrachromosomal islands 
[56-58]. Knockdown of PfSET2, the HKMT predicted to deposit H3K36me2/me3 in 
P. falciparum, results in decreased H3K36me3 levels and up-regulation of var gene 
expression [37, 56, 57]. However, H3K36me2/3 levels were only reduced in ring parasites, 
suggesting that alternative enzyme(s) might perform this methyltransferase activity in other 
stages [56]. Additionally, H4K20me3 was reported to be present in heterochromatic regions 
[29, 30, 36], but the repressive H3K27me3 mark, which hallmarks facultative 
heterochromatin in many multi-cellular organisms, has so far not been detected in 
P. falciparum [9].  
Formation of the silent heterochromatic state is crucial for the regulation of several clonally 
variant gene families and single heterochromatized genes (see below). Thus, it is of great 
interest to understand the mechanisms of heterochromatin formation in P. falciparum. In 
model organisms, assembly of heterochromatic domains is thought to happen in three 
different steps: (i) establishment of heterochromatin at nucleation sites due to lncRNAs or 
DNA-binding proteins that recruit an initial HKMT to deposit H3K9me2/3, (ii) subsequent 
spreading of its silencing state in a self-perpetuating manner into neighboring regions via 
HP1 and HKMT interactions and (iii) its maintenance over several generations due to 
identical re-establishment of its state on newly replicated chromatin after each cell division, 
all as concerted actions of different histone modifying “writer”, “eraser” and “reader” 
proteins [59-64]. In P. falciparum, heterochromatin establishment may involve PfHDA2, a 
member of the class II HDAC family, and the two NAD+-dependent/class III HDACs family 
members, PfSir2A and PfSir2B. Together, they may allow spreading of H3K9me3/PfHP1 by 
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removing activating acetyl marks (especially H3K9ac), but also by recruiting additional 
proteins that are required for heterochromatin establishment [23, 65-68]. Additional 
proteins suggested to be involved in heterochromatin establishment are PfOrc1 and PfAlba. 
PfOrc1 binds to TAREs in a PfSir2A dependent-manner and PfAlba-containing molecular 
complexes associate with TARE6 and co-localize with PfSir2A [23, 24, 69, 70]. Subsequent 
heterochromatin spreading may require, as in other organisms, binding of PfHP1 to 
methylated H3K9 which in turn leads to the recruitment of a H3K9 HKMT [34, 54, 59, 61]. 
The HKMT may methylate H3K9 on the neighboring nucleosome, which in turn would result 
in PfHP1 binding and heterochromatin spreading from small nucleation sites into large 
chromosome domains, thereby silencing underlying genes [71, 72]. Despite identification of 
numerous components of Plasmodium’s epigenetic machinery involved in heterochromatin 
formation, it still remains unclear how these components work together to orchestrate 
heterochromatin establishment, spreading and maintenance in P. falciparum. 
 
Epigenetic regulation of gene expression in P. falciparum 
Over the last decade, the awareness that epigenetic mechanisms play an essential role for 
P. falciparum’s biology increased. They control pathogenic processes like antigenic variation 
[73, 74], sequestration of infected erythrocytes [75] and selection of erythrocyte invasion 
pathways [75-77]. Furthermore, they are also involved in antibiotic resistance [78-80], 
adaptation to changing environments, for instance increased blood lactate-levels or 
increased body temperatures of the host (fever) [81], and nutrition availability and uptake 
[78, 80, 82]. Lastly, epigenetic mechanisms were shown to be crucial for gametocyte 
conversion and thus for parasite transmission [54, 65, 83, 84]. In this section, we discuss 
two of these processes in detail to illustrate the complexity of epigenetic regulation of gene 
expression. 
 
Epigenetic regulation of antigenic variation  
Our current knowledge on epigenetic mechanisms in P. falciparum mainly derives from 
studying the process of antigenic variation. Antigenic variation is based on multigene 
families (e.g. var, rifin, stevor and pfmc-2tm) located in heterochromatic subtelomeres and 
intrachromosomal islands. Most of these families encode proteins that are exported and 
anchored to the erythrocyte membrane [85-92]. Interestingly, within these families only a 
small subset of genes is expressed while other family members remain transcriptionally 
silenced. Remarkably, the active state of one gene and the silent state of all other family 
members can be maintained over generations of blood stage parasites, being inherited from 
one parasite to its descendants by an epigenetic memory [46, 93]. However, a small 
minority of parasites begins to express a different member within the gene family giving the 
infected red blood cell a “fresh makeup” [94]. Through this phenomenon, some parasites  
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Figure 1: Schematic representation of P. falciparum‘s chromatin landscape and stage-specific or 
transcription-coupled chromatin changes.  
Euchromatin (white parts of the schematic chromosome): Euchromatic intergenic regions are 
demarcated by PfH2A.Z/PfH2B.Z double-variant nucleosomes, H3K4me3 and H3K9ac. H3K4me3 
marks euchromatic intergenic regions in a stage-specific manner: low in early blood stages, high in 
late blood stages. H3K9ac is placed in a transcription-coupled manner: high in 5’ upstream regions of 
active genes, low in 5’ upstream regions of inactive genes. Centromere (silver ellipse): The centromere 
is a 4-4.5 kb region demarked by PfH2A.Z/PfH2B.Z/PfCenH3 triple-variant nucleosomes; its 2-2.5 kb 
AT-rich core is flanked by bidirectional promoters that give rise to small ncRNAs.Heterochromatin 
(black blocks): Subtelomeres and intrachromosomal islands are marked by H3K9me3, PfHP1 and 
H3K36me3. lncRNAs are transcribed in sense and antisense orientation from bidirectional intronic var 
gene promoters. 5’ upstream and bidirectional intronic var gene promoter of an active var gene are 
marked with H2A.Z/H2B.Z double-variant nucleosomes, H3K9ac and H3K4me3. In the subtelomeric 
non-coding region TAREs 1-6 express lncRNAs. 
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can escape the host’s immune system, thus ensuring parasite survival within its host and 
sustained infection. The most extensively studied multigene family, the var gene family, 
encompasses approximately 60 members. Interestingly, var gene expression occurs in a 
mutually exclusive manner, meaning a parasite expresses only a single var gene at a time 
while all other family members remain transcriptionally silent [95].  Every var gene consists 
of two exons separated by a highly conserved intron. Exon 1 encodes an extremely diverse 
extracellular binding region, while exon 2 encodes the more conserved intracellular domain. 
Together, they assemble the variant adhesion surface molecule “P. falciparum erythrocyte 
membrane protein 1” (PfEMP1) whose extracellular binding region is exposed at the surface 
of the infected erythrocyte during trophozoite and schizont stages. Thereby, PfEMP1 
exposes parasite antigens to the host immune system, which can be the target for an 
immune response. Nonetheless, PfEMP1 is an essential virulence factor that mediates 
adherence of trophozoite- and schizont-infected erythrocytes to the endothelium of 
capillaries and venules of the host, thus enabling the parasites to circumvent spleen-
mediated clearance. Adverse effects associated with the infection are adhesion-based 
complications like cerebral malaria and pregnancy-associated malaria [96]. 
Transcription of var genes occurs in 8–20-h-old ring stages of P. falciparum [51, 95, 97-100]. 
During the trophozoite and schizont stage (25–48 h after invasion) the active var gene is in 
a “poised” state, meaning it is not actively transcribed but still retains an epigenetic make-
up that prevents silencing and enables reactivation in the next generation [101]. With low 
frequency, a previously silenced var gene becomes active while the previously active gene 
becomes silent. It is currently unknown to which extent this infrequent switch is hard-wired 
into the parasite’s genome or linked to external factors. However, there are few indications 
that external factors, for instance, starvation stress, high body temperature and lactate 
levels contribute to var gene switching; potentially through modulation of NAD+-dependent 
Sir2 activity [81, 102-104].  
Over the last decade, tremendous progress has been made in unravelling the complex 
mechanisms of var gene regulation encompassing interaction of genetic elements, non-
coding RNAs, chromatin modifications and modifiers and specific subnuclear localization 
[13, 74, 100, 105, 106]. Crucial genetic elements involved in var gene regulation are the 5’ 
upstream var gene promoter that gives rise to PfEMP1-encoding transcripts as well as the 
var gene intron that contains bidirectional promoter activity [107-110]. Based on transgenic 
parasites expressing episomal or episomally integrated var promoters, the following 
observations were made: (i) 5’ upstream var promoter and intron pairing is required for var 
gene silencing and (ii) loss of one-to-one var promoter and intron pairing as well as 
integration of an unpaired promoter leads to var gene activation [108, 109, 111, 112]. 
Important cis-acting elements within the var locus have also been unraveled, which is 
further discussed elsewhere [15, 100, 113]. 
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Particular localization within the nucleus also influences var gene expression as telomeres, 
subtelomeric, and intrachromosomal var genes are tethered to the nuclear periphery and 
activation of a single var gene results in its “repositioning” into a special subnuclear 
expression site [15, 100]. Apart from genetic elements and subnuclear localization, lncRNAs 
were shown to play an important role in var gene regulation. In particular, lncRNAs 
transcribed in sense and antisense orientation from the bidirectional promoter within the 
var intron have gained a lot of attention [48, 74, 107, 114-116]. Sense lncRNAs are 
transcribed from the highly conserved exon2 and have a size of around 2–2.5 kb. They are 
expressed from all var genes at the time when the var upstream promoter is silent, meaning 
from the onset of DNA replication (~24 h post invasion) through schizogony and merozoite 
formation. They were shown to associate with chromatin [114-116] and were suggested to 
play a role in epigenetic memory of var expression [115]. Antisense lncRNA are transcribed 
from the variable exon 1 region of var genes at the same time as sense lncRNA and have a 
size of around 1.7 kb [114, 115]. Recently, it was shown that they associate specifically with 
the single active var gene during the ring stage and are incorporated into the chromatin. 
Moreover, expression of these lnRNAs in trans induces var gene activation in a sequence- 
and dose-dependent manner. Interference with antisense lncRNAs leads to silencing of the 
respective var gene, erases its epigenetic memory, and induces var gene switching [74]. 
Additionally, another family of lncRNAs named lncRNA-TARE-4L was detected [48]. These 
are transcribed from subtelomeric regions that contain a cluster of SIP2-binding motifs in 
the 5’ upstream promoter of a subset of var genes and are thought to play an important 
role in silencing adjacent var genes, probably by contributing to the regulation of epigenetic 
var gene memory [48, 50]. Additionally, active, “poised” and silenced var genes are specially 
marked by histone modifications and variants implying an essential role for histone 
chaperones and chromatin “readers”, “writers” and “erasers” in regulating var gene 
expression (Figure 1). Both active 5’ upstream and intronic var gene promoters are marked 
with H2A.Z/H2B.Z double-variant nucleosomes and the histone PTMs H3K9ac, 
H3K4me2/me3, as well as H4ac in case of the 5’ upstream promoter [26, 28, 30, 34]. The 
“writers” of H4ac and H3K4me2/me3 are histone acetyltransferase PfMYST and 
methyltransferase PfSet10, respectively, and were shown to be enriched at the active 5’ 
upstream var promoter [34, 101]. In the “poised” state, only H3K4me2 and PfSET10 
association were observed, while 5’ upstream promoter H2A.Z/H2B.Z incorporation was 
lost [28, 101, 117]. This implies a role for H3K4me2 in transmitting epigenetic memory, 
possibly by preventing H3K9me3 to spread into the var promoter region while the 5’ 
upstream promoter is transcriptional inactive during trophozoite and schizont stages [101, 
118]. In contrast, silenced var genes are constantly marked by PfHP1, H3K9me3 and 
H3K36me3, not only in their promoter regions but also over their coding sequences [30, 44, 
45, 56]. Intriguingly, var introns are constitutively covered by PfH2A.Z/PfH2B.Z [26, 28]. 
Depletion of PfHP1 or PfSET2 results in simultaneous activation of all var genes, even 
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outside of the perinuclear var gene expression site [37, 54, 56, 58]. Similarly, depletion of 
deacetylating enzymes also leads to up-regulation of all (PfHDA2) or subsets of var genes 
(PfSir2A and PfSir2B) [65, 66, 68] (Table 1).  
Although var genes represent the most investigated example of epigenetic regulation in the 
malaria parasite, we are far from understanding the complex interplay of various regulatory 
event that orchestrate mutually exclusive expression and switching. However, it seems 
evident that var gene expression depends on complex disassembly of heterochromatin at a 
single locus rather than on simple transcription factor activation. 
 
Epigenetic mechanisms involved in gametocyte conversion  
Asexual replication during the intra-erythrocytic cycle establishes and maintains infection 
of the host. To ensure transmission to other hosts, some parasites develop into gametocyte, 
through a process called gametocytogenesis. Unlike asexual parasites, gametocytes are 
unable to replicate within the mammalian host, but are infectious to the mosquito vector 
that subsequently transmits the parasites to new mammalian hosts [119].  To guarantee 
transmission and maintenance of infection at the same time, the switch from asexual 
replication to gametocyte conversion needs to be tightly controlled.  
Recent studies uncovered AP2-G, a member of the ApiAP2 transcription factor family, as a 
key regulator of gametocyte conversion in both P. falciparum and P. berghei [83, 84, 120]. 
P. berghei strains that lost their ability to generate gametocytes showed mutations within 
their pbap2-g locus and targeted disruption of the pbap2-g locus caused the same 
phenotype [84]. Similarly, levels of gametocyte formation in P. falciparum strongly correlate 
with pfap2-g expression levels and disruption of PfAP2-G function resulted in loss of 
gametocyte formation [83]. Both in P. falciparum and P. berghei, potential AP2-G binding 
motifs were identified to be enriched in the upstream region of early gametocyte genes as 
well as pfap2-g itself [83, 84]. Additionally, a potential downstream target of PbAP2-G, also 
a member of the AP2 transcription factor family, was identified. This AP2 modulates 
gametocyte conversion rates, but disruption of its gene locus does not erase gametocyte 
formation completely [84]. Collectively, these observations strongly indicate a cascade-like 
regulation of gametocyte conversion with AP2-G as master regulator and, perhaps even 
with an auto-regulatory feedback loop.  
Intriguingly, pfap2-g is the only AP2 family member marked by H3K9me3 and PfHP1, and its 
expression was recently revealed to be regulated on an epigenetic level [30, 31, 50, 54, 65]. 
Key regulators of pfap2-g expression are components of the epigenetic machinery involved 
in heterochromatin biology, PfHP1 and the histone deacetylase PfHDA2 [54, 65]. 
Conditional depletion of PfHP1 resulted in increased gametocyte conversion rates and 
transcriptional changes of genes associated with gametocyte development [54]. PfHP1 
depletion also inhibited mitotic proliferation and caused up-regulated heterochromatic 
multigene families. Accordingly, Brancucci and co-workers suggest that epigenetic silencing 
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of pfap2-g allows continuous mitotic proliferation and counteracts gametocyte conversion. 
Local dissociation of PfHP1 from the pfap2-g locus, however, activates pfap2-g and induces 
gametocyte conversion. In addition, conditional depletion of PfHDA2 resulted in a similar 
phenotype with up-regulation of pfap2-g and genes associated with gametocyte 
development. In contrast, knockout of NAD+-dependent deacetylases Sir2A and Sir2B does 
not appear to influence gametocyte conversion rates. In conclusion, PfHP1 and PfHDA2 may 
cooperate to strictly control gametocyte conversion rates, potentially as part of a speciﬁc 
silencing complex as found in other eukaryotes [54, 121, 122]. 
Despite these current and exiting findings, much still remains to be uncovered on the 
precise regulation of pfap2-g expression and additional factors involved in this process. For 
instance, different Plasmodium isolates and clones exhibit highly variable gametocyte 
conversion rates and host signals such as anemia and cytokines influence gametocyte 
conversion rates [46, 54, 65, 83, 84, 123-125].   
 
Concluding remarks and perspective 
Plasmodium parasites exhibit an exquisitely complex life cycle alternating between 
intracellular, differentiating stages and extracellular, invasive stages, not only in different 
cell types but also within two different hosts. Prerequisite for such successful stage 
transition and environmental adaption is a perfectly and tightly controlled gene expression. 
In the previous sections, two processes with major impact on Plasmodium’s survival 
illustrated the importance of epigenetic mechanisms in controlling P. falciparum’s gene 
expression. However, the spectrum of epigenetically regulated processes during blood 
stage development is much broader, ranging from erythrocytes invasion [75-77] and 
nutrition uptake [78, 80, 82] to growth adaptation due to environmental changes [81]. 
Moreover, other life cycle stages are poorly investigated and may reveal even more 
epigenetically regulated processes, for instance, variable expression of sporozoite surface 
proteins to evade the host’s immune system or variable expression of transport channels 
that might allow adjustments of nutrition uptake during liver stage development similar to 
clag 3.1 and clag 3.2 in blood stage development of the parasites [46]. Additionally, 
epigenetic mechanisms and components in other Plasmodium species are barely 
uncovered. Considering the key roles of epigenetic mechanisms in processes vital to 
parasite survival and transmission, identification of Plasmodium unique components of the 
epigenetic machinery provides great promise for drug development. Importantly, 
epigenetic drugs are successfully used in cancer treatment, for instance, Vorinostat 
(Zolinza) and Romidepsin (Istodax) in cutaneous T-cell lymphoma treatment [126, 127] 
and HDAC inhibitors were shown to inhibit malaria parasite growth efficiently [67, 
128].  HAT inhibition by curcumin and anacardic acid resulted in more moderate 
P. falciparum blood-stage growth inhibition [37, 42]. However, when used in combination 
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therapy, they might still be advantageous in counteracting rapidly increasing drug 
resistance [129]. Recently, two potential HKMT inhibitors, BIX01294 and its structurally 
related analogue TM2-115, were shown to inhibit parasite growth at all stages of the intra-
erythrocytic cycle and exhibit a rapid killing effect [130]. Despite these promising initial 
results, the major challenge will be to find drug targets and drugs unique for Plasmodium 
and to reduce off-target effects, which are known to occur for all current compounds as 
effectively as possible. Dissecting the intricate mechanisms of epigenetic regulation in detail 
will significantly contribute to this task. 
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Abstract 
Histones, by packaging and organizing the DNA into chromatin, serve as essential 
building blocks for eukaryotic life. The basic structure of the chromatin is established by 
four canonical histones (H2A, H2B, H3 and H4), while histone variants are more 
commonly utilized to alter the properties of specific chromatin domains. H3.3, a variant 
of histone H3, was found to have diverse localization patterns and functions across 
species but has been rather poorly studied in protists. Here we present the first genome-
wide analysis of H3.3 in the malaria-causing, apicomplexan parasite, P. falciparum, which 
revealed a complex occupancy profile consisting of conserved and parasite-specific 
features. In contrast to other histone variants, PfH3.3 primarily demarcates euchromatic 
coding and subtelomeric repetitive sequences. Stable occupancy of PfH3.3 in these 
regions is largely uncoupled from the transcriptional activity and appears to be primarily 
dependent on the GC-content of the underlying DNA. Importantly, PfH3.3 specifically 
marks the promoter region of an active and poised, but not inactive antigenic 
variation (var) gene, thereby potentially contributing to immune evasion. Collectively, 
our data suggest that PfH3.3, together with other histone variants, indexes the 
P. falciparum genome to functionally distinct domains and contribute to a key survival 
strategy of this deadly pathogen. 
 
Introduction 
In all eukaryotes, chromatin enables high-degree compaction of the genetic material 
while allowing access to the DNA for essential cellular processes such as transcription, 
replication, DNA damage response and repair. Canonical histones, namely H2A, H2B, H3 
and H4, are mainly synthesized and assembled into nucleosomes in a replication-coupled 
manner to form the basic layout of the newly synthetized chromatin [1-3]. In contrast, 
histone variants (non-allelic histone isoforms [1,3]), and most posttranslational histone 
modifications (e.g. acetylation, methylation [4]) are locally incorporated into chromatin 
in a replication-independent fashion to alter its properties and function. 
Given their essential function, histones are among the most conserved proteins and their 
evolutionary origins can be traced back to archaea, where one or two histone-like 
proteins are present [5]. In Eukarya, the histone family has expanded into canonical 
histones, the linker histone H1 and a great variety of histone variants for H2A, H2B and 
H3 [6]. Strikingly, the amino acid sequences of the four eukaryotic canonical histones 
and of many histone variants are extremely similar among distantly related species, 
although histone variants have emerged by convergent evolution [7-9]. The requirement 
of convergent evolution of histone variants indicates a universal theme in chromatin 
regulation; and indeed, some histone variants display universal functions. Histone H3 
variant CenH3, for instance, demarcates the centromere and functions in chromosome 
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segregation [10-13]. The function of H3.3, another member of the H3 histone family is 
however more diverse among the species. 
Phylogenetically earlier organisms, such as Saccharomyces cerevisiaeand the algal 
protist, Cyanidioschyzon merolae, possess only one form of non-centromeric H3 that is 
needed for both replication-coupled and replication-independent assembly [11,14]. This 
single form corresponds to variant H3.3 of higher eukaryotes, which suggests that 
canonical forms of H3 evolved recurrently in eukaryotic evolution, most likely by 
divergence from H3.3-like forms [15,16]. In most eukaryotes H3.3 differs from H3 only 
by few amino acid substitutions; for example, by four in most mammals and plants and 
by 16 in the ciliate Tetrahymena thermophila (Superphylum Alveolata) [11,17]. Yet, 
these few amino acid substitutions are sufficient to determine H3.3 and H3 chaperone 
selectivity and their respective nucleosome deposition pathways [18-21]. 
Genome-wide studies performed mainly in animals, but also in Arabidopsis 
thaliana revealed that H3.3 is mainly deposited into the coding sequence of transcribed 
genes, promoters of active and inactive genes, transcription start and end sites as well 
as further gene regulatory elements in euchromatic regions [8,16,22,23]. H3.3 is 
incorporated into transcription start sites and coding regions of genes in a transcription-
coupled manner [24,25]. However, enrichment of H3.3 has also been observed in regions 
of the genome that are presumed to be transcriptionally silent [26-30]. For example, in 
embryonic stem cells H3.3 contributes to the maintenance of the condensed chromatin 
state of telomeres [26,28,31,32], while it appears to be absent from the telomeres of A. 
thaliana [33,34]. Surprisingly, deletions of H3.3 genes are not always lethal, probably 
due to compensation by other H3 genes. For instance, increased H3 expression 
compensates for H3.3 lacking in D. melanogaster [35] and overexpression of H3.3 makes 
canonical H3 dispensable in T. thermophila [17]. In contrast, H3.3 disruption in D. 
melanogaster and in T. thermophila results in meiotic defects [17,36,37]. Furthermore, 
in mammals, H3.3 is not only required for reproduction but also for early development 
[32,38] and mutation in H3.3 can lead to various pediatric cancer types [39,40]. Hence, 
the function of H3 variants has been extensively studied in animals, fungi and plants - 
where it appears to have several conserved, but also specialized function. 
In this article, we focus on the localization and role of H3.3 in the apicomplexan 
parasite, Plasmodium falciparum. Besides the canonical histones four histone variants 
are encoded in the Plasmodium genome, i.e. PfH2A.Z, PfH2B.Z, PfCenH3 and PfH3.3 [41, 
42]. Interestingly, P. falciparum has an extremely AT-rich genome (on average ~80% 
adenine and thymine bases) where different genomic regions have distinctly different 
base composition. Earlier we observed an intriguing correlation between the base 
composition of these genomic regions and the incorporation of various histone variants 
[41]. Centromeres are formed via incorporation of PfCenH3 into a ~2kb long extremely 
AT-rich (~97% AT) sequence present once on every chromosome [13]. On the other end 
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of the spectrum are H3K9me3 and HP1-marked heterochromatic regions with distinctly 
higher GC content (~73% AT). These regions are present at the chromosome ends and 
some chromosome internal islands, and so far, have found to contain mainly canonical 
nucleosomes [43-46]. Within the euchromatic domain intergenic regions having 
distinctly higher AT-content (~87% AT) compared to coding sequences (~78% AT), are 
demarcated by double-variant nucleosomes containing PfH2A.Z and the Plasmodium-
specific variant PfH2B.Z [46-49]. Collectively these observations support a model in 
which histone variants help indexing the Plasmodium epigenome into functionally 
distinct domains and the rough blueprint of the epigenome is sketched by the AT-
content of the underlying sequence. Here, in further support of this model, we show 
that PfH3.3 demarcates euchromatic coding sequences and subtelomeric repeat regions 
in a GC-content coupled-manner. Furthermore, we observe that PfH3.3 specifically 
associates with the promoter region of the single expressed or poised - but not inactive 
- antigenic variation gene (var gene). This suggests that PfH3.3 might contribute to the 
epigenetic memory of vargene expression and hence could underlie a major defense 
mechanism of this deadly human pathogen. 
 
Results 
PfH3.3 primarily localizes to GC-rich euchromatic coding sequences and subtelomeric 
repetitive regions 
Plasmodium falciparum’s histone variant PfH3.3 (PF3D7_0617900) and its single copy 
canonical counterpart PfH3 (PF3D7_0610400) both encode for a 136 amino-acid protein. 
They only differ in eight amino acids including an Apicomplexan specific feature 
for PfH3.3, namely the substitution of the conserved amino acids RY with KF at position 
54 and 55 [42, 50]. With an identity of 94% they are hence difficult to investigate 
individually employing antibodies. 
We circumvented this problem by generating a P. falciparum 3D7 parasite line that 
expresses an episomal Ty1-tagged copy of PfH3.3 under the control of the chloroquine 
resistance transporter promoter (similar to pARL-1a-Ty1-H2A in ref. [47]). Additionally, 
to avoid any artefacts due to episomal (over)expression of the tagged protein, we 
engineered a construct (pHH1-PfH3.3-Ty1) that, after single crossover integration, 
resulted in a P. falciparum NF54-DCJ parasite line [51] expressing PfH3.3-Ty1 under 
control of the endogenous promoter (Fig. S1). Notably, these tagged lines show a very 
similar multiplication rate (data not shown) and expression pattern (Fig. S2) to wild type 
parasites, suggesting that the tag does not interfere with normal function of PfH3.3. 
To determine the genome-wide localization of PfH3.3, we performed chromatin 
immunoprecipitation of mono-nucleosomes using an anti-Ty1 antibody followed by next 
generation sequencing of the immunoprecipitated DNA (ChIP-seq). First, we performed 
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a test ChIP-seq on native chromatin isolated from the episomal Ty1-PfH3.3 line for two 
intraerythrocytic stages (30 and 40 hours post-invasion) in duplicates (Fig. S3). The 
respective ChIP input samples were sequenced as control. For detailed analysis we 
performed ChIP-seq on formaldehyde cross-linked chromatin from the 
endogenously PfH3.3-Ty1 line for four intraerythrocytic stages (10, 20, 30 and 40 hpi). 
Additionally, we performed ChIP-seq using an anti-H3 antibody that recognizes the C-
terminal end of both PfH3.3 and PfH3 (referred to as H3core control) and RNA-seq on 
the same four parasite populations. The resulting PfH3.3 ChIP-seq data were normalized 
either to input or H3core ChIP-seq data to correct for any biases due to differential cross-
linking, PCR amplification efficiency and reduced mapability of the highly AT-rich 
sequences, typical to the P. falciparum genome [47]. The normalized PfH3.3 ChIP-seq 
data from episomal and endogenously PfH3.3-tagged parasites displayed a highly similar 
localization pattern (Fig. S3A) and good genome-wide correlation (Fig. S3B; r = 0.71–
0.86), despite numerous technical differences between the two experiments (N-versus  
 
 
 
 
Figure 1: PfH3.3-Ty1 ChIP-seq profiles from different stages of intraerythrocytic development. 
ChIP-seq ratio tracks displaying relative enrichment of the endogenous PfH3.3-Ty1 compared to 
H3core (antibody capturing histone PfH3 and PfH3.3) over entire chromosome 1 (upper panel) or 
two smaller sections of it (lower panels). Red arrows indicate the directionality of the respective 
gene (“annot.”). Stages: ER: early rings (10 hpi), LR: late rings (20 hpi), T: trophozoites (30 hpi), S: 
schizonts (40 hpi). Heterochromatic regions are defined based on HP1 occupancy in an earlier 
study [43]. 
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C-terminal tagging, cross-linked versus native ChIP, different parasite lines, different 
library preparation methods) (Fig. S3). Hence, our ChIP-seq analysis provides a robust 
measure of PfH3.3 localization, which we analyzed in detail using the data from the 
endogenously tagged line.  
PfH3.3 is mainly enriched in euchromatic coding sequences and is generally absent in 
the heterochromatic domain with the exception of its enrichment over GC-rich 
subtelomeric repetitive sequences (Fig. 1). In these regions the occupancy of PfH3.3 is 
largely invariable through the intraerythrocytic stages. Additionally, PfH3.3 occupancy 
shows dynamic changes in euchromatic intergenic regions (Fig. 1). Centromeres are 
depleted of PfH3.3 and PfH3 (Fig. S4), as they are occupied by the third H3 
variant, PfCenH3 [13]. 
 
PfH3.3 is demarcating the P. falciparum genome and exogenous DNA sequences in a GC-
content coupled manner 
Visual inspection of the genome-wide PfH3.3 profiles led to the observation that PfH3.3 
is mainly incorporated into GC-rich sequences (Fig. 1), including euchromatic coding 
sequences with an average GC-content of ~22% and the subtelomeric repetitive 
sequences with an GC-content ~32%. While at these GC-rich regions PfH3.3 occupancy 
is invariable across the stages, AT-rich intergenic regions (average 14% GC) are only 
temporarily marked or completely depleted of PfH3.3 (Fig. 1). To further investigate the 
correlation between GC-content and PfH3.3 occupancy on a genome-wide level, we in 
silico subdivided the genome into 150 bp windows and calculated the GC percentage 
and PfH3.3 coverage for each window. In line with our visual observation, GC-poor 
intergenic regions show the lowest PfH3.3 coverage; whereas in euchromatic coding 
sequences PfH3.3 levels exhibited clear correlation with the GC-content (Fig. 2A and Fig. 
S5A for data from all four stages). 
 
 
 
Figure 2: PfH3.3 localizes to GC-rich regions within the P. falciparum genome and exogenous 
DNA. 
(A) Density plots depicting PfH3.3 levels in relation to GC-content. PfH3.3 levels and GC-content 
were calculated genome-wide per 150 bp windows. Data depicted are generated from schizont 
stages. IG: intergenic region, CS: coding sequence, Sub. Rep.: subtelomeric repetitive region. 
Pearson correlation values are displayed at the lower right corner of the graphs. (B) Screen shot 
from PfH3.3 ChIP-seq ratio tracks encompassing the integrated pHH1-PfH3.3-Ty1 plasmid 
sequence (left) and the sequence of two nearby genes (right). Grey blocks indicate non-unique 
P. falciparum sequences within the pHH1-PfH3.3-Ty1 plasmid, which were excluded from the 
analysis in (C). (C) Scatter plot of GC percentage and PfH3.3 occupancy over unique 75 bp windows 
of the integrated pHH1-PfH3.3-Ty1 plasmid. Stages: ER: early rings (10 hpi); LR: late rings (20 hpi), 
T: trophozoites (30 hpi), S: schizonts (40 hpi). Pearson correlation values are displayed at the lower 
right corner of the graphs.  
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Figure 3: PfH3.3 dynamically occupies intergenic regions predominantly during trophozoite 
stage. 
Heatmap represents relative mRNA abundance of 3800 genes (heterochromatic and genes with 
low mRNA abundance have been excluded) and relative PfH3.3 occupancy in upstream, coding 
and downstream region throughout intraerythrocytic development. Color-scale depicts the 
relative mRNA abundance in relation to the sum of the RPKM values in all four stages or the 
relative PfH3.3 occupancy in proportion to the sum of occupancy values in all four stages (green 
– low, red – high). 8 groups of co-expressed genes were identified using k-means clustering. The 
percentage of genes belonging to each cluster is displayed next to the heatmap. Stages: ER: early 
rings (10 hpi), LR: late rings (20 hpi), T: trophozoites (30 hpi), S: schizonts (40 hpi). 
 
Importantly, similar correlation was also observed in the ChIP-seq data obtained from 
the episomally tagged line (Fig. S5B). Subtelomeric GC-rich repetitive sequences display 
the highest PfH3.3 levels. Thus, our genome-wide computational analysis is consistent 
with the initial observation. 
Additionally, we tested whether PfH3.3 is also incorporated into an exogenous DNA in a 
GC-dependent manner. Therefore, the non-P. falciparum-specific sequences within the 
integrated pHH1-Ty1-PfH3.3 plasmid were examined for their GC-content and PfH3.3 
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occupancy. Also, here a clear correlation of incorporated PfH3.3 and GC-content can be 
observed (Fig. 2B, C). As these exogenous sequences are unlikely to contain sequence-
element for recruitment or detainment of PfH3.3 or its chaperone, these findings 
support a base-content-driven genome marking by PfH3.3. 
 
PfH3.3 dynamically occupies intergenic regions predominantly during trophozoite 
development 
The dynamic occupancy of H3.3 in some intergenic regions prompted us to test whether 
correlation exists between temporal gene activity and the dynamics of PfH3.3 occupancy. 
Genes were clustered according to their relative mRNA abundance (matching RNA-seq data) 
during the intraerythrocytic cycle and matched with the respective PfH3.3 occupancy values 
(in proportion of the sum of the occupancy values) for upstream regions, coding sequences 
and downstream regions (Fig. 3). Whereas PfH3.3 coverage in coding sequences showed no 
obvious stage-dependent or transcription-coupled dynamics, mainly upstream regions but 
to some extent also downstream regions showed dynamic PfH3.3 enrichment during the 
intraerythrocytic cycle. Interestingly, most intergenic regions have the highest 
relative PfH3.3 occupancy during the trophozoite stage largely independent of their 
transcriptional dynamics. 
To investigate PfH3.3 enrichment in relation to gene expression level, we plotted the 
mRNA abundance (RPKM values) for each gene against PfH3.3 occupancy in coding, 
upstream or downstream regions for each stage separately (Fig. S6). This analysis also 
did not reveal clear correlations between transcription and PfH3.3 occupancy. Only in 5′ 
intergenic regions and in particular at the trophozoite stage were moderate correlations 
observed. 
In summary, PfH3.3 is temporarily enriched in AT-rich, 5′ intergenic regions mainly at the 
trophozoite stage. While this enrichment is somewhat more apparent for very highly 
expressed genes, and least apparent for (nearly) silent genes (Fig. S6), it does not exhibit 
clear correlation to gene expression dynamics (Fig. 3). 
 
PfH3.3 marks the promoter of the active and poised var gene 
Persistence of P. falciparum within the human bloodstream primarily depends on 
the var multigene family, encoding for a highly variable cytoadherence protein called 
P. falciparum erythrocyte membrane protein 1 (PfEMP1) [52-55]. Only one of the 
~60 var gene family members is expressed in any given parasite while other family 
members remain transcriptionally silenced. Importantly, var genes are expressed in a 
clonally variant fashion [56] as the same var gene is reactivated over several generation 
by a yet elusive mechanism of epigenetic memory [57, 58]. 
In order to investigate the role of PfH3.3 in var gene regulation, we specifically looked 
at the var2CSA locus of CSA-selected (10, 20, 30, 40 hpi) (Fig. S7A) and non-selected (mix 
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of trophozoites and schizonts) parasites. Interestingly, PfH3.3 is enriched in the 
promoter as well as in the coding region of the active as well as poised var2CSA gene 
(Fig. 4A) (Note that the var gene is only transcribed during rings stages while at 
trophozoites and schizonts stages it is poised, yet marked for reactivation in the next 
generation). The var2CSA gene in non-CSA selected parasites, however, is clearly less 
enriched in PfH3.3 and only shows PfH3.3 coverage at the var2CSA intron and the 
second exon (regions which are known to be transcribed from the var intronic promoter 
[55, 59-63]) (Fig. 4A). To ensure that this observation was not an artefact due to the 
comparison of two independently generated data sets (as the CSA-selected and non-
selected parasites originate from independent experiments) we performed a ChIP-qPCR 
experiment that enabled us to directly compare the var2CSA locus of CSA-selected and 
non-selected parasites. First, a culture of endogenously PfH3.3-Ty1 expressing NF54-DCJ 
P. falciparum parasites was selected for var2CSA expression via chondroitin sulfate 
affinity purification (var2CSA positive line). Subsequently, half of the culture was treated 
with blasticidin (2.5 mM), which forced a switch to another var promoter 
(PF3D7_0223500) driving expression of the BSD resistance cassette [51]. Successful 
selection for parasites expressing var2CSA or PF3D7_0223500 was confirmed by RT-qPCR 
(Fig. S7). Subsequently, ChIP-qPCR was performed for the active histone modification 
H3K9ac, the inactive histone modification H3K9me3, the histone variant PfH2A.Z and 
for PfH3.3 for three different time points (15, 25 and 40 hpi). The switch from var2CSA 
expression to PF3D7_0223500 was confirmed at the epigenetic level: CSA-selected 
parasites showed high H3K9ac recoveries for the whole promoter region of the 
var2CSA gene and low H3K9me3 recoveries for the promoter as well as coding sequences 
(Fig. 4B). BSD-selected parasites, however, showed the opposite pattern (Fig. 4B). As also 
reported earlier, only the CSA-selected parasite line showed high occupancy of PfH2A.Z 
close to the promoter start site 1500 bp upstream of the ATG [49]. Incorporation 
of PfH3.3 into the promoter region of the var2CSA gene was clearly increased when the 
gene was active compared to its silenced state validating the observation made based 
on the ChIP-seq data. In summary, PfH3.3 stably occupies the promoter region and 
coding sequence of the active var gene but is evidently less incorporated into the 
promoter and coding sequence of silenced var genes. 
 
 
 
Figure 4: PfH3.3 marks the promoter of the active and poised, but not the inactive var gene. 
(A) RNA-seq and ChIP-seq ratio tracks displaying PfH3.3 enrichment over H3core over the var2CSA 
locus. Data was obtained from var2CSA-selected parasites at four intraerythrocytic stages (ER, LR, 
T, S) as well as from unselected mixed stage parasites (mainly containing trophozoites and 
schizonts, T/S). Arrows indicate the approximate position of primers used in (B). (B) Bar graphs 
displaying ChIP-qPCR data for H3K9ac (euchromatic mark) and H3K9me3 (heterochromatic mark) 
marking as well as PfH3.3 and PfH2A.Z occupancy over the var2CSA locus in CSA-selected (red) or 
- BSD-selected (grey) parasites. After affinity-based selection for var2CSA-expressing parasites  
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half of the parasite population was forced to express PF3D7_0223500 by blasticidin treatment 
(NF54-DCJ strain: first exon of PF3D7_0223500 is replaced by a blasticidin resistance cassette). 
Numbers indicate the position of the forward primer relative to the ATG. Stages (R: rings (15 hpi); 
T: trophozoites (25 hpi); S: schizonts (40 hpi)) are depicted by different shades. 
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Discussion 
Here we present the first genome-wide analysis of histone variant H3.3 in the 
apicomplexan parasite, P. falciparum. Interestingly, PfH3.3 has a distinct localization 
compared to other variants. While PfH2A.Z and PfH2B.Z [48] as well as PfCenH3 [13] 
appear to occupy AT-rich sequences, PfH3.3 is most commonly found in GC-rich coding 
sequences and the subtelomeric repetitive regions (Fig. 1) and only temporarily occupies 
AT-richer intergenic regions (Fig. 3). In many animals, H3.3 is also found in coding 
regions, where it is incorporated during transcriptional elongation [24, 25]. In 
P. falciparum, however, we could not observe a clear correlation between PfH3.3 
occupancy in euchromatic coding sequences and the steady-state mRNA level of the 
corresponding genes (Fig. 3, Fig. S6). Instead we find that most coding sequences are 
constantly marked by PfH3.3 throughout the intraerythrocytic cycle and we observed a 
positive correlation between PfH3.3 occupancy and the GC-content of the underlying 
DNA (Fig. 2A). This correlation is even more striking over exogenous DNA sequences that 
do not contain any P. falciparum “compatible” gene regulatory elements (Fig. 2B/C). 
Furthermore, although transcriptionally silent heterochromatic regions appear to have 
a generally lower PfH3.3 occupancy, GC-richer coding sequences are yet more likely to 
contain some PfH3.3 (Fig. 2A). These observations together suggest that PfH3.3 
incorporation to coding regions does not (necessarily) require transcriptional activity 
and PfH3.3 occupancy is rather influenced by the GC-content of DNA sequence. 
Next to constant occupancy of PfH3.3 at euchromatic intergenic regions we observe 
clear PfH3.3 marking at subtelomeric repeat sequences. In mammals, PfH3.3 is also 
deposited at repressive chromatin regions and in mouse embryonic cells additionally at 
the telomeres [26, 28, 31, 64], suggesting that PfH3.3 might serve a conserved telomere 
associated function. However, unlike in mouse embryonic stem cells [31, 64], PfH3.3 
occupancy seems to be uncoupled from K9me3 marking. In fact, PfH3.3 appears to be 
specifically depleted from most heterochromatic regions - marked by K9me3 and HP1 in 
P. falciparum - except for the subtelomeric repetitive regions (Figs 1 and 2). Notably, 
these latter regions have the highest density of G quadruplex motifs in P. falciparum 
genome [65]. Since, earlier work in mouse established a potential link between G 
quadruplex sequences and H3.3 occupancy at the telomeres [66], it is conceivable that 
a similar link might underlie the subtelomeric H3.3 localization in P. falciparum. 
However, it is even more straightforward to think these regions have high PfH3.3 
occupancy simply because they have a distinctly higher GC content (Fig. 2A), providing 
further support for the above model. 
In addition to the GC-based correlation of Pf H3.3 localization to coding and 
subtelomeric sequences, we observe dynamic incorporation of PfH3.3 into AT-rich 
intergenic regions, almost exclusively at the trophozoite stages. This stage is peculiar in 
two ways: i) this is the stage when extensive replication of the parasites genome begins; 
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ii) this is the transcriptionally most active stage. Notably, in contrast to many other 
eukaryotic cells, cell division during the intraerythrocytic cycle of P. falciparum does not 
only double the DNA content, but rather results in 8 to 32 genome copies. Given that an 
enormous amount of histones needed to support the synthesis of the new chromatin it 
is conceivable that both H3 variants (PfH3 and PfH3.3) need to be incorporated during 
replication to the newly synthetized chromatin, after which PfH3.3 might be 
preferentially retained at GC-rich sequences. A similar phenomenon is observed in 
mouse spermatocytes, when almost all histones are replaced by protamine to form a 
highly compact paternal chromatin, nucleosomes that are retained at unmethylated 
CpG-rich sequences, primarily contain H3.3 [67]. Alternatively, the stage-specific 
incorporation of PfH3.3 to promoter regions could be explained by temporal 
transcriptional activity, typical to intraerythrocytic stages of malaria parasites (Fig. 3). In 
fact, in many other organisms H2A.Z and H3.3 containing nucleosomes are located 
around the transcriptional start site (for review see ref. [68]). However, while our 
analysis revealed a moderate correlation between mRNA abundance and PfH3.3 
enrichment in promoter regions in particular at the trophozoite stage (Fig. S6) PfH3.3 
occupancy profiles in promoter regions are largely uncoupled from the dynamics of their 
transcriptional activity (Fig. 3). Accordingly, while we cannot completely exclude the 
possibility that PfH3.3 is incorporated to some promoter regions in a transcription 
coupled manner, the extensive incorporation of PfH3.3 to intergenic regions at the 
trophozoite stage is perhaps better explained by the replicative activity of this stage. 
In mammalian cells, the different distribution patterns of H3.3 compared to H3 is 
achieved by histone- and site-specific chaperones. While H3.3 is deposited at 
euchromatic regions by the chaperone Histone regulator A (HIRA) replication-
independently [20, 69], the death-associated protein (DAXX) together with the α-
thalassemia and/or mental retardation X-linked syndrome protein (ATRX) mediates H3.3 
deposition in pericentric heterochromatin and telomeric regions [26, 27]. H3 deposition, 
however, is mediated by the chaperone CAF-1 replication-dependently [20]. Recognition 
of H3 and H3.3 by these chaperons is mediated by amino acid residues at positions such 
as 87 and 90 [18, 19, 70], which also differ in PfH3 and PfH3.3 [18, 19, 42, 50, 70] and 
might support differential recognition by different chaperon proteins. Thus far, however, 
only one P. falciparum protein with weak homology to both CAF1 and HIRA has been 
identified (PF3D7_0501800). Therefore, additional experiments will have to be 
performed to determine whether this protein supports the incorporation of both PfH3 
and PfH3.3 during replication or yet unidentified PfH3/PfH3.3-specific chaperons exist 
that ensure differential genomic incorporation of PfH3 and PfH3.3. 
Of particular interest is the specific PfH3.3 incorporation to the promoter region of the 
active, but not inactive var gene (Fig. 4). This is similar to the earlier reported specific 
incorporation of the PfH2A.Z/PfH2B.Z double-variant nucleosomes around the 
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transcription start site of the active var gene during the ring stage, when this gene is 
being actively transcribed [49]. Furthermore, the active var promoter is marked by two 
active marks (H3K9ac and H3K4me3), while the poised var gene carries H3K9ac and 
H3K4me2 [58, 71, 72]. Interestingly, unlike PfH2A.Z/PfH2B.Z, PfH3.3 is retained at this 
AT-rich var promoter even after active transcription has ceased (so called poised state). 
This raises the exciting possibility that PfH3.3 may contribute to the epigenetic memory 
of var gene expression [57, 58], and enables the parasites to express the same var gene 
over several generations. In line with such hypothesis, nuclear transplantation 
experiments in Xenopus laevisshowed that H3.3 mediates the epigenetic memory of 
certain genes; and H3.3 overexpression in nuclear transplant embryos even enhances 
this effect [73-75]. Furthermore, H3.3 enrichment at promoters has also been observed 
for inactive genes, which are potentially in a poised state [25, 76, 77] as we observe it 
for the poised var2CSA gene during the second half of the intraerythrocytic cycle. All in 
all, these observations made in other organisms support the idea of a potential role 
of PfH3.3 in epigenetic memory in P. falciparum. In order to investigate the functional 
relevance of PfH3.3 in parasite biology in general or in vargene regulation in particular, 
we made several attempts to tag PfH3.3 with a AID-GFP-glmS [78, 79] or GFP-glmS 
[79] tag. Unfortunately, these attempts failed to result in viable parasite lines using 
these rather bulky conditional knock-down tags, hinting towards an essential function 
of PfH3.3. Accordingly, whether PfH3.3 is critical for “epigenetic memory” of var gene 
expression and how it could excerpt such function will be the subject of future studies. 
In summary, we show that PfH3.3 has a complex localization pattern that consists of 
conserved, but also parasite-specific features. It demarcates euchromatic coding and 
subtelomeric repetitive sequences in a GC-content coupled manner. Within the coding 
sequences it might promote the process of transcription by forming labile nucleosomes, 
as has been reported for other organisms. The strong marking of subtelomeric repetitive 
sequences resembles findings from higher eukaryotes, which could elude to a conserved, 
yet uncharacterized function. Excitingly, PfH3.3 specifically marks the promoter region 
of the var gene in its active and poised, but not inactive state and could contribute to 
the process of antigenic variation which is critical to immune evasion of this deadly 
pathogen. 
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Methods 
Generation of Ty1-tagged PfH3.3 parasites 
In order to profile PfH3.3, 3D7 P. falciparum parasites were transfected with a pARL-1a- plasmid 
[80] encoding a N-terminally Ty1-tagged version of PfH3.3 (PF3D7_0617900) under the control of 
the chloroquine resistance transporter promoter (similar to pARL-1a-Ty1-H2A in ref. [47]) and 
cultured in presence of 40 nM WR99210. To generate PfH3.3 profiles from endogenously 
expressed PfH3.3, NF54-DCJ P. falciparum parasites [51] were transfected with a pHH1-plasmid 
[81] encoding a C-terminally Ty1-tagged version of PfH3.3 (PF3D7_0617900) and a CTG instead of 
an ATG as “start codon” (Fig. S1A). Parasites were cultured in presence of 2.5 nM WR99210. Single 
crossover integration of the plasmid resulted in parasites that express a fully functional PfH3.3-
Ty1 under the endogenous promoter (ATG as start codon) and a non-functional untagged PfH3.3 
(CTG as start codon) (Fig. S1B). A clonal parasite line was obtained by limiting dilution. Correct 
integration of the pHH1-plasmid and absence of wild type parasites was confirmed by performing 
Southern Blot analysis (Fig. S1B, C). Expression of episomal and endogenously-expressed 
tagged PfH3.3 was confirmed using the monoclonal anti-Ty1 antibody (BB2) [82] that exclusively 
recognizes the tagged PfH3.3 protein on Western blot (Fig. S1D). 
 
Parasite culture and collection of parasites 
Parasites were cultured in standard RPMI medium supplemented with 10% human serum (AB), 
0.2% NaHCO3 and 2.5% human O+ red blood cells. Culturing occurred in 250 ml tissue culture flasks 
placed in candle jars or in an incubator with a gas composition of 3% O2, 4% CO2 and 93% N2 and 
incubated at 37 °C. Parasites were synchronized with sorbitol treatments and Percoll gradient 
centrifugations as described previously [47]. During collections, medium was changed every 
10 hours, but not less than 10 hours before collection to ensure optimal parasite growth. After 
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20 hours post invasion (hpi), medium volume was doubled. During each medium change parasite 
cultures were mixed to minimize growth differences within single culture flasks. For the 
generation of genome-wide PfH3.3 profiles early ring (10 hpi), late ring (20 hpi), trophozoite 
(30 hpi) and schizont stages (40 hpi) were collected. For the ChIP-qPCR investigation 
of PfH3.3 var2CSA- or PF3D7_0223500-selected parasites, ring, trophozoite and schizont stages 
were collected at 15, 25 and 40 hpi. Parasite cultures used for RNA extraction or native ChIP were 
immediately placed and processed on ice (4 °C). Parasite cultures used for cross-linked ChIP were 
immediately treated with 1% formaldehyde (final concentration) and incubated at 37 °C for 10 min 
while shaking. Cross-linking reaction was quenched by adding 0.125 M glycine (final 
concentration). All subsequent steps were performed at 4 °C unless noted otherwise. To remove 
contaminating human white blood cells that would cause considerable background upon 
sequencing, all blood used for collection of sequence samples was filtered through Plasmodipure 
filters (EuroProxima). Ethic statement: Blood and serum was obtained from the local blood bank 
(Sanquin) with the full consent of healthy donors to use this material for malaria research. 
 
var2CSA (PF3D7_1200600) and PF3D7_0223500 selection 
Endogenously PfH3.3-Ty1 expressing NF54-DCJ P. falciparum parasites were selected for var2CSA 
expression by affinity purification as in ref. [83]. For this purpose, petri dishes (150 × 15 mm, BD 
biosciences Falcon 351058) were coated with Chondroitin Sulfate A (0.05% CSA in PBS) overnight 
and subsequently blocked with 1% Casein/PBS solution for at least one hour and rinsed with RPMI 
twice. In the meanwhile, parasite cultures were centrifuged, resuspended in RPMI containing 10% 
human serum and transferred to the petri dishes. Subsequently, petri dishes containing the 
parasite culture were incubated for 30 min at 37 °C in a candle jar. Afterwards, unbound parasites 
and non-infected erythrocytes were removed by gentle RPMI washes. Bound parasites were 
extensively resuspended in complete medium, fresh blood was added, and parasites were 
cultured as described above. var2CSA panning was repeated several times to achieve an 
increasing proportion of var2CSA-expressing parasites. Subsequent switching to PF3D7_0223500 
expression, was enforced by culturing the parasites with 2.5 mM Blasticidin [51]. 
Successful var gene selection was confirmed via RNA extraction (RNeasy mini kit, Qiagen) followed 
by cDNA synthesis and subsequent quantitative real time PCR (qPCR) using vargene specific 
primers [71, 84] (Fig. S7A, B). 
 
cDNA synthesis and qPCR 
To synthesize the cDNA 0.5–5 ug of total RNA were mixed with random hexamer primers (0.5 ug, 
Roche), OligodT12-18 (0.5 ug, Invitrogen) and dNTPs (0.5 mM in the final volume of 20 ul, 
Invitrogen) and incubated for 5 min at 70 °C. Then first strand synthesis was performed for 1 hour 
at 42 °C in First Strand Buffer supplemented with DTT (10 mM), Superscript III (200 units) and 
RNasin Plus RNase inhibitor (40 units, Promega), after which superscript III was inactivated by 
incubation at 70 °C for 15 minutes. RT “minus” reactions (where Superscript III was replaced by 
water) were performed in all cases as negative control. Subsequent qPCR was performed using 
the CFX96 Real Time Systems C1000 Touch Thermal Cycler. P. falciparum genomic DNA served as 
standard (500 pg, 50 pg, 5 pg). SYBRgreen supermix (BioRad) and primers were mixed according 
to manufacturer’s instructions. qPCR was performed in 96 well plate format (BioRad) using the 
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following protocol: 95 °C for 3 min, (94 °C for 10 sec, 52 °C for 30 sec, 68 °C for 30 sec) 39x, 95 °C 
1 min, 65 °C 1 min and a gradient from 65 °C to 94.5 °C with a 0.5 °C increase every 10 sec. 
 
Western Blot analysis 
Nuclear extracts from the 3D7 mother line (~40 ug), the 3D7 parasites expressing Ty1-PfH3.3 
episomally (~60 ug) and the NF54-DCJ parasites expressing PfH3.3-Ty1 under the endogenous 
promoter respectively, were separated on 18% SDS-PAGE and transferred to a protean 
nitrocellulose membrane (Whatman, 0.45 mm). The membrane was probed with mouse anti-Ty1 
antibody (1:2000, BB2 antibody in ref. [82]) and rabbit anti-histone H3 antibody (1:3000, Abcam 
ab1791) and secondary goat anti-mouse IRDye680 (1:10000, LI-COR Biosciences 926-32220) and 
goat anti-rabbit IRDye 800CW (1:10000, LI-COR 926-32211). Fluorescence was measured on the 
Odyssey system (LI-COR Biosciences). 
 
Southern Blot analysis 
Genomic DNA was isolated from native nuclei using phenol-chloroform extraction as described 
previously [47]. 2.5 μg of genomic DNA and 0.5 ng of plasmid DNA were digested with EcoRI and 
XbaI (NEB) (Fig. S1B). A PfH3.3 sequence specific hybridization probe was generated by PCR 
labelling using Digoxigenin-11-dUTP (DIG) (alkali-labile, Roche) according to manufacturer’s 
instructions. The PCR reaction was performed using the Advantage® cDNA PCR Kit and Polymerase 
Mix (Clonetech) and a DIG-dUTP to dTTP ratio of 1:3 under the following PCR conditions: 5 min 
95 °C; 30 s 95 °C, 30 s 52 °C, 90 s 68 °C (35 cycles); 5 min 68 °C (Fig. S1B). Gel preparation, 
subsequent DNA transfer to a positively charged Nylon membrane (Hybond-N+, GE Healthcare 
Amersham), prehybridization (DIG Easy Hyb Kit from Roche, 65 °C) and probe-DNA hybridization 
(DIG Easy Hyb Kit from Roche, 65 °C) were all performed according to manufacturer’s 
recommendations. The detection of the hybridized probe was performed using the DIG Wash and 
Block Buffer Set, the anti-Digoxigenin antibody (anti-Digoxigenin-AB conjugate Fab frag; 1:10 000 
dilution) and the CDP-Star Kit (ready-to-use) from Roche according to manufacturer’s instructions. 
 
Chromatin immunoprecipitation 
After erythrocyte and parasite lysis using 0.05% saponin and a hypotonic buffer (10 mM Tris pH 
8.0, 3 mM MgCl2, 0.2% NP-40, Roche Protease Inhibitor Cocktail) respectively, native nuclei (ChIP-
seq of episomal Ty1-PfH3.3 and var gene switch experiment, see below) or formaldehyde-cross-
linked nuclei (ChIP-seq experiment) were separated from cell debris using a 0.25 M sucrose buffer 
cushion as described before [47]. Subsequent, cross-linked chromatin was prepared as described 
in ref. [85] with a few adjustments. In short, for generation of genome-wide PfH3.3 profiles, 
enzymatic MNase digestion of cross-linked chromatin was performed using digestion buffer 
(50 mM Tris pH7.4, 4 mM MgCl2, 1 mM CaCl2, 0.075% NP40, Roche Protease Inhibitor Cocktail) 
with 0.5 U MNase (Worthington Biochemicals Corporation) in 150 μl aliquots for 6 min (10 hpi), 
12 min (20 hpi) or 13 min (30 hpi & 40 hpi) at 37 °C. Optimal digestion times were empirically 
determined for each stage by test-digestion of a nuclear aliquot for varying times, to obtain 
primarily mono-nucleosomal DNA fragments. Digestion reactions were stopped by adding 150 μl 
quenching solution (2% Triton X100, 0.6% SDS, 300 mM NaCl, 6 mM EDTA, Roche Protease 
Inhibitor Cocktail) and placing the samples on ice. Subsequently, digested chromatin was 
Chapter 3
 
 
68 
sonicated for 6 × 10 sec (setting low, BioruptorTM Next Gen, Diagenode) to free cross-linked 
chromatin from nuclear membranes. Approximately 200 ng of digested DNA-containing cross-
linked chromatin was incubated in ChIP buffer (150 mM NaCl, 20 mM Tris pH 8.0, 2 mM EDTA, 1% 
Triton X-100, 0.15% SDS, Roche Protease Inhibitor Cocktail) with 2 μg of anti-Ty1, 1 ug of anti-
histone H3 (recognizes PfH3 and PfH3.3, Abcam Ab1791) or 1 μg polyclonal anti-IgG (Upstate 12-
370) overnight at 4 °C while rotating, followed by the addition of 10 μl ProtA and 10 ul ProtG 
dynabeads (Life Technologies, 10008D and 10009D) and further incubation at 4 °C for 2 h. For the 
H3core antibody (capturing histone PfH3 and PfH3.3) one ChIP reaction was performed, 
for PfH3.3 (anti-Ty1) four ChIP reactions were performed in parallel per life cycle stage to ensure 
sufficient amount of DNA for subsequent ChIP-seq. After washing with three different buffers 
(buffer1, 1x: 20 mM Tris pH 8.0, 2 mM EDTA, 1% Triton-X100, 0.1% SDS, 150 mM NaCl; buffer 2, 
2x: 20 mM Tris pH 8.0, 2 mM EDTA, 1% Triton-X100, 0.1% SDS, 500 mM NaCl and buffer 3, 2x: 
10 mM Tris pH 8.0, 1 mM EDTA) immunoprecipitated chromatin was eluted using 1% SDS and 
0.1 M NaHCO3. Immunoprecipitated chromatin was decross-linked (1% SDS, 0.1 M NaHCO3, 1 M 
NaCl) overnight at 45 °C shaking, followed by DNA isolation via QIAquick column purification 
(Qiagen). 
To investigate PfH3.3 and PfH2A.Z occupancy as well as H3K9ac and H3K9me3 marking of 
the var2CSA locus of var2CSA- or PF3D7_0223500-selected parasites, chromatin was extracted 
and native ChIPs were performed as described previously [47]. Native chromatin was digested 
with 0.5 U MNase in 150 μl aliquots for 4 min (15 hpi var2CSA-selected parasites), 7 min (15 hpi, 
25 hpi, 40 hpi PF3D7_0223500-selected parasites and 25 hpi var2CSA-selected parasites) and 
10 min (40 hpi Var2CSA-selected parasites) at 37 °C in a waterbath and regular tapping of the 
tubes (again optimal digestion times to primarily mono- nucleosomal fragments were determined 
empirically by a test-digestion of a nuclear-aliquot from each sample). Subsequent chromatin 
extraction was performed in low-salt buffer (buffer1: 50 mM Tris pH 7.4, 4 mM MgCl2, 1 mM CaCl2, 
Roche Protease Inhibitor Cocktail; buffer2: 10 mM Tris pH 7.4, 1 mM EDTA, Roche Protease 
Inhibitor Cocktail; buffer3: 1 mM Tris pH 7.4, 0.2 mM EDTA, Roche Protease Inhibitor Cocktail) and 
incubated with 1 volume ChIP incubation buffer (100 mM NaCl, 19.7 mM Tris pH 7.4, 6.25 mM 
EDTA, 1% Triton X-100, 0.1% SDS). For native ChIP reactions, native chromatin (containing about 
200 ng DNA) from each time point of var2CSA- and PF3D7_0223500-selected parasites was 
incubated with 2 μg of anti-Ty1 (PfH3.3), 0.5 μl polyclonal H2A.Z [47], 1 μg of polyclonal anti-
H3K9/14ac antibody (Diagenode, C15410200), 1 μg of polyclonal H3K9me3 (in house, corresponds 
to Merck Millipore 07-442) or 1 μg polyclonal IgG (Upstate 12-370) overnight at 4 °C followed by 
the addition of 20 μl ProtA/G dynabeads and further incubation at 4 °C for 2 h. 200 ng of native 
chromatin were kept as input. After washing with buffers three different buffers (buffer 1, 1x: 
50 mM Tris pH 7.5, 10 mM EDTA, 100 mM NaCl, 0.5% Triton X-100, 0.05% SDS; buffer 2, 2x: 50 mM 
Tris pH 7.5, 10 mM EDTA, 150 mM NaCl, 0.5% Triton X-100, 0.05% SDS and buffer 3, 2x: 50 mM 
Tris pH 7.5; 10 mM EDTA, 250 mM NaCl) immunoprecipitated DNA was eluted and purified using 
PCR purification columns. 
 
ChIP-qPCR 
To test relative enrichment of PfH3.3-Ty1, H2A.Z, H3K9ac and H3K9me3 xlChIP was performed as 
described above. qPCR (Bio-Rad MyIQ) on each ChIP sample was performed alongside with a 1:10 
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dilution series of the corresponding input DNA to calculate recovery as a percentage of input. 
Recovery values for the var2CSA locus where normalized across the different samples using primer 
sets for regions that are invariably marked with the histone mark/variant. For H3K9ac, PfH2A.Z 
and PfH3.3 primers for actin (PF3D7_1246200, coding sequence and -1100bp promoter region) 
and seryl-tRNA synthetase (PF3D7_0717700, coding sequence), HSP70 (PF3D7_0818900, coding 
sequence and -1000 promoter regions) and 18s RNA (PF3D7_1148600, coding sequence) were 
chosen. For H3K9me3 primers for bp the telomere repetitive regions, a rifin (PF3D7_0324500, - 
400bp promoter regions) and AP2G (PF3D7_1222600, coding sequence). Normalization factor was 
calculated by dividing the average of the recoveries from the control primers within each sample 
with the average of the average recovery values across the samples. Finally, all recovery values 
from the var2CSA specific primers have been multiplied by the normalization factors. The 
normalization factor scaled between 0.75 and 1.8. 
 
ChIP-seq library preparation 
For each sequencing library generated from endogenously PfH3.3-Ty1 expressing NF54-
DCJ P. falciparum parasites 3 ng of ChIP DNA were end repaired, extended with 3′ A-overhangs, 
and ligated to barcoded NextFlex adapters (Bio Scientific) [86]. Subsequent library amplification 
was performed under similar conditions as described previously [85] with a few adjustments: First, 
2x KAPA HiFi HotStart ready-mix (KAPA Biosystems) and NextFlex primers were used for 4 cycles 
of PCR amplification (98 °C for 2 min; 4 cycles of 98 °C for 20 sec, 62 °C for 3 min; 62 °C for 5 min). 
Subsequently, amplified libraries were size selected for 270 bp (mono-nucleosomes + ~125 bp 
NextFlex adapter) using 2% E-Gel Size Select Agarose Gels (Thermo Fisher Scientific) and again 
amplified as described above for 9 cycles. To deplete adapter dimers and clean-up the DNA, 
libraries were subsequently purified with Agencourt AMPure XP bead (Beckman Coulter) (1:1 
library beads ratio) before sequencing. Sequencing libraries generated from episomally Ty1-
PfH3.3-expressing parasites were generated as described in refs [47, 86]. 
 
RNA-seq library preparation 
The preparation of strand-specific RNA-seq libraries was performed as in ref. [85]. In short, after 
total RNA isolation (with on-column DNase treatment) and oligo-dT-selection [87] PolyA-selected 
RNA was further treated with DNase (TURBO DNase, Ambion) to remove remaining genomic DNA. 
Subsequently, 1.2 μg PolyA-selected total RNA equivalent (see ref. [87] for details) for 10 hpi and 
2 μg for 20 hpi, 30 hpi and 40 hpi were fragmented by means of alkaline hydrolysis (5x 
fragmentation buffer: 200 mM Tris acetate pH 8.2, 500 mM potassium acetate, 150 mM 
magnesium acetate) for 2 min at 85 °C in 250 μl volume. RNA was precipitated overnight and 
checked for genomic DNA contamination using qPCR, followed by - if needed - another DNase 
treatment and RNA precipitation for clean-up. Remaining material was processed for strand-
specific RNA-seq as in ref. [85]. To prevent unwanted DNA-dependent second strand cDNA 
synthesis - a major source of artificial antisense ‘transcripts’ [88] −0.2 μg Actinomycin D was 
included into the first strand synthesis reaction, which was followed by a 15 min 70 °C enzyme 
deactivation step and QIAquick MinElute purification (Qiagen). During second strand synthesis 
replacement of dTTP with dUTPs resulted in incorporation of U-bases into the second cDNA 
strand. Subsequently, 2 ng double stranded cDNA were used for each sequencing library which 
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were prepared as described above with the exception that after adaptor ligation samples were 
treated with USER enzyme (New England Biolabs) for 15 min at 37 °C that resulted in dUTP-
dependent second strand-specific degradation, followed by a first amplification cycle (4 cycles), 
size-selection for 300–400 bp fragments, a second amplification cycle (9 cycles) and Ampure Beads 
purification (see above). 
 
High throughput sequencing 
ChIP-seq and strand-specific RNA-seq libraries generated from endogenously PfH3.3-Ty1 
expressing NF54-DCJ parasites were sequenced on a HiSeq 2000 system (Illumina) to obtain 
100 bp single-end reads (TruSeq SE Cluster Kit v2). ChIP-seq libraries generated from episomal 
Ty1-PfH3.3 expressing parasites were sequenced on a GAIIx system (Illumina) to obtain 75 bp 
single-end reads (Standard Cluster Generation KitV4). 100 bp and 75 bp reads respectively were 
mapped against the Plasmodium falciparum genome assembly (PlasmoDB v6.1) for ChIP samples 
or against the Plasmodium falciparum annotated transcripts (PlasmoDB v6.1) for mRNA samples 
using BWA [89]. Single-end ChIP and RNA reads were filtered to mapping quality ≥15 and only 
uniquely mapped reads (between 13.5 and 23.5 million reads for ChIP-seq and 15.2 and 26.8 
million reads for RNA-seq) were used for further analysis. 
 
High-throughput sequencing data analysis 
To visualize ChIP-seq and RNA-seq data in the UCSC browser, all libraries were normalized to the 
number of mapped reads per million (RPM). For log2 ratio tracks PfH3.3 values were divided 
through the respective PfH3core values and log2 was calculated (“unmappable” regions 
containing the value 0 were discarded). Bedgraph.gz files were generated using bedtools v2.20.1. 
Genome browser tracks were set to ‘mean’ as windowing function and ‘16’ as smoothing window 
function.  
To investigate the correlation of PfH3.3 with the GC-content of the Plasmodium 
falciparum genome the genome was binned into 150 bp windows and the GC-content as well 
as PfH3.3 and PfH3core tags were calculated in each window. PfH3.3 tags were divided 
through PfH3core tags (windows containing the value 0 were discarded), log2 transformed and 
plotted over the GC-content as a density plot using the python package seaborn 0.6.0 in ipython 
notebook (Enthought Canopy 1.5.5.3123). For more detailed analysis the 150 bp windows were 
intersected with different chromatin domains e.g. heterochromatic or euchromatic regions (at 
least 50% overlap) using bedtools v2.20.1 and depicted as described above. 
In order to investigate the correlation of PfH3.3 in upstream regions, downstream regions or 
coding sequences with mRNA abundance, the genome was subdivided as described [85]. In short, 
intergenic regions between convergent and divergent genes were split in half and each half was 
assigned to the nearest gene. Intergenic regions between genes with the same orientation were 
split in 3/4 and 1/4. The longer part was assigned to the upstream region of the nearest gene and 
the shorter part to the downstream region of the other gene. All upstream and downstream 
regions were shortened to a maximum of 3 kb as this covers the vast majority of upstream regions 
in full length but excludes some extremely long intergenic regions. PfH3.3 and PfH3core tags were 
calculated within each upstream region, downstream region and coding sequence, normalized to 
the amount of reads per kb per million mapped reads (RPKM) and PfH3.3/PfH3core ratios (PfH3.3 
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occupancy) were determined. To assess RNA abundance of each gene, RNA-seq data were mapped 
against the annotated P. falciparum transcriptome, tags were counted for each transcript 
(excluding tRNAs, rRNAs, mitchochondrial and apicoplast RNA) and RPKM values were calculated. 
To illustrate the dynamics of RNA expression during intraerythrocytic development, the relative 
RNA abundance was calculated by dividing the amount of tags per transcript of each 
intraerythrocytic stage through the sum of tags per transcript of all four investigated 
intraerythrocytic stages (Heterochromatic genes and 25% of euchromatic genes with the lowest 
expression has been excluded from this analysis). Subsequently, RNAs were clustered into eight 
groups according to their expression pattern throughout the intraerythrocytic cycle using k-means 
clustering (Multi Experiment Viewer 4.9.0). Clusters were visualized in a heatmap. After 
calculating the relative PfH3.3 occupancy in upstream regions for all four intraerythrocytic stages 
as described above, the profile of PfH3.3 occupancy in upstream regions was matched to the 
respective RNA expression profile. The same method was applied to coding sequences and 
downstream regions. 
To illustrate the relationship between PfH3.3 enrichment and gene expression level, RPKM values 
were log10 transformed and plotted against log2 transformed PfH3.3 occupancy levels of 
matching upstream region, downstream region and coding sequence. 
 
Data Availability 
ChIP-seq and RNA-seq datasets will be available via GEO (accession number GSE80466) and 
PlasmoDB. 
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Figure S1: Generation of endogenously tagged PfH3.3-Ty1 parasite line.  
(A) Map of the pHH1-PfH3.3-Ty1 integration vector. (B) Schematic representation of the fragments 
obtained from the i) integration vector ii) the wild type and iii) tagged PfH3.3 locus after EcoRI/XbaI 
digestion. Gel picture shows the successful DIG labelling of 349bp DNA probe corresponding to the 
coding sequence of PfH3.3. (C) Southern Blot confirming successful integration of PfH3.3-Ty1 into the 
parasite’s genome of two independent clones of the P. falciparum NF54- DCJ line. (D) Western Blot 
demonstrating the expression of Ty1-tagged PfH3.3 both from an episomal construct as well as from 
the endogenous locus. The blot was stained with Ty1-tag specific antibody (BB2, red) and H3core 
antibody (green). 
 
 
 
 
 
 
 
 
Figure S2: Wild type and endogenously tagged PfH3.3-Ty1 parasites show a similar RNA expression 
pattern.  
RPKM values were calculated for wild type 3D7 85 and endogenously tagged PfH3.3-Ty1 DCJ parasites 
for all transcripts excluding tRNAs, rRNAs, mitchochondrial and apicoplast RNA. Log10 transformed 
RPKM values are depicted for early rings, late rings, trophozoites and schizonts. Pearson correlation 
values are displayed at the lower right corner of the graphs. A red square represents PfH3.3.  
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Figure S3: Ratio tracks of PfH3.3-Ty1 ChIP-seq obtained from two different parasite lines at two 
stages of intraerythrocytic development.  
(A) ChIP-seq ratio tracks of trophozoite (T) and schizont (S) stages are depicted in purple and violet 
for two biological replicates of the episomally Ty1-PfH3.3 expressing 3D7 parasite line (N-terminally 
tagged PfH3.3, native ChIP, linear amplification protocol, normalized over input) and in orange for 
endogenously PfH3.3-Ty1 expressing NF54-DCJ parasites (C-terminally tagged PfH3.3, cross-linked 
ChIP, KAPA amplification protocol, normalized over H3core values). (B) Pearson correlation values 
calculated from log2 transformed PfH3.3/Input or PfH3.3/H3core values for all three ChIPs-seq data 
sets in two intraerythrocytic stages.  
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Figure S4: Centromere regions are PfH3.3 depleted and marked by PfCenH3. 
PfCenH3, but also PfH3.3-Ty1 and H3core ChIP-seq tracks were normalized over input since the 
H3core antibody only captures PfH3 and PfH3.3. PfCenH3 clearly marks centromeres (upper panel) 
whereas PfH3.3 (middle panel) but also PfH3 (lower panel) is depleted from these sites. Normalized 
ChIP-seq data are depicted from schizont stages (40hpi). Centromeres are indicated by black boxes.  
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Figure S5: PfH3.3 localizes to GC-rich regions within the P. falciparum genome throughout 
intraerythrocytic development.  
Density plots depicting PfH3.3 levels in relation to GC-content. PfH3.3 levels and GC-content were 
calculated genome-wide per 150 bp windows. (A) Data depicted are generated from endogenously 
tagged PfH3.3-Ty1 DCJ parasites for four different intraerythrocytic stages: Early rings (10hpi), late 
rings (20hpi), trophozoites (30hpi) and schizonts (40hpi). (B) Data depicted are generated from 
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episomally Ty1-PfH3.3 expressing parasites (see Fig. S3 “episomal 1”) at schizont stage. IG: intergenic 
region, CS: coding sequence, Sub. Rep.: subtelomeric repetitive region. Pearson correlation values are 
displayed at the lower right corner of the graphs.  
 
 
 
 
 
Figure S6: Correlation between steady state mRNA abundance and PfH3.3 occupancy at four 
intraerythrocytic stages. 
Scatter plots depicting log10 transformed RPKM values from all transcripts excluding tRNAs, rRNAs, 
mitchochondrial and apicoplast RNA in relation to log2 transformed PfH3.3/H3core ratios in upstream 
regions, coding sequences and downstream regions. RNA- and ChIP-seq analysis were performed on 
early rings, late rings, trophozoites and schizonts from the endogenously tagged PfH3.3-Ty1 DCJ 
parasite line. Pearson correlation values are displayed at the higher right corner of the graphs.  
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Figure S7: Endogenously PfH3.3-Ty1 expressing NF54-DCJ P. falciparum parasites were successfully 
selected for var2CSA and PF3D7_223500 expression. 
(A) Two independent, endogenously PfH3.3-Ty1 expressing NF54-DCJ P. falciparum parasites clones 
were selected for var2CSA expression by repeated rounds of var2CSA panning. Successful var gene 
selection was confirmed via RNA extraction followed by cDNA synthesis and subsequent qPCR using 
one var2CSA specific primer pair and 10 primers pairs specific for 10 other var genes. (B) CSA-selected 
parasites were treated with Blasticidin. This selected for parasites expressing PF3D7_223500 since in 
this parasite line the PF3D7_223500 promoter drives the expression of the BSD resistance cassette 
(bsd). Successful var gene switch was confirmed via RNA extraction followed by cDNA synthesis and 
subsequent qPCR using one specific primer pair for bsd, one specific primer pair for var2CSA and 
primers pairs specific for 8 other var genes.
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Summary 
Heterochromatin-dependent gene silencing is central to the adaptation and survival of 
Plasmodium falciparum malaria parasites, allowing clonally variant gene expression during 
blood infection in humans. By assessing genome-wide heterochromatin protein 1 (HP1) 
occupancy, we present a comprehensive analysis of heterochromatin landscapes across 
different Plasmodium species, strains and life cycle stages. Common targets of epigenetic 
silencing include fast-evolving multi-gene families encoding surface antigens and a small set 
of conserved HP1-associated genes with regulatory potential. Many P. falciparum 
heterochromatic genes are marked in a strain-specific manner, increasing the parasite’s 
adaptive capacity. Whereas heterochromatin is strictly maintained during mitotic 
proliferation of asexual blood stage parasites, substantial heterochromatin reorganization 
occurs in differentiating gametocytes and appears crucial for the activation of key 
gametocyte-specific genes and adaptation of erythrocyte remodeling machinery. 
Collectively, these findings provide a catalog of heterochromatic genes and reveal 
conserved and specialized features of epigenetic control across the genus Plasmodium. 
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Introduction 
Malaria is caused by unicellular eukaryotes of the genus Plasmodium that belongs to an 
ancient group of obligate endoparasites known as Apicomplexa. The Plasmodium genus 
comprises a few hundred species infecting birds, reptiles or mammals and their radiation is 
estimated to have occurred about 130 million years ago (1). Members of the Vinckeia 
subgenus parasitize non-primate mammals, among which rodents and bats are the most 
abundant. This group includes parasites of rodents such as P. berghei, P. yoelii, P. chabaudi 
and P. vinckei, which serve as important models to interrogate Plasmodium biology. 
Parasites belonging to the subgenera Plasmodium and Laverania infect humans or other 
primates. Five species are known to naturally infect humans, namely P. vivax, P. ovale, 
P. malariae, P. knowlesi (all members of the Plasmodium clade) and P. falciparum 
(Laverania clade). 
Malaria parasites of mammals are transmitted between their intermediate hosts by female 
Anopheles mosquitoes. Their life cycle is complex involving several stage transitions and 
replication phases as well as colonization of different cell types and tissues. In the 
bloodstream, parasites invade red blood cells (RBCs) and undergo intracellular 
multiplication via schizogony, which involves progression through the ring and trophozoite 
stages followed by multiple nuclear divisions before a single cytokinesis event leads to the 
production of up to 32 merozoites ready to invade other RBCs. Repeated rounds of these 
cycles are responsible for all malaria-related morbidity and mortality. For malaria 
transmission to occur, mosquitoes must ingest male and female gametocytes with their 
blood meal. These sexual precursors emerge at a low rate from the proliferating pool of 
blood stage parasites and are essential to complete sexual reproduction and subsequent 
sporozoite formation in the mosquito vector. Upon injection into the skin through a 
mosquito bite, sporozoites migrate to the liver, undergo intra-hepatic schizogony and 
release over 10’000 merozoites that commence blood stage infection. 
Proteins involved in functions at the host-parasite interface have been key to the 
evolutionary success of malaria parasites (2). Genes encoding such factors comprise up to 
15% of all parasite genes and belong to various dynamically evolving multi-gene families (3). 
Characteristic features of these gene families are that they (1) primarily encode proteins 
exported to the RBC; (2) display high levels of sequence polymorphism between paralogs 
and across strains, and substantial differences in copy number between species; (3) mostly 
locate to subtelomeric gene arrays (with the exception of P. knowlesi where they occur 
throughout the genome); and (4) are often species- or clade-specific (3, 4). A prime example 
of species-specific gene families is the 60-member var gene family in P. falciparum. Each var 
gene encodes a variant of the major surface antigen P. falciparum erythrocyte membrane 
protein 1 (PfEMP1) that mediates adhesion of iRBCs to several host receptors (5). Members 
of gene families represented in multiple species include the Plasmodium interspersed 
repeat (pir) genes (6), fam-a, -b, -c genes (7), Plasmodium helical interspersed subtelomeric 
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(phist) genes (8, 9) or reticulocyte-binding-like (rbl) genes (10). Independent of their size 
and species distribution these gene families provide a fertile ground for genetic 
diversification and are a driving force of evolutionary adaptation. 
A number of studies conducted in P. falciparum showed that these multi-gene families are 
located in heterochromatin (11-13). Heterochromatin is characterized by trimethylation of 
lysine 9 on histone H3 (H3K9me3) and the consequent binding of heterochromatin protein 
1 (HP1), a conserved regulator of heterochromatin formation and heritable silencing (14). 
P. falciparum encodes a single HP1 protein termed PfHP1 (11, 15). In asexual blood stage 
parasites PfHP1/H3K9me3 demarcate large heterochromatic domains in all subtelomeric 
regions and in a few internal regions of some chromosomes (11-13). These heterochromatic 
domains are virtually confined to non-syntenic regions and include over 400 genes, almost 
all of which are members of multi-gene families (11). As a consequence, these genes are 
subject to clonally variant expression, providing the parasites with a strong potential for 
phenotypic diversification and rapid adaptation for instance through antigenic variation or 
expression of alternative invasion ligands or nutrient transporters (16, 17). In addition, a 
few single genes are also associated with PfHP1, some of which have orthologs in other 
Plasmodium spp. (11). One of these loci encodes the transcription factor AP2-G, the master 
regulator of gametocytogenesis (18, 19). PfHP1-dependent silencing of pfap2-g prevents 
sexual commitment, while activation of this locus triggers sexual conversion and 
subsequent gametocyte differentiation, thus facilitating parasite transmission to the 
mosquito vector (18-21). 
These and other studies provided clear evidence that epigenetic regulation, particularly 
heterochromatin formation, is central to adaptation and survival of malaria parasites. To 
date, however, heterochromatin organization has almost exclusively been investigated in 
P. falciparum strain 3D7 blood stage schizonts. It is currently unknown whether the 
heterochromatin landscape differs between P. falciparum strains, whether other 
Plasmodium spp. display similar heterochromatin landscapes, or to what extent HP1 
contributes to life cycle stage transitions and parasite differentiation. 
 
Results 
Conserved and species-specific aspects of the heterochromatin landscape across the 
Plasmodium genus 
To investigate evolutionary aspects of heterochromatin organization we profiled genome-
wide HP1 occupancy in multiple Plasmodium species by chromatin immunoprecipitation 
sequencing (ChIP-seq). For P. falciparum we used our recently generated polyclonal rabbit 
α-PfHP1 antibody (20). Guided by a phylogenetic tree constructed from HP1 orthologs 
(Figure S1) we generated additional polyclonal rabbit antibodies against PvHP1 (to study 
HP1 in P. vivax and P. knowlesi) and PbHP1 (to study HP1 in P. berghei, P. chaubaudi and 
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P. yoelii). Immunofluorescence assays (IFAs) using these antibodies visualized punctate 
signals in the nuclei of all species that are reminiscent of the perinuclear chromosome end 
clusters observed in P. falciparum (20) (Figures 1A and S1). In Western blot analyses these 
antibodies detected a protein of the expected size of HP1 in each species (for P. vivax 
Western blot analysis was not performed due to lack of a suitable parasite sample) (Figure 
S1). 
Using these antibodies, we mapped HP1 occupancy in schizonts of P. falciparum strain 3D7, 
P. berghei ANKA, P. chabaudi chabaudi AS, P. yoelii yoelii YM, P. knowlesi clone A1-C.1 (22) 
as well as P. vivax field isolates. In all species HP1 predominantly localizes to subtelomeric 
heterochromatic domains on all chromosomes and to a few internal regions on some 
chromosomes (Figures 1B and S2). The only exception is P. knowlesi, where subtelomeric 
occupancy is much less pronounced but numerous chromosome-internal HP1-demaracted 
domains are observed (Figures 1B and S2). We next calculated HP1 enrichment values for 
each gene and employed a binomial Gaussian mixture model to call HP1-associated genes 
with high confidence (Figure 1C and Table S1). HP1 occupancy in P. falciparum is largely 
restricted to the var, rif, stevor, phist, pfmc-2tm and other gene families encoding known or 
predicted exported proteins in accord with a previous report (11). In P. vivax most HP1-
occupied genes belong to the vir family and members of the cir, bir and yir families make 
up the majority of HP1-associated genes in P. chabaudi, P. berghei, and P. yoelii, 
respectively. The dispersed HP1-demarcated domains in P. knowlesi capture the kir and 
SICAvar families and the interstitial telomere repeat sequences (ITSs) that are linked to 
these loci throughout the genome (4) (Figure 1C, S3 and Table S1).  
Most other HP1-associated genes in P. vivax, P. knowlesi and the three rodent-infecting 
species are members of gene families encoding other known or predicted exported proteins 
including phist, stp1, fam-a, fam-b and fam-c genes (Figure 1C, Table S1) (3). Moreover, 
several species possess small heterochromatic gene families involved in RBC invasion such 
as the pc235, pb235 and py235 genes encoding rhoptry proteins (P. chabaudi, P. berghei, 
P. yoelii) (23), or in metabolism such as lpl genes encoding lysophospholipases 
(P.  falciparum, P. vivax, P. knowlesi, P. chabaudi, P. yoelii) and acs genes encoding acyl-CoA 
synthetases (P. falciparum, P. chabaudi).  
All species also contain a few HP1-associated genes encoding proteins involved in regulation 
of gene expression, vesicular transport, cell division, RBC invasion, sexual development or 
transmission (summarized in the category “other” (Figure 1C and Table S1). Notably, while 
the multi-gene families have no or limited orthology, most of these genes have orthologs 
including some with conserved synteny across species. The extent of HP1 enrichment at 
these loci varied across species and most were bound by HP1 only in one species (Tables S1 
and S2). However, six conserved syntenic orthologs were associated with HP1 in more than 
one species (Figure 2A).  
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Figure 1. HP1 localisation and genome-wide HP1 occupancy in six different Plasmodium species. 
(A) IFAs showing HP1 localisation (green) in P. falciparum (α-PfHP1 antibodies), P. vivax and 
P. knowlesi (α-PvHP1 antibodies), and P. chabaudi, P. berghei, P. yoelii (α-PbHP1 antibodies) 
trophozoites. Nuclei were stained with DAPI (blue). Scale bar, 2.5 µm. (B) Log2-transformed 
Heterochromatin profiling in malaria parasites
 
 
91 
ChIP/Input ratio tracks from schizont stages of six Plasmodium species. Coding sequences are shown 
as blue (sense strand) and red (antisense strand) boxes. (C) Relative composition of heterochromatic 
genes in six Plasmodium species, classified into multi-gene families or groups of “unknown”, 
“unknown exported” and “other”. Numbers indicate the total number of high-confidence 
heterochromatic genes. See also Figures S1, S2 and S3 and Tables S1 and S2. 
 
 
Four of them encode putative transcriptional or post-transcriptional regulators of gene 
expression, namely the ApiAP2 TFs AP2-G (18, 19) and AP2-SP3/AP2-Tel (24, 25), an RNA-
binding protein and a CCCH-type zinc finger (ZnF) protein that is only conserved in P. vivax 
and P. knowlesi. Interestingly, ap2-g was the only gene with clear HP1 enrichment in all 
species (Figure 2B), underscoring its crucial role in controlling the switch to sexual 
differentiation (18-21). ap2-sp3/ap2-tel was bound by HP1 in P. vivax and the three species 
infecting rodents.  
The two genes encoding the ZnF and RNA-binding proteins and a gene encoding a conserved 
Plasmodium protein of unknown function were significantly enriched only in the 
P. vivax/knowlesi clade (Figure 2A). cap380, encoding an oocyst capsule protein essential 
for oocyst development in P. berghei (26), is associated with HP1 in P. vivax, P. knowlesi, 
P. berghei and P. chabaudi, partially marked in P. falciparum, but not in P. yoelii (Figure 2C).  
In summary, in all Plasmodium species examined most HP1-enriched genes belong to 
species-, clade- or pan-specific multi-gene families with documented or probable functions 
in antigenic variation, immune evasion or host cell invasion. In addition, each species 
contains a small number of HP1-associated single copy genes, many of which are conserved 
in other Plasmodium spp. and have known or predicted roles in fundamental parasite 
biology. 
 
P. knowlesi parasites proliferating in macaque or human RBCs display altered PkHP1 
occupancy at several loci 
P. knowlesi parasites have been adapted to continuous in vitro culture in human RBCs (22, 
27). We reasoned that the adaptation to growth in human RBCs may have involved 
epigenetic changes. We therefore compared the PkHP1 binding profiles of P. knowlesi 
clones A1-C.1 (see above) and A1-H.1, which have been adapted to long-term in vitro 
culture in M. fascicularis and human RBCs, respectively (22). Only twelve genes 
differentially marked by PkHP1 between the two clones (≥ 2.5-fold change in PkHP1 
occupancy) (Table S3). The six loci with higher PkHP1 enrichment in human RBC-adapted 
parasites encode a KIR protein, a lysophospholipase, a PHIST protein, and three tryptophan-
rich antigens (TRAGs) (Figure 3A, Table S3). The six genes with reduced PkHP1 occupancy in 
human RBC-adapted parasites encode two members of the SICAvar family, a protein of 
unknown function, a predicted exported protein, the secreted ookinete protein PSOP7, and 
a putative histone RNA hairpin-binding protein (Figure 3B, Table S3).  
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Figure 2. Conserved single copy 
genes associated with HP1 in more 
than one species. 
(A) HP1 enrichment values for 
conserved syntenic orthologs in six 
Plasmodium species. Asterisks 
denote high confidence hetero-
chromatic genes (p > 0.99999). (B) 
HP1 enrichment tracks over the ap2-
g locus in six Plasmodium species. 
Coding sequences are shown as blue 
(sense strand) and red (antisense 
strand) boxes. (C) HP1 enrichment 
tracks over the cap380 locus in six 
Plasmodium species. See also Tables 
S1 and S2. 
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Figure 3. Genes differentially marked by PkHP1 in P. knowlesi parasites invading human or macaque 
RBCs. 
(A) HP1 enrichment tracks over the six genes showing >2.5-fold increased HP1 occupancy in 
P. knowlesi A1-H.1 compared to A1-C.1. Coding sequences are shown as blue (sense strand) and red 
(antisense strand) boxes. (B) HP1 enrichment tracks over the six genes showing >2.5-fold increased 
HP1 occupancy in P. knowlesi clone A1-C.1 compared to A1-H.1. See also Table S3. 
 
Noteworthy, TRAG proteins interact with RBC receptors and have proposed roles in invasion 
(28, 29) and PHISTproteins play central roles in RBC remodelling (9). Furthermore, the 
P. knowlesi gene encoding a Plasmodium exported protein of unknown function 
(PKNH_0734900) has an ortholog in P. vivax, a parasite that naturally infects humans. 
Hence, these epigenetic changes may indeed represent signatures of positive selection 
during adaptation but replicate in vitro selection experiments and further characterization 
of candidates are needed to test this intriguing possibility experimentally.  
 
Heterochromatin organization is variable between different P. falciparum strains 
We next profiled HP1 occupancy in P. falciparum schizont stages of strain NF54 (30), the 
NF54-derived clone 3D7 (31), and the recently culture-adapted Ghanaian strain Pf2004 (32, 
33) and Cambodian strain NF135 (34). To allow direct comparison of PfHP1 occupancy, all 
ChIP-seq reads were mapped against the 3D7 genome (PlasmoDB v26). The four strains 
displayed largely similar heterochromatin organization but distinct PfHP1 occupancy was 
still evident, predominantly at the border of heterochromatic domains (Figure 4A). 
Importantly, mapping the Pf2004 ChIP-seq reads against the matching Pf2004 genome 
revealed that many changes in PfHP1 occupancy occurred in syntenic regions (Figure S4), 
demonstrating that differences at heterochromatin borders are not solely due to genetic 
rearrangements.  
To identify genes with altered PfHP1 occupancy ChIP/input enrichment values were z-score 
transformed and grouped using k-means clustering (Figure 4B and Table S4). Of all 
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heterochromatic genes (clusters 1 to 11; 279 genes) one third displayed variable PfHP1 
occupancy across strains (clusters 5 to 11; 88 genes). Interestingly, most of these genes 
localize close to heterochromatin boundaries (Figure 4B) and show variation in expression 
between laboratory lines (16) (Table S4). While most var, stevor and rifin genes were stably 
marked by PfHP1, members of other gene families such as phist, fikk or surfin and genes 
encoding unknown exported proteins were overrepresented among the variably marked 
genes (Figures 4C and 4D, Table S4). Pseudogenes were also more abundant in this class, 
suggesting they may provide “buffer zones” for heterochromatin reorganization. Variable 
PfHP1 occupancy was also observed for most PfHP1-associated single copy genes and small 
gene families (category “other”) (Figure 4D). This set includes genes encoding proteins 
implicated in erythrocyte invasion (eba-181) (35), RBC remodeling in gametocytes (geco) 
(36), mosquito midgut invasion (warp) (37), sporozoite maturation or egress (ccp1, crmp4) 
(38, 39), or liver stage development (lsa1) (40). Notably, however, four such genes (ap2-g, 
clag3.2, dblmsp2 and another gene encoding a DBL-domain containing protein) showed 
stable PfHP1 enrichment in all strains (Figure 4C), suggesting stable heterochromatin 
inheritance at these loci provides a selective growth advantage in vitro. Indeed, depletion 
of HP1 from the pfap2-g locus leads to cell cycle exit and sexual differentiation (20). dblmsp2 
encodes a putative invasion factor expressed only in a small fraction of schizonts (41).  
 
 
 
Figure 4. Strain-specific differences in heterochromatin organization in P. falciparum schizonts. 
(A) Log2-transformed ChIP/Input ratio tracks from P. falciparum strains Pf2004, NF135, NF54 and 3D7 
schizonts. Chromosome 8 and zoom-ins of its proximal end and the distal end of chromosome 12 are 
depicted as representative examples. Coding sequences are shown as blue (sense strand) and red 
(antisense strand) boxes. 
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(B) Heatmap based on k-means clustering of z-score-transformed ChIP/Input ratios calculated for each 
gene. Clusters containing genes with variable HP1 occupancy are marked in turquoise. Chromosome 
maps depict the position of variably marked genes (turquoise) in relation to HP1-demaracted 
heterochromatin (brown tracks; average z-score-transformed ChIP/Input ratios across the strains 
calculated in 1000 bp windows). (C) Relative composition of invariably marked heterochromatic genes 
(clusters 1 to 4), classified into multi-gene families or groups of “unknown exported” and “other”. (D) 
Relative composition of variably marked heterochromatic genes (clusters 5 to 11), classified into 
multi-gene families and groups of “unknown exported” and “other”. See also Figure S4 and Table S4.  
 
clag3.2 and its paralog clag3.1 encode related variants of the surface transport channel 
PSAC (42); parasites express either one of the two variants and some preferentially express 
clag3.1 in vitro (43, 44). Collectively, these observations highlight a high degree of variability 
in heterochromatin organization that likely contributes to phenotypic variation of malaria 
parasites. Interestingly, by analzsing gene expression data from field isolates (45) we found 
that variably marked heterochromatic genes display a significantly higher degree of 
expression variation compared to euchromatic genes and, to a lesser extent, also to 
invariably marked genes, suggesting that this relation may be relevant in vivo (Figure S4 and 
Table S4). 
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Heterochromatin organization is invariable between different stages of asexual intra-
erythrocytic development 
To assess whether and to what extent PfHP1-dependent gene expression contributes to the 
regulation of gene expression during the intra-erythrocytic developmental cycle (IDC) we 
mapped PfHP1 occupancy in P. falciparum 3D7 ring stages, trophozoites and schizonts. The 
profiles were highly similar in all three stages (Figure 5A). PfHP1 enrichment values of 
individual genes were highly correlated and we did not identify any genes with significantly 
altered PfHP1 occupancy across the IDC (Figure 5B and Table S5). Comparison of our data 
with a RNA-seq dataset (46) confirmed that most PfHP1-associated genes are expressed at 
low levels during the IDC (11) and that most clonally variant genes are PfHP1 target genes 
(16) (Figure 5C). Interestingly, genes with lower PfHP1 occupancy showed somewhat higher 
expression and this set includes many experimentally confirmed clonally variant genes (16). 
 
 
 
Figure 5. Genome-wide PfHP1 localization is invariable across the IDC. 
(A) Log2-transformed ChIP/Input ratio tracks from P. falciparum 3D7 ring, trophozoite and schizont 
stages. Chromosome 3 is depicted as a representative example. Coding sequences are shown as blue 
(sense strand) and red (antisense strand) boxes. (B) Pairwise comparisons of PfHP1 coverage of 
individual genes between the three IDC stages. r, Pearson correlation values. (C) Scatter plots 
displaying for each gene the maximum transcript level during the IDC (46) (grey dots) in relation to 
HP1 occupancy in schizonts (green dots). Genes were sorted according to HP1 occupancy. Genes with 
clonally variant expression (16) are marked with a red circle. var genes are indicated as blue dots. See 
also Table S5. 
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var genes appear to be special in this regard since they show moderate expression despite 
high PfHP1 occupancy levels. In summary, these results reveal that PfHP1-mediated 
silencing does not contribute in any major way to the temporal regulation of gene 
expression during the IDC. 
 
The switch from asexual proliferation to sexual differentiation in P. falciparum is 
accompanied by marked changes in the heterochromatin landscape 
We performed PfHP1 ChIP-seq experiments on Pf2004 schizonts, stage II/III gametocytes 
and stage IV/V gametocytes. Mapping the PfHP1 ChIP-seq reads against both the 3D7 and 
Pf2004 reference genomes highlighted clear differences in PfHP1 occupancy between 
asexual and sexual stages that were particularly evident from the expansion of subtelomeric 
heterochromatic domains in gametocytes (Figures 6A, 6B and S5).  
Calculation of PfHP1 enrichment values followed by z-score transformation and k-means 
clustering identified 104 genes with altered PfHP1 occupancy between schizonts and 
gametocytes (clusters 5 to 8) (Figure 6B and Table S6). Of these, only 15 genes showed 
reduced PfHP1 occupancy in gametocytes (cluster 5). This set includes pfap2-g (18), the 
gametocyte-specific gene pfgeco (36) and seven additional genes at the distal end of 
chromosome 14 that include five known markers of early gametocytogenesis (pfg14_744, 
pfg14_748, PF3D7_1476600, PF3D7_1477400, gexp17) (47-49) (Figures 6A, 6B and S5, 
Table S6). Clusters 6 to 8 contain 89 genes specifically bound by PfHP1 in gametocytes 
(Figures 6A, 6B and S6, Table S6). Intriguingly, this set is enriched for genes encoding 
proteins implicated in RBC remodeling. Of particular interest is the subtelomeric region at 
the left arm of chromosome 2 where the heterochromatic domain is extended by almost 50 
kb in gametocytes. This differentially marked region includes three genes encoding proteins 
involved in knob formation, namely the knob-associated heat shock protein 40 (KAHsp40) 
(50), PfEMP3 (51) and the knob-associated histidine-rich protein (KAHRP) (52). In addition, 
five members of the fikk family, which encode exported serine-threonine protein kinases 
implicated in host cell remodeling (53, 54), are enriched in PfHP1 in gametocytes. Increased 
PfHP1 occupancy is also observed at the gene encoding MESA, an exported protein of 
unknown function that binds to the RBC membrane skeleton protein 4.1 (55) and at 15 phist 
genes.  
In summary, these data suggest that heterochromatin remodeling contributes in a major 
way to the establishment of a gametocyte-specific transcriptional program. It should be 
noted, however, that the majority of genes differentially expressed between asexual and 
sexual blood stages are not marked by HP1 in either stage (11, 56), suggesting that 
sequence-specific transcription factors such as AP2-G and AP2-G2 (18, 19, 57) are the main 
drivers of stage-specific gene expression during sexual differentiation.  
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Figure 6. Differences in heterochromatin organization between asexual and sexual P. falciparum 
blood stage parasites. 
(A) Log2-transformed ChIP-seq ChIP/Input ratio tracks from P. falciparum Pf2004 schizonts and stage 
II/III and stage IV/V gametocytes. The proximal end of chromosome 2 is depicted as an example for 
an expanded heterochromatic domain in gametocytes. Genes involved in knob formation (kahsp40, 
PF3D7_0201800; pfemp3, PF3D7_0201900; kahrp, PF3D7_0202000) are marked in orange. Early 
gametocyte markers PF3D7_1476500, PF3D7_1476600, PF3D7_1477300 (pfg14_744/phist), 
PF3D7_1477400 (phist), PF3D7_1477700 (pfg14_748/phista), PF3D7_1478000 (gexp17) at the distal 
end of chromosome 14 have reduced PfHP1 occupancy in gametocytes and are marked in purple. 
(B) Heatmap based on k-means clustering of z-score-transformed ChIP/Input ratios calculated for each 
gene. Examples of genes with reduced (cluster 5) or increased (clusters 6 to 8) HP1 occupancy in 
gametocytes are highlighted in purple or orange, respectively. Chromosome maps depict the position 
of genes with reduced (purple) or increased (orange) HP1 occupancy in gametocytes in relation to 
PfHP1-demaracted heterochromatin (green tracks and blue inverted tracks are z-score-transformed 
ChIP/Input ratios in schizonts and stage IV/V gametocytes, respectively, calculated in 1000 bp 
windows). See also Figure S5 and Table S6. 
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Discussion 
We show that heterochromatin formation at chromosome ends and their perinuclear 
clustering is a conserved feature of chromatin organization across the Plasmodium genus. 
Furthermore, in all six species examined heterochromatin primarily embeds members of 
the various species-, clade- or pan-specific multi-gene families with known or predicted 
roles in antigenic variation and other host-parasite interrelations, independent of 
chromosomal location. While in P. berghei, P. chabaudi, P. yoelii and P. vivax 
heterochromatin is mostly confined to chromosome ends, P. falciparum features some 
additional intra-chromosomal heterochromatic islands, and in P. knowlesi chromosome-
internal HP1-demaracted domains are scattered throughout the genome. These differences 
in heterochromatin distribution mirror the differences in the genome-wide localization of 
gene families between the species. These observations, in particular the intriguing 
association of PkHP1 with the numerous individual kir and SICAvar loci (Figure S3), lends 
support to the idea that unknown DNA elements linked to sequences of gene family 
members may be directly involved in the formation and/or local containment of 
heterochromatin. The ITS elements found at kir and SICAvar loci are interesting first 
candidates to be tested for such putative functions. 
Some conserved single copy genes are subject to HP1-dependent gene silencing in at least 
one of the species analyzed. Heterochromatinization of these genes may be used to prevent 
their expression during certain phases of the life cycle and/or to express them in a clonally 
variant manner to facilitate alternative phenotypes conducive to parasite adaptation. Even 
though some of these genes display only subtle HP1 enrichment and may represent false 
positive hits, this list constitutes a valuable resource for the exploration of genus-, clade- or 
species-specific heterochromatic genes with functions in key biological processes (Table S2). 
Here, we focused our attention on the six syntenic orthologs that are heterochromatic in 
more than one species. Remarkably, next to ap2-g this set includes three other genes with 
likely roles in regulating gene expression. Of these, AP2-SP3/AP2-Tel that has recently been 
studied in P. falciparum and P. berghei. In P.  falciparum, this factor binds the telomeric tract 
(25) and disruption of ap2-sp3/ap2-tel impairs parasite proliferation (58). In P. berghei, 
however, AP2-SP3/AP2-Tel is dispensable for intra-erythrocytic growth and sexual 
development but essential for sporozoite maturation (24). These rather conflicting findings 
may be explained by functional divergence of AP2-SP3/AP2-Tel in different malaria 
parasites. Consistent with this hypothesis we found that ap2-sp3/ap2-tel is marked by HP1 
in P. vivax and the three species infecting rodents, but not in P. falciparum and P. knowlesi. 
Another interesting HP1 target gene encodes a putative CCCH-type ZnF protein in P. vivax 
(PVP01_0604500) and P. knowlesi (PKNH_0603500). Proteins carrying these domains 
typically bind RNA and control gene expression by regulating mRNA turnover (59). Hence, 
this factor may act in a similar way to regulate important processes specifically in the 
P. vivax /P. knowlesi clade and it will be interesting to know in which life cycle stage(s) this 
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may take effect. 
A previous study reported a substantial degree of variegated gene expression in 
P. falciparum and showed that most genes affected are located in heterochromatin (16). 
Their results also suggested that the transcriptional states of individual genes are stably 
inherited during in vitro culture. Our results are consistent with these findings. First, up to 
one third of all heterochromatic genes showed variable PfHP1 occupancy between strains, 
which likely contributes to differential gene expression. Second, we observed a complete 
lack of variation in PfHP1 occupancy between the different IDC stages and found only twelve 
differentially marked genes between two clones of P. knowlesi that have been cultured 
independently in RBCs from two different hosts for over 200 generations (22). Together, 
these findings suggest that heterochromatin is faithfully maintained and that heritable 
changes occur rather infrequently during asexual proliferation in vitro. 
In many multicellular eukaryotes epigenetic mechanisms are employed in a developmental 
context to progressively silence groups of genes no longer required in differentiated cells 
(60). We found that in a somewhat analogous fashion many genes display altered HP1 
occupancy between asexually reproducing and sexually differentiating parasites. 
Importantly, since these cell populations were generated from the same strain in one 
continuous in vitro culture experiment, the observed changes directly reflect the dynamics 
of heterochromatin re-structuring associated with the cell fate switch. Besides ap2-g, a few 
other early gametocyte-specific genes showed reduced HP1 occupancy already in stage II/III 
gametocytes, suggesting their de-repression occurred alongside that of ap2-g during sexual 
commitment or in the subsequent gametocyte ring stages. On the contrary, a larger group 
of genes devoid of HP1 in schizonts became heterochromatinized during gametocyte 
differentiation. Strikingly, many of these genes encode RBC remodelling factors. The most 
compelling example is related to the knob structures, parasite-induced aggregates 
underneath the erythrocyte membrane that are crucial for the PfEMP1-dependent 
adherence of iRBCs to endothelial cells and their consequent sequestration in the 
microvasculature (61). Although stage I to IV gametocytes also sequester, primarily in the 
bone marrow (62), their cytoadhesive properties are markedly different and reflected in the 
absence of knobs in gametocyte-infected erythrocytes (63, 64). Our findings suggest that 
the mechanism responsible for preventing expression of these structures in gametocytes is 
based on HP1-dependent silencing of kahrp and other genes linked to knob formation. 
Given that many additional genes implicated in host cell remodeling also become associated 
with HP1 in gametocytes, we speculate that P. falciparum gametocytes use 
heterochromatin spreading as a general mechanism to inactivate host cell remodeling 
machinery that is crucial for the survival of asexual parasites but incompatible with the 
distinct biology of differentiating gametocytes. 
Qualitative comparison between our data and genome-wide H3K9me3 ChIP-seq profiles 
obtained from P. falciparum oocysts and salivary gland sporozoites (65) suggests that 
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further expansion of heterochromatic domains in these life cycle stages might lead to 
silencing of yet another set of genes during development in the mosquito (Figure S5). 
Collectively, our findings reveal that distinct changes in heterochromatin organization 
accompany developmental stage transitions during parasite transmission, reflecting the 
different biology, environmental niches, and requirements for rapid adaptive responses 
associated with each life cycle stage. Such silencing mechanisms must be reversed at some 
point to enable re-expression of affected genes during the life cycle stages where their 
expression is required. Two recent studies provided evidence that epigenetic 
reprogramming during mosquito passage may reset virulence gene expression in 
P. chabaudi (66, 67). Based on our results HP1 likely plays a central role in such a process, 
and it will be interesting to build on the tools and knowledge generated here to investigate 
this intriguing possibility in more detail. 
In conclusion, we demonstrate that the HP1-dependent silencing of genes implicated in 
antigenic variation, invasion, or sexual conversion is evolutionary conserved in malaria 
parasites. We further identify a number of genes that are marked by HP1 specifically in one 
or a few species only. These may play crucial roles in the adaptive control of species- or 
clade-specific processes. Our results also reveal that gametocyte differentiation is 
accompanied by changes in heterochromatin distribution that potentially affect the 
expression of more than 100 genes. This raises the exciting possibility that despite their 
large evolutionary distance malaria parasites employ a similar strategy as metazoans to 
regulate expression of cell type-specific genes via heterochromatinization.  
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KEY RESOURCES TABLE 
 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
Antibodies   
Rabbit polyclonal anti-Plasmodium 
falciparum HP1 
Brancucci et al., 
2014 
N/A 
Rabbit polyclonal anti-Plasmodium 
berghei HP1 
This paper N/A 
Rabbit polyclonal anti-Plasmodium vivax 
HP1 
This paper N/A 
Alexa Fluor 488-conjugated Goat anti-
Rabbit IgG 
ImmunoJackson Cat#111-545-003 
Alexa Fluor 488-conjugated Goat anti-
Rabbit IgG 
Thermo Fisher 
Scientific 
Cat#A-11008 
Bacterial and Virus Strains  
E. coli Rosetta 2 (DE3) EMD Millipore Cat#71397-3 
Biological Samples   
Plasmodium vivax clinical isolates Shoklo Malaria 
Research Unit, 
Thailand 
N/A 
Plasmodium vivax thin blood smear  Swiss TPH / 
PNGIMR  
N/A 
Chemicals, Peptides, and Recombinant Proteins 
Plasmodium berghei HP1 This paper N/A 
Plasmodium vivax HP1 This paper N/A 
Dynabeads Protein A Thermo Fisher 
Scientific 
Cat#10008D 
Dynabeads Protein G Thermo Fisher 
Scientific 
Cat#10009D 
Nycodenz Axis-Shield Cat#1002424 
Formaldehyde solution 36.5-38%  Sigma-Aldrich Cat#F8775 
ProLong Antifade mountant with DAPI Thermo Fisher 
Scientific 
Cat#P36931 
VECTASHIELD mounting medium 
containing DAPI 
Vector Laboratories Cat#H-1200 
cOmplete™, Mini Protease Inhibitor 
Cocktail 
Sigma-Aldrich Cat#11836153001 
Critical Commercial Assays 
NEXTflex® ChIP-Seq Barcodes - 24 Bio Scientific Cat#NOVA-514122 
KAPA HiFi HotStart ready mix KAPA Biosystems Cat#KM2602 
Agencourt AMPure XP Beckman Coulter Cat#A63880 
NextSeq 500/550 High Output v2 kit (75 
cycles) 
Illumina Cat#FC-404-2005 
Deposited Data 
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ChIP-Seq data This paper GEO: GSE102695 
Pf2004 draft genome assembly Pf3K consortium 
and the Wellcome 
Trust Sanger 
Institute 
ftp://ftp.sanger.ac.uk/pub/pr
oject/pathogens/Plasmodium
/falciparum/PF3K/SecondSet
ReferenceGenomes/DraftAnn
otation/Pf2004/. 
Experimental Models: Cell Lines 
Parasite strain: Plasmodium falciparum 
3D7 
Walliker et al., 1987 Alan Cowman, WEHI, 
Melbourne, Australia 
Parasite strain: Plasmodium falciparum 
Pf2004/164tdT 
Brancucci et al., 
2015 
N/A 
Parasite strain: Plasmodium falciparum 
NF54 
Delemarre and van 
der Kaay, 1979 
Robert Sauerwein, 
Radboudumc, Nijmegen, NL 
Parasite strain: Plasmodium falciparum 
NF135 
Teirlinck et al., 2013 Robert Sauerwein, 
Radboudumc, Nijmegen, NL 
Parasite strain: Plasmodium knowlesi A1-
H.1 
Moon et al., 2013 Mike Blackman, Francis Crick 
Institute, London, UK 
Parasite strain: Plasmodium knowlesi A1-
C.1 
Moon et al., 2013 Mike Blackman, Francis Crick 
Institute, London, UK 
Parasite strain: Plasmodium berghei 
ANKA 
BEI Resources 
(MR4) 
N/A 
Parasite strain: Plasmodium chabaudi 
chabaudi AS 
Spence et al., 2011 Jean Langhorne, Francis Crick 
Institute, London 
Parasite strain: Plasmodium yoelii yoelii 
YM 
BEI Resources 
(MR4) 
N/A 
Experimental Models: Organisms/Strains 
Mouse: BALB/c  (female) In Vivos Pte Ltd. 
SIngapore 
NA 
Oligonucleotides 
Pb_F: aaaagatttcatatgacaggatcagatg This paper N/A 
Pb_R: ttccctcgagcaccgttctatatctaagtc This paper N/A 
SUMO_F: 
tttcatatgcatcatcatcatcatcacgggtcggactcag
aagtcaatc 
This paper N/A 
SUMO_R: 
cctaggatccggcgccaccaatctgttctctgtg 
This paper N/A 
Pv_F: actggatccgatgaagagtttgaaatagg This paper N/A 
Pv_R: tgtgctcgagtacttaggccgttcggtatcg This paper N/A 
Recombinant DNA 
pET20b(+) EMD Millipore Cat#69739-3 
pET_PbHP1-6xHis This paper N/A 
pETA-HS This paper N/A 
pETA-HS-PvHP1 This paper N/A 
pETA-Strep This paper N/A 
pETA_Strep-PvHP1-6xHis This paper N/A 
Software and Algorithms 
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Clustal Omega Sievers et al., 2011 https://www.ebi.ac.uk/Tools/
msa/clustalo/ 
MEGA7 Kumar et al., 2016 http://www.megasoftware.n
et/download_form 
Olympus DP manager software 
(v2.2.1.195) 
Olympus N/A 
ImageJ Schneider et al., 
2012 
https://imagej.net/Download
s 
Nikon Elements Advanced Research Nikon N/A 
Leica IM1000 software Leica N/A 
Fiji Schinderlin et al., 
2012 
https://imagej.net/Fiji 
jvenn Bardou et al., 2014 http://jvenn.toulouse.inra.fr/
app/index.html 
BWA (v0.7.12-r1039) Li and Durbin, 2009 https://insidedna.me/tool_pa
ge_assets/pdf_manual/bwa.p
df 
SAMtools (v1.2) Li and Handsaker et 
al, 2009 
http://www.htslib.org/downl
oad/ 
BEDTools (v2.20.1) Quinlan and Hall, 
2010 
http://bedtools.readthedocs.i
o/en/latest/content/installati
on.html 
SignalMap Software v2.0 Roche http://sequencing.roche.com
/en/products-solutions/by-
category/target-
enrichment/software/signal-
map-software.html 
UCSC Genome Browser UCSC Genome 
Browser 
https://genome-
store.ucsc.edu/ 
Rstudio (v3.3.2) RStudio https://www.rstudio.com/pr
oducts/rstudio/download/ 
Other 
Plasmodipure filters EuroProxima Cat#8011Filter25u 
HisTrap HP GE Healthcare Cat#17-5248-01 
HiTrap Protein A HP GE Healthcare Cat#17-0403-01 
HiTrap NHS activated HP column GE Healthcare  Cat#17-0716-01 
StrepTrap HP GE Healthcare Cat#28-9136-30 
Amicon Ultra Centrifugal Filter 10KDa EMD Millipore Cat#UFC801024 
E-Gel Size Select agarose gel Thermo Fisher 
Scientific 
Cat#G661012 
Non-woven fabric filters ZXBio.net N/A 
Glycerolyte Solution 57 Fenwal Cat#FWL4A7831 
BD Vacutainer™ Plastic Blood Collection 
Tubes with Sodium Heparin: 
Conventional Stopper 
Fisher Scientific Cat#BD367874  
BD Vacutainer™ Plastic Blood Collection 
Tubes with K2EDTA: Tube Stopper 
Fisher Scientific Cat#BD367844  
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EXPERIMENTAL MODEL AND SUBJECT DETAILS 
 
Mouse model 
Mice used in this study (BALB/c mice; age 6-8 weeks; weight 25-30 g) were maintained in accordance 
with the NACLAR (National Advisory Committee for Laboratory Animal Research) guidelines under the 
Animal & Birds (Care and Use of Animals for Scientific Purposes) Rules of Singapore with approval 
from the Institutional Animal Care and Use Committee (IACUC) of Nanyang Technological University 
(NTU) of Singapore (Approval number: ARFSBS/NIE A002). All animals used in this study were obtained 
from InVivos Pte Ltd and subsequently housed under SPF conditions at NTU. P. berghei, P. chabaudi 
and P. yoelii infections for obtaining parasites for chromatin extraction were performed on female 
BALB/c mice (age 6-8 weeks; weight 25-30g). Mice were infected with an initial inoculum of 5x105 
parasites and were exsanguinated by cardiac puncture when parasitaemia levels reached between 
10-20%. 
 
P. falciparum parasites 
P. falciparum parasites were cultured at 37°C at 5% haematocrit based on the original protocol 
published by Trager and Jensen (68). Growth synchronization was achieved by repeated sorbitol 
treatments (69). 3D7 parasites were cultivated with AB+ human RBCs in RPMI 1640/25 mM Hepes 
standard culture medium supplemented with 0.5% Albumax II. NF54 and NF135 parasites were 
cultivated with O+ human RBCs in RPMI 1640/25 mM Hepes standard culture medium supplemented 
with 10 % human serum. Pf2004/164tdTom parasites (33) were cultivated with AB+ human RBCs in 
RPMI 1640/25 mM Hepes standard culture medium supplemented with 10 % human serum. 
Pf2004/164tdTom gametocytes were generated by inducing sexual commitment as described (33). 
After re-invasion cultures were treated with 50mM N-acetylglucosamine (70) for three consecutive 
days to eliminate asexual parasites. 
 
P. knowlesi parasites 
P. knowlesi A1-H.1 parasites were grown at 37°C in O+ human RBCs obtained from the United 
Kingdom National Blood Transfusion Service. P. knowlesi A1-C.1 parasites were grown in 
M. fascicularis blood provided by NIBSC (UK), which was collected by venous puncture into K2 EDTA 
BD Vacutainers (Fisher Scientific) as described previously (22). Samples of M. fascicularis blood used 
for parasite culture were provided by the National Institute for Biological Standards and Control. The 
rationale and procedures for venepuncture and blood sample collection were reviewed by the local 
Animal Welfare and Ethical Review Body (the Institutional Review Board) of the National Institute for 
Biological Standards and Control and performed under licence (PPL70/8506) granted by the United 
Kingdom Home Office as governed by United Kingdom law under the Animals (Scientific Procedures) 
Act 1986. Animals were handled in strict accordance with the “Code of Practice Part 1 for the housing 
and care of animals (21/03/05)” available at https://www.gov.uk/research-and-testing-using-animals. 
The work also met the National Centre for the Replacement Refinement and Reduction of Animals in 
Research (NC3Rs) guidelines on primate accommodation, care, and use 
(https://www.nc3rs.org.uk/non-human-primate-accommodation-care-and-use), which exceed the 
legal minimum standards required by the United Kingdom Animals (Scientific Procedures) Act 1986, 
associated Codes of Practice, and the US Institute for Laboratory Animal Research Guide. Parasite 
cultures were synchronised by centrifugation through a density cushion of Nycodenz (Axis-Shield) as 
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previously described (22). 
 
P. vivax parasites 
The clinical P. vivax isolates examined in this study were collected under the following approved 
ethical guidelines and protocols: OXTREC 45-09 and OXTREC 17-11 (Centre for Clinical Vaccinology and 
Tropical Medicine, University of Oxford, Oxford, UK), MUTM 2008-215 from the Ethics committee of 
the Faculty of Tropical Medicine (Mahidol University, Bangkok, Thailand) and MRAC No. 16.01 from 
the Medical Research Advisory Committee of Papua New Guinea. To obtain P. vivax parasites for 
chromatin extraction eight clinical isolates were collected from malaria patients attending clinics run 
by the Shoklo Malaria Research Unit, Mae Sot, Thailand. Five milliliters of whole blood were collected 
in lithium heparin collection tubes by venepuncture from each patient using Sodium Heparin BD 
Vacutainers (Fisher Scientific). After leukocyte depletion using non-woven fabric filters (ZXBio.net) 
these samples were cryopreserved in glycerolyte 57 solution (Fenwal) and stored in liquid nitrogen 
(71). Frozen samples were thawed using a series of NaCl gradients (12%, 1.6% and 0.9%) and matured 
ex vivo for 40 hours as described (71, 72). 
 
METHOD DETAILS 
 
P. falciparum sample collection and chromatin preparation 
Chromatin from 3D7 ring stages (8-16 hpi), trophozoites (32-30 hpi) or schizonts (40-48 hpi) 
(approximately 0.75-1.5x109 parasites each) and from Pf2004/T164dTom schizonts, stage II/III 
gametocytes (day four after re-invasion) or stage IV/V gametocytes (day nine after re-invasion) 
(approximately 2x108 parasites each) was prepared by crosslinking cultures with 1% formaldehyde 
(Sigma-Aldrich) for 15 min at 37ºC. Crosslinking reactions were quenched by 0.125 M glycine. Nuclei 
were isolated by releasing parasites from iRBCs using 0.05% saponin followed by lysis in CLB (20 mM 
Hepes, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 0.65% NP-40, 1mM DTT, 1x protease inhibitor (Sigma-
Adrich), pH 7.9). Nuclei were washed and snap-frozen in CLB supplemented with 50% glycerol. 
Chromatin from NF54 and NF135 schizont stages (approximately 2-4x109 parasites each) was 
prepared by passing the cultures through Plasmodipure filters (EuroProxima) to remove white blood 
cells prior to formaldehyde crosslinking for 10 min at 37ºC and quenching in 0.125 M glycine. Nuclei 
were isolated by releasing parasites from iRBCs using 0.05% saponin followed by gentle 
homogenisation (pestle B, 15 strokes) in CLB2 (10 mM Tris-HCl, 3 mM MgCl2, 0.2% NP40, 1x protease 
inhibitor (Sigma-Adrich), pH 8.0) and centrifugation through a 0.25 M sucrose cushion (in CLB2) at 
2000 rpm for 10 min at 4°C. Nuclei were snap-frozen in CLB2 supplemented with 20% glycerol. Frozen 
nuclei were thawed and resuspended in sonication buffer (50mM Tris-HCl, 1% SDS, 10mM EDTA, 1x 
protease inhibitor (Sigma-Adrich), pH 8.0) and sonicated for 20-24 cycles of 30 sec ON/30 sec OFF 
(setting high, BioruptorTM Next Gen, Diagenode). Chromatin fragment sizes ranged from 100-600 bp 
as determined by de-crosslinking a 50 µl aliquot and running the purified DNA on a 1% agarose gel. 
 
P. knowlesi sample collection and chromatin preparation 
Cultures containing a schizont parasitaemia of around 5% were passed through Plasmodipure filters 
(EuroProxima) to remove white blood cells prior to crosslinking for 10 min at 37ºC in 1% formaldehyde 
(Sigma-Aldrich) and quenching in 0.125 M glycine. Red blood cells were removed by lysis on ice for 10 
min with 0.15% saponin/PBS before washing the pellet in PBS and snap-freezing the parasite pellets 
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in liquid nitrogen. Nuclei were isolated by lysis in CLB, washed and aliquots corresponding to 
approximately 1x109 nuclei were snap-frozen in CLB supplemented with 50% glycerol. Preparation of 
sheared chromatin was performed as described above for P. falciparum. 
 
P. berghei, P. chabaudi and P. yoelii sample collection and chromatin preparation 
For each of the three parasite species, whole blood of infected mice containing approximately 5x109 
schizonts (three mice for P. yoelii yoelii YM, four mice for P. chabaudi chabaudi AS, five mice for 
P. berghei ANKA) was diluted in standard P. falciparum culture medium and passed through a 
Plasmodipure filter (EuroProxima) to remove white blood cells. The purified RBCs were collected by 
centrifugation at 2’000 rpm for 5 min, resuspended in 30 ml culture medium and crosslinked at 37˚C 
for 10 min in presence of 1% formaldehyde (Sigma-Aldrich). Crosslinking reactions were quenched by 
0.125 M glycine. The crosslinked RBCs suspension was split into three equal aliquots, centrifuged at 
2’000 rpm for 5 min, supernatants were removed and the RBC pellets snap-frozen in liquid nitrogen. 
Nuclei were isolated by releasing parasites from iRBCs using 0.05% saponin followed by lysis in CLB 
(20 mM Hepes, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 0.65% NP-40, 1mM DTT, 1x protease inhibitor 
(Sigma-Adrich), pH 7.9). Again, nuclei were washed and aliquots corresponding to approximately 
1x109 nuclei were snap-frozen in CLB supplemented with 50% glycerol. Preparation of sheared 
chromatin was performed as described above for P. falciparum. 
 
P. vivax sample collection and chromatin preparation 
The P. vivax ex vivo schizont cultures were crosslinked at 37˚C for 10 min in presence of 1% 
formaldehyde (Sigma-Aldrich) and subsequently the reactions were quenched by 0.125 M glycine. The 
crosslinked RBCs were centrifuged at 200 g for 5 min, supernatants were removed and the RBC pellets 
snap-frozen in liquid nitrogen. The eight samples were thawed and pooled and nuclei isolated by 
releasing parasites from iRBCs using 0.05% saponin followed by lysis in CLB. Nuclei were washed and 
snap-frozen in CLB supplemented with 50% glycerol. Preparation of sheared chromatin was 
performed as described above for P. falciparum. 
 
Phylogenetic analysis of Plasmodium HP1 orthologs 
Protein sequences of Plasmodium HP1 orthologs were downloaded from PlasmoDB v33 and used to 
perform a multiple sequence alignment using Clustal Omega (73) with default parameters. 
Phylogenetic tree construction was done with MEGA7 (74) using the Neighbor-joining method and 
1’000 bootstrap replicates. 
 
Generation and affinity purification of 𝜶𝜶-PbHP1 and α-PvHP1 antibodies 
All recombinant proteins were expressed in Rosetta2(DE3) cells (EMD Millipore) using auto-induction 
(75). The sequence encoding PbHP1 was amplified from gDNA using primers Pb_F 
(aaaagatttcatatgacaggatcagatg) and Pb_R (ttccctcgagcaccgttctatatctaagtc) and cloned into pET20b(+) 
(EMD Millipore) using NdeI and XhoI restriction sites in order to express PbHP1 fused to a C-terminal 
6xHis tag (pET_PbHP1-6xHis). Recombinant PbHP1-6xHis was purified using a HisTrap HP column (GE 
Healthcare) using buffer NiB (50 mM H3PO4, 0.5 M NaCl, 20 mM imidazole, pH 7.4) supplemented with 
8 M urea for lysis, binding and washing, and buffer NiE (50mM H3PO4, 0.5 M NaCl, 225 mM imidazole, 
pH 7.4) containing 8 M urea for elution. The elution was diluted 1:4 with H2O and the eluted proteins 
were precipitated with trichloroacetic acid (TCA). PvHP1 was expressed as an N-terminally tagged 
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6xHis-SUMO fusion protein (HS-PvHP1). The parental expression vector pETA-HS was generated by 
introducing a sequence encoding a fusion tag consisting of a 6xHis stretch followed by Saccharomyces 
cerevisiae SUMO, amplified from gDNA using primers SUMO_F (tttcatatgcatcatcatcatcatcacgggtcggact 
cagaagtcaatc) and SUMO_R (cctaggatccggcgccaccaatctgttctctgtg) between the NdeI and BamHI sites 
of pET20(b)+ (EMD Millipore), yielding a vector similar to the one described by Malakhov and 
colleagues (76). The pvhp1 insert was cloned into pETA-HS by ligating a BamHI/XhoI-digested PCR 
product amplified from gDNA using primers Pv_F (actggatccgatgaagagtttgaaatagg) and Pv_R 
(tgtgctcgagtacttaggccgttcggtatcg) (pETA-HS-PvHP1). HS-PvHP1 was purified using a HisTrap HP 
column (GE Healthcare) and buffers NiB for lysis, binding and washing, and buffer NiE for elution. The 
elution was subject to buffer exchange with NiB supplemented with 1 mM Tris-(2-carboxyethyl)-
phosphin (TCEP) and the HS-PvHP1 fusion protein was digested using recombinant SUMO protease 
(L403-K621 of S. cerevisia ULP1; GB1-ULP1-6xHis). The cleaved tag and SUMO protease were 
subtracted using a HisTrap HP column (GE Healthcare) and the purified untagged PvHP1 protein was 
precipitated with TCA. 
Purified recombinant PbHP1-6xHis and untagged PvHP1 were used to immunize rabbits (Pacific 
Immunology). Total rabbit IgG from anti-PbHP1 and anti-PvHP1 immune sera were purified using 
HiTrap Protein A HP columns (GE Healthcare) using a mild arginine elution method similar to the one 
described by Arakawa and colleagues (77), with the exception that a linear combined pH and arginine 
gradient elution was used instead of stepwise elution. Rabbit sera were diluted 1:3 using buffer IgGA 
(750 mM L-arginine, 150 mM H3PO4, 150 mM citric acid, pH 7.3), bound to 5 ml HiTrap Protein A HP 
columns (GE Healthcare) and washed with five column volumes (CVs) of buffer IgGA. Antibodies were 
eluted using a linear gradient (eight CVs) of buffers IgGA to IgGB (2 M L-arginine, 150 mM H3PO4, 150 
mM citric acid, adjusted to pH 3.7 using HCl). The antibodies eluted in a symmetrical peak (maximum 
at 1.4 M arginine and pH 5). Purified antibodies were subject to buffer exchange with PBS. 
Affinity purification of α-PbHP1 antibodies was done as previously described for α-PfHP1 antibodies 
(20) with the exception that the PbHP1-6xHis antigen was bound to the nickel column in buffer NiB 
containing 2 M urea. For the PvHP1 antigen, we first generated the parental pETA_Strep vector 
facilitating expression of N-terminally Strep(II)-tagged and C-terminally 6xHis-tagged fusion proteins 
by replacing the NdeI/BamHI fragment in pET20b(+) with an annealed double-stranded 
oligonucleotide (Strep_F (tatggctagctggagccacccgcagttcgaaaaag) and Strep_R (gatcctttttcgaactgcggg 
tggctccagctagcca)) encoding Met-Ala-Ser-Strep(II). Next, the same PCR product that was used to 
generate HS_PvHP1 (see above) was cloned into the pETA_Strep vector using BamHI and XhoI to 
obtain pETA_Strep-PvHP1-6xHis. The Strep(II)-PvHP1-6xHis fusion protein was purified using a HisTrap 
HP column (GE Healthcare) and the same buffers as used for purification of HS-PvHP1 (see above) 
followed by a StrepTrap HP column (GE Healthcare) using buffer NiB containing 1 mM EDTA for 
washing or 2.5 mM desthiobiotin for elution. The purified protein was subject to buffer exchange with 
coupling buffer (0.2 M NaHCO3, 0.5 M NaCl, pH 8.3). Next, the protein was coupled to a HisTrap NHS-
activated HP column (GE Healthcare) following the supplier’s instructions. α-PvHP1 IgG was diluted 
1:5 in buffer IgGA and bound to the Strep(II)-PvHP1-6xHis column. The column was washed with 20 
CVs of buffer IgGA and eluted with buffer IgGB. Both, α-PvHP1 and α-PbHP1 antibodies were finally 
subject to buffer exchange with PGS (20 mM H3PO4, 30 mM KOH, 25% glycerol, 250 mM Na2SO4, pH 
6.8) and concentrated to 0.4-0.7 mg/ml using an Amicon Ultra spin filter with a 10K cutoff (EMD 
Millipore). 
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Fluorescence microscopy 
IFAs for P. falciparum were performed as described previously (20). IFAs for P. berghei, P. chabaudi 
and P. yoelii were performed with acetone:methanol (9:1)-fixed cells using rabbit α-PbHP1 (1:250) 
and Alexa Fluor 488-conjugated α-rabbit IgG (1:500) (ImmunoJackson). Slides were viewed under 
Olympus IX71 fluorescence microscope using a 100x oil immersion objective and equipped with an 
Olympus DP30BW camera. Images were acquired via the Olympus DP manager software (v2.2.1.195) 
and processed using ImageJ (v1.440) (78). IFAs for P. knowlesi were performed using blood smears 
fixed with 4% paraformaldehyde for 30 min followed by three washes in PBS and permeabilisation in 
0.1% Triton-X100 for 10 min. Slides were blocked overnight at 4°C in 3% BSA/PBS and then labelled 
with rabbit α-PvHP1 (1:600) and Alexa Fluor 488-conjugated α-rabbit IgG (1:5’000) (Thermo Fisher 
Scientific). The smear was mounted in ProLong Antifade mountant with DAPI (Thermo Fisher 
Scientific). Slides were viewed with a Nikon Ti E inverted microscope using a 100x oil immersion 
objective and imaged with an ORCA Flash 4.0 CMOS camera (Hamamatsu). Images were acquired and 
processed using the Nikon Elements Advanced Research software package. IFAs for P. vivax were 
performed using methanol-fixed thin blood smears. Slides were blocked using 3% BSA/PBS and then 
labeled with α-PvHP1 (1:500) and Alexa Fluor 488- conjugated α-rabbit IgG (1:500) (Thermo Fisher 
Scientific) antibodies in 3% BSA/PBS. Slides were mounted using VECTASHIELD mounting medium 
containing DAPI (Vector Laboratories). Images were taken at 100-fold magnification on a Leica DM 
5000B microscope with a Leica DFC 345 FX camera, acquired via the Leica IM1000 software, and 
processed using Fiji (79). For each experiment, images were acquired and processed with identical 
settings. 
 
Western Blot 
P. berghei, P. chabaudi and P. yoelii schizonts were enriched using a 50-60% Histodenze (Sigma-
Aldrich) gradient. Parasites were released from iRBCs by saponin lysis, resuspended in Urea extraction 
buffer (EMD Millipore) and separated by SDS-PAGE. Proteins were detected using rabbit α-PbHP1 
(1:2’000) antibodies. P. knowlesi A1-H.1 schizonts were enriched on a density cushion of 55% 
Nycodenz (Axis-Shield) stock solution (27.6% (wt/vol) Nycodenz in 10 mM Hepes, pH 7.0) in RPMI-
1640 medium. RBCs were lysed using 0.15% saponin/PBS and the resultant parasite pellet was diluted 
1:100 in Urea extraction buffer (40 mM Tris-HCl, 1 mM EDTA, 8 M Urea, 5% SDS, 1x protease inhibitor 
cocktail (Sigma-Adrich), 1% -mercaptoethanol), mixed with SDS sample buffer and separated by SDS-
PAGE alongside a similarly treated uninfected RBC control. PkHP1 was detected with rabbit α-PvHP1 
antibodies (1:5’000). 
 
Chromatin immunoprecipitation 
For each ChIP reaction, sonicated chromatin containing 500 ng of DNA was incubated in incubation 
buffer (0.75% SDS, 5% Triton-X100, 750 mM NaCl, 5 mM EDTA, 2.5 mM EGTA, 100 mM Hepes, pH 7.4) 
with either 1 µg rabbit α-PfHP1 (for P. falciparum), 1 µg rabbit α-PvHP1 (for P. vivax and P. knowlesi) 
or 1 µg rabbit α-PbHP1 (for P. berghei, P. chaubaudi and P. yoelii) as well as 10 µl protA and 10 µl 
protG Dynabeads suspension (Thermo Fisher Scientific).   
For each sample four ChIP reactions were prepared and incubated overnight at 4°C while rotating. 
Beads were washed twice with wash buffer 1 (0.1% SDS, 0.1% DOC, 1% Triton-X100, 150 mM NaCl, 1 
mM EDTA, 0.5 mM EGTA, 20 mM Hepes, pH 7.4), once with wash buffer 2 (0.1% SDS, 0.1% DOC, 1% 
Triton-X100, 500 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 20 mM Hepes, pH 7.4), once with wash buffer 
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3 (250 mM LiCl, 0.5% DOC, 0.5% NP-40, 1 mM EDTA, 0.5 mM EGTA, 20 mM Hepes, pH 7.4) and twice 
with wash buffer 4 (1 mM EDTA, 0.5 mM EGTA, 20 mM Hepes, pH 7.4). Each wash was performed for 
5 min at 4°C while rotating. Subsequently, immunoprecipitated chromatin was eluted in elution buffer 
(1% SDS, 0.1M NaHCO3) at room temperature. The eluted chromatin samples and the corresponding 
input samples (sonicated input chromatin containing 500 ng DNA) were de-crosslinked in 1% SDS/0.1 
M NaHCO3/1 M NaCl at 45°C overnight while shaking. For each parasite strain or species the separate 
ChIP samples were combined and the DNA was purified using QIAquick MinElute PCR columns 
(Qiagen). 
 
High throughput sequencing 
For each sequencing library 2-10 ng of ChIP or input DNA were end-repaired, extended with 3′ A-
overhangs and ligated to barcoded NextFlex adapters (Bio Scientific) as described previously (80). 
Libraries were amplified (98°C for 2 min; four cycles 98°C for 20 sec, 62°C for 3 min; 62°C for 5 min) 
using KAPA HiFi HotStart ready mix (KAPA Biosystems) and NextFlex primer mix (Bio Scientific) as 
described (46). 225-325 bp fragments (including the 125 bp NextFlex adapter) were size-selected using 
a 2% E-Gel Size Select agarose gel (Thermo Fisher Scientific) and amplified by PCR for eight or ten 
cycles (Table S7) under the same condition as described above. Library purification and removal of 
adapter dimers was performed with Agencourt AMPure XP beads in a 1:1 library:beads ratio (Beckman 
Coulter). ChIP-seq libraries were sequenced for 75 bp single-end reads using the NextSeq 500/550 
High Output v2 kit (Illumina) on the Illumina NextSeq 500 system. 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
 
High throughput sequencing data analysis 
Using BWA samse (v0.7.12-r1039) (81) sequencing reads were mapped against the respective 
reference genomes available on PlasmoDB v26, namely P. berghei ANKA, P. chabaudi chabaudi, 
P. yoelii yoelii YM, P. falciparum 3D7, P. knowlesi H and P. vivax P01 (PlasmoDB v29). Reads from the 
P. falciparum Pf2004 ChIP-seq libraries were additionally mapped against a Pf2004 genome assembly, 
which was obtained after long-read PacBio sequencing in the framework of the Pf3K reference project. 
Mapped reads were filtered to mapping quality ≥15 (SAMtools v1.2) (82) and only uniquely mapped 
reads (3.4-22 million reads for α-HP1 ChIP samples and 6.5-55 million reads for input samples) were 
used for further analysis (Table S7). ChIP-seq data were visualized in the UCSC Genome browser 
(https://genome-store.ucsc.edu/). All libraries were normalized to the number of mapped reads per 
million (RPM) and bedgraph files were generated using BEDtools (v2.20.1) (83). For log2 ratio tracks 
α-HP1 ChIP values were divided by input values and log2-transformed using BEDtools (v2.20.1) (83). 
Within the UCSC genome browser tracks were smoothened and the windowing function was set as 
‘mean’. 
To calculate the HP1 coverage for individual genes, tags were counted in a 1000 bp window (ATG ± 
500 bp) for each coding sequence and offset by +1 to avoid division by zero while calculating fold 
changes in coverage. α-HP1 ChIP-seq and input tag counts were normalized to the number of reads 
per kb per million mapped reads (RPKM). ChIP-seq enrichment values were calculated as α-HP1 ChIP 
[RPKM]/input [RPKM]. Genes encoded by the mitochondrial or apicoplast genomes and nuclear genes 
with low mappability (input RPKM < 5) were excluded from downstream analysis. 
To visualize the genome-wide HP1 coverage in schizont stages of the six Plasmodium species 
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(P. berghei, P. yoelii, P. chaubaudi, P. knowlesi, P. vivax, P. falciparum) the respective reference 
genomes were divided into 1000 bp windows using BEDtools (v2.20.1) (83). For each window ChIP-
seq enrichment values were calculated as described above, log2-transformed and visualized using the 
software SignalMap v2.0 (www.sequencing.roche.com). Windows with less than five tag counts in the 
ChIP-seq and/or the input sample were set to '0' and defined as regions with low mappablity. To 
identify and compare the sets of heterochromatic genes across the six Plasmodium species ChIP-seq 
enrichment values were calculated and assigned to either a ‘heterochromatic’ or ‘euchromatic’ 
compartment. To do so, we fitted a bivariate Gaussian mixture model to the data and calculated the 
probabilities (p) for genes to belong to either one of the two compartments using the modelling tool 
‘normalmixEM‘ from the R package ‘mixtools’. For further analysis genes with p > 0.99999 for the 
‘heterochromatic’ compartment were considered high confidence heterochromatic genes. Genes 
with 0.99999 > p > 0.95 were considered potential heterochromatic genes and genes with p < 0.95 
were placed in the ‘euchromatic’ compartment. To look for orthologs and syntenic orthologs, high 
confidence heterochromatic genes (p > 0.99999) for each species were imputed into PlasmoDB v33. 
For instance, the orthologs (syntenic/non-syntenic) for P. falciparum heterochromatic genes (403 
genes) were transformed into orthologs of P. berghei ANKA, P. yoelii yoelii YM, 
P. chaubaudi chabaudi, P. knowlesi strain H and P. vivax P01 using the function ‘transform by 
orthology’ in PlasmoDB. Similarly, the orthologs for heterochromatic genes in P. vivax (834 genes), 
P. knowlesi (355 genes), P. berghei (192 genes), P. chabaudi (369 genes) and P. yoelii (907 genes) were 
individually transformed into orthologs of the five other Plasmodium species. Ortholog sets 
(syntenic/non-syntenic) among the species were identified using jvenn (Bardou et al., 2014) and 
assigned according to the species identifier pf, pv, pk, pb, pc or py (Tables S1 and S2). 
To investigate the association between heterochromatic region and distribution of kir and SICAvar 
genes as well as interstitial telomere repeat sequences (ITSs) PkHP1 coverage in P. knowlesi schizont 
stages was depicted as described above. Coding sequences of kir/kir-like and SICAvar genes were 
depicted according to their genomic coordinates within the P. knowlesi H genome (PlasmoDB v26). 
ITSs were identified by searching the P. knowlesi genome for occurrences of GGGTTTA or GGGTTCA 
repeats on both strands using regular expression. The number of these sequences were counted at 
every 100 bp window and windows with three or more hits were considered (imperfect repeats with 
mismatches were not considered). To compare PkHP1 occupancy between two clones of P. knowlesi 
(A1-H.1 and A1-C.1) the ratio between PkHP1 occupancy values (ChIP/Input) were calculated for each 
gene. Based on visual inspection of the UCSC Genome browser tracks we considered 2.5-fold 
difference as a marked and likely influential change in in PkHP1 occupancy. Genes with low 
mappability (input RPKM < 5) in at least one of the clones were excluded from downstream analyses. 
To allow direct comparison of HP1 gene coverage across different P. falciparum strains (3D7, Pf2004, 
NF135 and NF54) PfHP1 ChIP-seq reads from all four strains were mapped against the P. falciparum 
3D7 reference genome (PlasmoDB v26). ChIP-seq reads from strain Pf2004 schizonts were additionally 
mapped against the Pf2004 reference genome (Table S7). Note that although matching reference 
genomes do exist for NF54 and NF135 (Plas_falc_NF54_v1 and Plas_falc_NF135_5_C10_v1; 
http://protists.ensembl.org) the assembly and annotation of these reference genomes are 
fragmented and not sufficiently informative for analysis of heterochromatin organization. Genes with 
low mappability (input RPKM < 5) in at least one of the strains were excluded from downstream 
analyses. For the remaining genes ChIP-seq enrichment values were z-score transformed, k-means 
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clustered and depicted as heatmap using the R package ‘pheatmap’. To visualize the average HP1 
occupancy for all strains investigated in this study (Figure 4B), the 3D7 reference genome was divided 
into 1000 bp windows using BEDtools (v2.20.1) (83). For each window ChIP-seq enrichment values 
were calculated as described above, z-score transformed, averaged across the strains and visualized 
using the software SignalMap v2.0 (www.sequencing.roche.com). Coding sequences of the genes in 
k-means clusters 5 to 11 were depicted according to their location within the P. falciparum 3D7 
genome (PlasmoDB v26).   
For the comparison of intra-erythrocytic stages, ChIP-seq enrichment values were calculated using 
ChIP RPKM values of ring stages (8-16 hpi), trophozoites (24-32 hpi) or schizonts (40-48 hpi) and input 
RPKM values obtained from the schizont sample. The relation between PfHP1 gene coverage and 
transcript abundance was visualized by sorting PfHP1 ChIP-seq enrichment values for each gene in 
schizont stages from high to low, plotted against the corresponding transcript abundance value 
(RPKM). For the latter, directional RNA-seq data from eight intra-erythrocytic stages (46) were aligned 
against the annotated P. falciparum 3D7 transcriptome (PlasmoDB v26) and filtered for uniquely 
mapped reads and mapping quality ≥ 15. Reads were separated according to the strand they mapped 
to (sense strand FLAG16; antisense strand FLAG0). Reads aligning to the sense strand were used for 
further analysis. For each transcript (excluding mitochondrial RNA and apicoplast RNA) tags were 
counted, offset by +1 and normalized to the number of reads per kb per million mapped reads. For 
each gene the maximum transcript abundance value (RPKM) observed during intra-erythrocytic 
development was plotted in the scatter plot and var genes as well as genes displaying clonally variant 
expression (16) were specifically highlighted. 
To assess differences in PfHP1 occupancy between Pf2004 schizonts, stage II/III gametocytes and 
stage IV/V gametocytes ChIP-seq reads were mapped against the P. falciparum 3D7 genome 
(PlasmoDB v26) and the P. falciparum Pf2004 reference genome (Table S7). Genes with low 
mappability (input RPKM < 5) in at least one of the stages were excluded from downstream analysis. 
For the remaining genes ChIP-seq enrichment values were z-score transformed, k-means clustered 
and depicted as a heatmap using the R package ‘pheatmap’. To visualize the genome-wide PfHP1 
occupancy for schizont stages and stage IV/V gametocytes (Figure 6C) the P. falciparum 3D7 reference 
genome was divided into 1000 bp windows using BEDtools (v2.20.1) (83). For each window ChIP-seq 
enrichment values were calculated as described above, z-score transformed and visualized using the 
software SignalMap v2.0 (www.sequencing.roche.com). Coding sequences of the genes in k-means 
clusters 5 and 6 to 8 were depicted according to their location within the P. falciparum 3D7 genome 
(PlasmoDB v26). Additionally, we visually compared our Pf2004 PfHP1 ChIP-seq data with the midgut 
oocyst and salivary gland sporozoite H3K9me3 ChIP-seq datasets generated by Gómez-Díaz and 
colleagues (65) using the UCSC genome browser (https://genome-store.ucsc.edu/). Midgut oocyst 
and salivary gland sporozoite H3K9me3 ChIP-seq and input data (GEO accession numbers 
GSM1981878, GSM1981880, GSM1981883, GSM1981885) were aligned to the P. falciparum 3D7 
reference genome (PlasmoDB v26) (Table S7) and processed as described above to generate bedgraph 
log2 H3K9me3-ChIP/Input ratio files. 
 
Data availability 
The ChIP-seq data have been deposited in the Gene Expression Omnibus repository under ID code 
GSE102695. The sequence and annotation of the Pf2004 genome is available at 
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ftp://ftp.sanger.ac.uk/pub/project/pathogens/Plasmodium/falciparum/PF3K/SecondSetReferenceG
enomes/DraftAnnotation/Pf2004/. 
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Supplementary information 
SUPPLEMENTARY FIGURES 
 
 
 
Figure S1. Phylogenetic analysis of HP1 orthologs in Plasmodium species (related to Figures 1 and 
S2, and STAR Methods). 
(A) Multiple sequence alignment of Plasmodium HP1 orthologs. Conserved residues are marked by 
asterisks. The positions of the PfHP1 chromo- and chromoshadow domains (11) are indicated above 
the alignment. (B) Phylogenetic tree of Plasmodium HP1 orthologs. Bootstrap values are indicated at 
the nodes (based on 1’000 replicates). Antibodies used to immune-precipitate HP1-associated 
chromatin from the six Plasmodium species for ChIP-seq experiments are shown on the right. 
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Figure S2. Detection of HP1 by IFAs and Western blot analysis (related to Figures 1 and S1, and STAR 
Methods). 
(A) Representative IFA images obtained with α-PbHP1 antibodies showing perinuclear HP1 localisation 
(green) in P. chabaudi, P. berghei and P. yoelii trophozoite and schizont stage parasites. Nuclei were 
stained with DAPI (blue). DIC, differential interference contrast. Scale bar, 2.5 µm. The red-framed 
images are identical to those presented in Figure 1A. (B) α-PbHP1 Western blot analysis detects a 
single protein at sizes expected for PyHP1, PbHP1 and PcHP1 (~32-33 kDa) in whole cell lysates 
generated from P. yoelii (lane 2), P. berghei (lane 3) and P. chabaudi (lane4), respectively, but not in 
uninfected RBCs (lane 1; negative control). The lower band in lane 4 may represent a proteolytic 
degradation product of PcHP1. Generation of the polyclonal affinity-purified α-PbHP1 antibodies is 
explained in detail in the Experimental Procedures section. (C) Representative IFA images obtained 
with α-PvHP1 antibodies showing perinuclear HP1 localisation (green) in P. vivax trophozoites (note 
that schizont stages were not observed in this sample) and P. knowlesi trophozoite and schizont stage 
parasites. Nuclei were stained with DAPI (blue). DIC, differential interference contrast. Scale bar, 2.5 
µm. The red-framed images are identical to those presented in Figure 1A. (D) α-PvHP1 Western blot 
analysis detects a single protein at the expected size for PkHP1 (~32 kDa) in whole cell lysates 
generated from P. knowlesi (lane 2), but not in uninfected RBCs (lane 1; negative control). Generation 
of the polyclonal affinity-purified α-PvHP1 antibodies is explained in detail in the Experimental 
Procedures section. 
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Figure S3: Genome-wide overviews of HP1 localization in schizont stages of six different 
Plasmodium species (related to Figure 1).  
Chromosome maps depicting HP1-demaracted heterochromatin over all 14 chromosomes of schizont  
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stages from P. falciparum (3D7), P. vivax, P. knowlesi (A1-C.1) P. chabaudi, P. berghei and P. yoelii.  
Log2-transformed HP1-ChIP/Input ratios were calculated in 1000 bp windows. Regions with low 
mappability are highlighted by grey bars.  
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Figure S4: Genome-wide association of SICAvar genes, kir genes and ITS elements with 
heterochromatic regions in P. knowlesi (related to Figure 1). 
Chromosome maps depicting HP1-demaracted heterochromatin on all 14 chromosomes in P. knowlesi 
(A1-C.1). Log2-transformed HP1-ChIP/Input ratios were calculated in 1000 bp windows. Coding 
sequences of kir/kir-like genes and SICAvar genes are depicted in blue and orange, respectively. 100 
bp windows containing three or more interstitial telomere repeat sequences (ITSs) are marked in red. 
Regions with low mappability are highlighted by grey bars. 
 
 
 
 
 
 
 
 
Figure S5. Strain-specific differences in heterochromatin organization in syntenic regions of the 
genome (related to Figure 4 and Table S4). 
(A) Log2-transformed PfHP1-ChIP/Input ratio tracks generated from P. falciparum Pf2004 and 3D7  
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schizont stage parasites. The upper tracks were generated by 
mapping 3D7 (green) and Pf2004 (blue) ChIP-seq reads against 
the 3D7 reference genome (PlasmoDB v26). The Pf2004 ChIP-
seq data were also mapped against the matching P. falciparum 
Pf2004 genome (lower tracks). Syntenic regions are marked in 
grey and regions with changing PfHP1 occupancy within these 
regions are framed. Coding sequences are shown as blue (sense 
strand) and red (antisense strand) boxes. (B) Violin plot of gene 
expression variation in the heterochromatic and euchromatic 
groups of genes. Y-axis: standard deviation (SD) of relative gene 
expression levels determined by microarray analysis in 549 
P. falciparum field samples (45) (only group A isolates, which all 
consisted of young ring stage parasites and displayed 
consistently low gametocyte densities (45), were included in this 
analysis). X-axis: genes with invariable HP1 occupancy (clusters 
1-4) and variable HP1 occupancy (clusters 5-11) are shown in 
brown and blue, respectively. Euchromatic genes (clusters 12-
14) are shown in grey. p values of Wilcoxon Rank Sum tests are 
shown on top for each pair of groups. 
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Figure S6. Altered heterochromatin organization in P. falciparum gametocytes, midgut oocysts and 
salivary gland sporozoites (related to Figure 6 and Table S6). 
(A) Log2-transformed PfHP1-ChIP/Input ratio tracks generated from P. falciparum Pf2004 schizonts 
and stage II/III and IV/V gametocytes. ChIP-seq reads were aligned against the Pf2004 genome and 
depicted as in Figure 6A. Genes involved in knob formation (orange) and early gametocyte markers 
(purple) are highlighted and their Pf2004 Gene IDs are shown. Coding sequences are shown as blue 
(sense strand) and red (antisense strand) boxes. (B) Log2-transformed PfHP1-ChIP/Input ratio tracks 
from different P. falciparum life cycle stages mapped against the 3D7 reference genome. The 
heterochromatic domains on chromosome 2 and zoom-in views of the proximal and distal ends of 
chromosome 10 and 11, respectively, are depicted as representative examples. PfHP1-ChIP/Input 
ratio tracks of Pf2004 schizonts, stage II/III and IV/V gametocytes are depicted in blue. H3K9me3-
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ChIP/Input ratio tracks of midgut oocysts and salivary gland sporozoites from P. falciparum field 
isolates (65) are depicted in brown. Genes differentially marked in sporozoites compared to 
gametocytes are highlighted in pink (the corresponding Gene IDs are listed below the tracks). Coding 
sequences are shown as blue (sense strand) and red (antisense strand) boxes. 
 
 
 
SUPPLEMENTARY TABLES 
 
Table S1-S7, please download online. 
 
Table S1. Genome-wide HP1 occupancy in six Plasmodium species (related to Figures 1 and 2, and 
Tables S2, S3, S4, S5 and S7). 
ChIP/input enrichment values were calculated over a 1000 bp window (ATG ± 500 bp) for each coding 
sequence of the respective reference genomes in P. falciparum, P. vivax, P. knowlesi, P. chabaudi, 
P. berghei and P. yoelii schizont stages. Column A: chromosome number. Columns B-C: Nucleotide 
positions at the start and end of each 1000 bp window. Columns D-E: Gene IDs and annotations. 
Columns F-G: RPKM values for the α-ChIP and input samples. Column H: HP1 enrichment values 
(ChIP/input ratio). Columns I-J: Probability values (p) for genes to belong to either the euchromatic or 
the heterochromatic group of genes. Column K: Heterochromatic gene family classification. Columns 
L-M: Plasmodium species encoding an ortholog or syntenic ortholog. Columns N-O: Orthologs are 
heterochromatic in multiple species or a single species only. High-confidence heterochromatic genes 
(p > 0.99999) and potential heterochromatic genes (0.99999 > p > 0.95) are highlighted in orange and 
light blue, respectively. Genes with very low mappability (RPKM value < 5 in at least one input sample) 
are highlighted in grey and were excluded from downstream analyses. This file contains six 
worksheets. (xlsx format). 
 
Table S2. List of all HP1-enriched genes that have orthologs in at least one other Plasmodium species 
(related to Figures 1 and 2, and Tables S1 and S7). 
Columns A-B: Gene IDs and annotations. Column C: HP1 enrichment values (ChIP/input ratio). Column 
D: Heterochromatic gene family classification. Columns E-F: Plasmodium species encoding an ortholog 
or syntenic ortholog. Column G: Number of Plasmodium species in which the orthologous gene is HP1-
enriched. Columns H-AB: Gene IDs of orthologs in P. falciparum, P. vivax, P. knowlesi, P. chabaudi, 
P. berghei and P. yoelii. HP1-enriched orthologs are highlighted in orange. (xlsx format). 
 
Table S3. Genome-wide PkHP1 occupancy in P. knowlesi clones A1-H.1 and A1-C.1 (related to Figure 
3, and Tables S1 and S7). 
ChIP/input enrichment values were calculated over a 1000 bp window (ATG ± 500 bp) for each coding 
sequence of the P. knowlesi reference genome in P. knowlesi clones A1-H.1 and A1-C.1 schizont 
stages. Column A: chromosome number. Columns B-C: Nucleotide positions at the start and end of 
each 1000 bp window. Columns D-E: Gene IDs and annotations. Columns F-I: RPKM values for the α-
ChIP and input samples for each of the two clones. Columns J-K: PkHP1 enrichment values (ChIP/input 
ratio) for each of the two clones. Column L: fold change in PkHP1 occupancy in A1-H.1 compared to 
A1-C.1. Genes with ≥ 2.5-fold higher or lower PkHP1 occupancy in A1-H.1 are highlighted in light or 
dark orange, respectively. The ChIP-seq values for P. knowlesi clone A1-C.1 are identical to those listed 
in Table S1. Genes with very low mappability (RPKM value < 5 in at least one input sample) are 
highlighted in grey and were excluded from downstream analyses. (xlsx format). 
 
Chapter 4
 
 
126 
Table S4. Genome-wide HP1 occupancy in four different P. falciparum strains (related to Figures 4 
and S4, and Tables S1 and S7). 
ChIP/input enrichment values were calculated over a 1000 bp window (ATG ± 500 bp) for each coding 
sequence of the P. falciparum 3D7 reference genome in schizont stages of P. falciparum strains 
Pf2004, NF135, NF54, and 3D7. Column A: chromosome number. Columns B-C: Nucleotide positions 
at the start and end of each 1000 bp window. Columns D-E: Gene IDs and annotations. Columns F-M: 
RPKM values for the α-ChIP and input samples for each of the four strains. Columns N-Q: PfHP1 
enrichment values (ChIP/input ratio) for each of the four strains. Columns R-U: z-score-transformed 
ChIP enrichment values for each of the four strains. Column V: k-means cluster numbers (1-14). 
Column W: gene family classification. Column X: heterochromatic pseudogenes. Column Y: genes 
previously shown to be variantly expressed in vitro (16). Column Z: degree of variation in gene 
expression (SD) in field samples (45). Genes with variable PfHP1 occupancy between the strains are 
marked in blue (k-means clusters 5 to 11). Genes with very low mappability (RPKM value < 5 in at least 
one input sample) are highlighted in grey and were excluded from downstream analyses. The ChIP-
seq values for P. falciparum 3D7 schizonts are identical to those listed in Tables S1 and S5. (xlsx 
format). 
 
Table S5. Genome-wide PfHP1 occupancy in ring stages, trophozoites and schizonts (related to 
Figure 5, and Tables S1 and S7). 
ChIP/input enrichment values were calculated over a 1000 bp window (ATG ± 500 bp) for each coding 
sequence of the P. falciparum 3D7 reference genome in ring stages, trophozoites and schizonts stages 
of P. falciparum 3D7 parasites. Column A: chromosome number. Columns B-C: Nucleotide positions 
at the start and end of each 1000 bp window. Columns D-E: Gene IDs and annotations. Columns F-H: 
RPKM values for theα-ChIP samples for each of the three IDC stages. Column I:  RPKM values for the 
input sample from schizonts. Columns J-L: PfHP1 enrichment values (ChIP/input ratio) for each of the 
three IDC stages. Column M: peak transcript abundance during the IDC (RNA-seq RPKM values from 
(46). Column N: genes previously shown to be variantly expressed in 3D7 parasites (16). Genes with 
very low mappability (RPKM value < 5 in the input sample) are highlighted in grey and were excluded 
from downstream analyses. The ChIP-seq values for P. falciparum 3D7 schizonts are identical to those 
listed in Tables S1 and S4. (xlsx format). 
 
Table S6. Genome-wide HP1 occupancy in P. falciparum schizonts and gametocytes (related to 
Figures 6 and S5, and Tables S4 and S7). 
ChIP/input enrichment values were calculated over a 1000 bp window (ATG ± 500 bp) for each coding 
sequence of the P. falciparum 3D7 reference genome in schizont stages, stage II/III and stage IV/V 
gametocytes of P. falciparum strain Pf2004. Column A: chromosome number. Columns B-C: 
Nucleotide positions at the start and end of each 1000 bp window. Columns D-E: Gene IDs and 
annotations. Columns F-K: RPKM values for the α-ChIP and input samples for each of the three stages. 
Columns L-N: PfHP1 enrichment values (ChIP/input ratio) for each of the three stages. Columns O-Q: 
z-score-transformed ChIP enrichment values for each of the three stages. Column R: k-means cluster 
numbers (1-12). Genes with lower or higher PfHP1 occupancy in gametocytes compared to schizonts 
are marked in green (k-means cluster 5) or blue (k-means clusters 6 to 8), respectively. Genes with 
very low mappability (RPKM value < 5 in at least one input sample) are highlighted in grey and were 
excluded from downstream analyses. The ChIP-seq values for P. falciparum Pf2004 schizonts are 
identical to those listed in Table S4. (xlsx format). 
 
Table S7. ChIP-seq libraries (related to Tables S1 to S6, and STAR Methods). 
Column A: Information on the species, strains, clones and stages of Plasmodium parasite samples 
harvested for ChIP-seq experiments. Column B: DNA sample type used for library preparation. Column 
C: Antibodies used in the ChIP experiment. Column D: Number of PCR cycles used in the first and 
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second library amplification. Columns E-F: Number of reads before filtering (total) and after filtering 
for uniquely mapping reads (unique). Column G: Versions of the reference genomes used for read 
mapping. 
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Malaria is caused by Plasmodium parasites that proliferate in the bloodstream. During 
each replication cycle some parasites differentiate into gametocytes, the only forms able 
to infect the mosquito vector and transmit malaria. Sexual commitment is triggered by 
activation of AP2-G, the master transcriptional regulator of gametocytogenesis. 
Heterochromatin protein 1 (HP1)-dependent silencing of ap2-g prevents sexual 
conversion in proliferating parasites. Here, we identified Plasmodium falciparum 
gametocyte development 1 (GDV1) as an upstream activator of sexual commitment. We 
found that GDV1 targeted heterochromatin and triggered HP1 eviction thus de-repressing 
ap2-g. Expression of GDV1 was responsive to environmental triggers of sexual conversion 
and controlled via a gdv1 antisense RNA. Hence, GDV1 appears to act as cell fate decision 
factor that induces sexual differentiation by antagonizing HP1-dependent gene silencing. 
Heterochromatin protein 1 (HP1) is a conserved regulator of heterochromatin formation, 
heritable gene silencing and variegated gene expression (1). In Plasmodium falciparum, 
HP1-dependent clonally variant expression allows parasites to adapt rapidly to 
environmental challenges encountered during infection (2-4). For example, immune 
evasion via antigenic variation of var/PfEMP1 is the hallmark of Plasmodium survival. Other 
processes, such as expression of red blood cell (RBC) invasion ligands or nutrient 
transporters, are similarly regulated in this parasite (4). Most clonally variant genes cluster 
in subtelomeric domains but some also occur in chromosome-internal heterochromatic 
regions. In addition, HP1 forms microdomains at some euchromatic genes (2). One of these 
encodes the transcription factor AP2-G that is required for sexual conversion and 
differentiation (2, 5-7). HP1-dependent regulation of ap2-g controls the rate at which 
parasites commit to sexual differentiation (7).  
To explore the mechanisms regulating HP1 occupancy in P. falciparum we identified HP1-
interacting proteins by liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
analysis of native HP1 complexes that were purified by co-immunoprecipitation (co-IP) from 
parasites expressing GFP-tagged HP1 (7) (Fig. 1A and Table S3). Interestingly, we 
consistently observed GDV1 among the potential HP1 interaction partners (Table S1). GDV1 
is a nuclear protein implicated in sexual commitment and early gametocytogenesis but its 
exact function remains unknown (8). We therefore created a parasite line for the 
conditional expression of fluorescently labelled ectopic GDV1 (GDV1-GFP-DD) (Fig. 1B). 
Proteins tagged with the immunophilin protein-folding chaperone FKBP destabilisation 
domain (DD) are proteolytically degraded unless cells are cultured in presence of Shield-1, 
a small molecule ligand stabiliser (9, 10). Thus, GDV1-GFP-DD is barely detectable in 
parasites cultured in absence of Shield-1 (3D7/GDV1-GFP-DDOFF), but its expression is 
markedly induced in parasites grown in presence of Shield-1 (3D7/GDV1-GFP-DDON) (Fig. 1, 
B and C). In agreement with the co-IP results GDV1-GFP-DD co-localizes with HP1 at the 
nuclear periphery (Fig. 1C and Fig. S1). Furthermore, we found that recombinant HP1 and 
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GDV1 formed a complex (Fig. S1) and that HP1 co-purified with GDV1-GFP-DD in reverse co-
IPs (Fig. 1D, Tables S2 and S4). The chromodomain-helicase-DNA-binding protein 1 (CHD1) 
and a protein of unknown function (PF3D7_1451200) also consistently co-purified with both 
HP1 and GDV1-GFP-DD (Tables S1 and S2). Given that CHD1 plays important roles in cell fate 
decision and heterochromatin remodelling in other organisms (11, 12) and that GDV1 is 
implicated in gametocytogenesis (8) it appears that this putative regulatory complex may 
function in activating sexual commitment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. GDV1 interacts with HP1.  
(A) Endogenous hp1 locus in 3D7/HP1-GFP parasites 
and α-HP1 Western blots of the α-HP1-GFP co-IP and 
negative control samples. Results are representative 
of three biological replicates. (B) gdv1-gfp-dd 
expression plasmid and α-GFP Western blots of 
3D7/GDV1-GFP-DDOFF and 3D7/GDV1-GFP-DDON 
parasites. α-HP1 antibodies served as loading control. 
(C) GDV1-GFP-DD/HP1 co-localisation IFAs in 
3D7/GDV1-GFP-DDOFF and 3D7/GDV1-GFP-DDON 
trophozoites (24-32 hpi). DIC, differential 
interference contrast. Scale bar, 2.5 µm (0.5 µm for 
the magnified views in the rightmost images). Results 
are representative of three biological replicates. (D) 
α-GFP and α-HP1 Western blots of the α-GDV1-GFP-
DD co-IP and negative control samples. Results are 
representative of three biological replicates. 
 
 
Malaria parasites proliferate by iterative rounds of intra-erythrocytic replication through 
schizogony, merozoite release and RBC re-invasion. The decision to enter 
gametocytogenesis is made in the cell cycle prior to sexual differentiation; sexually 
committed schizonts release merozoites that invade RBCs and differentiate all into either 
female or male gametocytes (13, 14) (Fig. 2A).  
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Fig. 2. GDV1 induces sexual commitment and differentiation.  
(A) Schematic illustrating the iterative cycles of schizogony and RBC re-invasion (top) or sexual 
commitment, RBC re-invasion and gametocyte differentiation (bottom). ER/LR, early/late ring stages; 
T, trophozoites; ES/LS, early/late schizonts; gen, generation; hpi, hours post-invasion; asterisk, time 
point of α-Pfs16 IFAs. (B) Top panel: α-Pfs16 IFAs identifying stage I gametocytes. Quantification of 
Pfs16-positive parasites is shown at the right (results are the mean of three biological replicates (200 
infected RBCs counted per sample); error bars indicate SD). Bottom panel: Giemsa-stained blood 
smears showing stage V gametocytes. Scale bars, 5 µm. (C) Western blot showing GDV1-GFP-DD 
expression in presence of increasing Shield-1 concentrations. α-GAPDH and α-HP1 antibodies served 
as loading controls. Percentages of Pfs16-positive parasites are shown at the bottom (400 infected 
RBCs counted per sample). (D) Endogenous gdv1 locus in 3D7/3xHA-GDV1 parasites and 3xHA-
GDV1/HP1 co-localisation IFAs in trophozoites (24-32 hpi). Scale bar, 2.5 µm. (E) Sexual conversion 
rates in 3D7/3xHA-GDV1 parasites cultured in presence or absence of choline (results are the mean 
of three biological replicates (>190 infected RBCs counted per sample); error bars indicate SD). (F) Left 
panel: Western blot showing 3xHA-GDV1 expression levels in 3D7/3xHA-GDV1 parasites cultured in 
presence or absence of choline. α-HP1 antibodies served as loading control. Right panel: Percentages  
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of 3xHA-GDV1-positive parasites in presence or absence of choline (results are the mean of three 
biological replicates (>100 infected RBCs counted per sample); error bars indicate SD). (G, H) 
Comparison of mean expression levels of all genes in 3D7/GDV1-GFP-DDON versus 3D7/GDV1-GFP-
DDOFF (G) and F12/GDV1-GFP-DDON versus F12/GDV1-GFP-DDOFF parasites (H). Significantly de-
regulated genes are indicated by circles (mean fold change cut-off >1.5; q-value (fdr) cut-off <0.15). 
Known early gametocyte markers (7, 8, 17) are labelled orange. Line graphs show fold changes in 
expression across seven consecutive TPs. pfs16/pfg27/gexp02, early gametocyte markers (15, 22, 32); 
pk4 (PF3D7_0628200)/glu-tRNA-l. (PF3D7_1331700), control genes (7). 
 
To test if GDV1 triggers sexual commitment, 3D7/GDV1-GFP-DDOFF parasites were split and 
cultured in the absence or presence of Shield-1. After re-invasion, stage I gametocytes were 
quantified by immuno-fluorescence assays (IFA) using antibodies against the gametocyte 
marker Pfs16 (15). Strikingly, the 3D7/GDV1-GFP-DDON population displayed a sexual 
conversion rate of 57.2% (+/- 10.0 SD) compared to 11.0% (+/- 2.4 SD) in 3D7/GDV1-GFP-
DDOFF parasites, and these gametocytes differentiated normally into both male and female 
gametocytes and showed a typical female-biased sex ratio (Fig. 2B and Fig. S2). Moreover, 
Shield-1 titration revealed a positive correlation between ectopic GDV1-GFP-DD expression 
levels and sexual conversion rates (Fig. 2C). To test if endogenous GDV1 levels similarly 
correlate with gametocyte conversion we used CRISPR/Cas9-based gene editing to append 
a triple hemagglutinin (HA) tag to the N-terminus of GDV1 (3D7/3xHA-GDV1) (Fig. S3). 
Endogenous 3xHA-GDV1 co-localised with HP1 as expected (Fig. 2D and Fig. S3) but was only 
expressed in some parasites. We next quantified 3xHA-GDV1 expression under conditions 
that either suppress or favour sexual conversion. To this end, we made use of the recent 
discovery of choline as an inhibitor of sexual commitment (16). 3D7/3xHA-GDV1 parasites 
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cultured in the presence or absence of 2 mM choline displayed sexual commitment rates of 
1.8% (+/- 0.3 SD) or 30.9% (+/- 3.8 SD), respectively (Fig. 2E). Strikingly, parasites cultured 
in the absence of choline showed markedly increased 3xHA-GDV1 expression levels (Fig. 
2F). This was accounted for by a higher proportion of 3xHA-GDV1-positive cells (48.6% (+/- 
3.4 SD) in absence compared to 16.4% (+/- 1.8 SD) in presence of choline) (Fig. 2F) and 
comparatively higher 3xHA-GDV1 expression levels in individual 3xHA-GDV1-positive 
parasites (Fig. S3). Together, these results show that GDV1 activates sexual conversion in a 
dose-dependent manner and that endogenous GDV1 expression can be induced by 
environmental signals triggering sexual commitment. 
We next performed comparative transcriptome analyses using two-colour microarrays. 
3D7/GDV1-GFP-DDOFF ring stage parasites were split, cultured separately in absence or 
presence of Shield-1 and total RNA was harvested at seven paired time points spanning the 
remaining 24 hours of generation 1 (24-32 hours post-invasion (hpi); 32-40 hpi, 40-48 hpi) 
and the first 40 hours after re-invasion in generation 2 (8-16 hpi, 16-24 hpi, 24-32 hpi, 32-
40 hpi) (Fig. 2A). As expected, GDV1-GFP-DD expression triggered a transcriptional response 
characteristic of sexual commitment and early differentiation. This was evident from the 
induction of ap2-g in generation 1, followed by activation of early gametocyte markers (5, 
7, 8, 17) after re-invasion (Fig. 2G, Fig. S4 and Table S5). In F12 parasites, a 3D7-derived 
gametocyte-deficient clone carrying a loss-of-function mutation in ap2-g (5, 18), GDV1-GFP-
DD expression still activated ap2-g but failed to launch a sexual differentiation response 
(Fig. 2H and Table S6). Next to ap2-g only eight other genes were significantly induced in 
F12/GDV1-GFP-DDON parasites, all of which are marked by HP1. This set included dblmsp2, 
which was also induced in 3D7/GDV1-GFP-DDON parasites (Fig. 2, G and H). Given that 
DBLMSP2 is a merozoite surface antigen expressed only in a small subpopulation of 
schizonts (19, 20) the GDV1-dependent activation of the dblmsp2 locus suggests it may be 
expressed specifically in sexually committed schizonts. In summary, these findings show 
that GDV1 is an upstream activator of sexual commitment and likely triggers this process by 
antagonising HP1-dependent silencing of ap2-g. 
To test if GDV1 associates with heterochromatin in vivo we conducted comparative ChIP-
seq experiments. 3D7/GDV1-GFP-DDOFF parasites were split at 28-34 hpi, cultured in parallel 
in the absence or presence of Shield-1 and paired chromatin samples were harvested two 
(30-36 hpi), six (34-40 hpi) and ten (38-44 hpi) hours after Shield-1 addition. We found that 
(1) GDV1-GFP-DD associates specifically with heterochromatin throughout the genome (Fig. 
3A, Fig. S5, Table S7); (2) GDV1-GFP-DD occupancy was markedly higher in 3D7/GDV1-GFP-
DDON compared to 3D7/GDV1-GFP-DDOFF parasites (Fig. S5, Table S7); and (3) GDV1-GFP-DD 
occupancy is highly correlated with that of HP1 (Fig. 3B). Moreover, GDV1-GFP-DD 
occupancy peaked six hours post-induction and decreased substantially thereafter (Fig. 3A, 
Fig. S5, Table S7). This drop in GDV1-GFP-DD signal coincided with a reduced HP1 occupancy 
over heterochromatic genes in 3D7/GDV1-GFP-DDON compared to 3D7/GDV1-GFP-DDOFF  
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Fig. 3. GDV1 associates with heterochromatin throughout the genome and triggers HP1 removal at 
ap2-g.  
(A) HP1 over input ratio track from 3D7/GDV1-GFP-DDOFF schizonts (38-44 hpi, TP3) (grey). ChIP-seq 
subtraction tracks display relative enrichment of GDV1-GFP-DD in 3D7/GDV1-GFP-DDON schizonts 
two (30-36 hpi, TP1), six (34-40 hpi, TP2) and ten (38-44 hpi, TP3) hours after Shield-1 addition (blue), 
and relative depletion of HP1 in 3D7/GDV1-GFP-DDON parasites at TP3 (green). (B) Correlation 
between GDV1-DD-GFP enrichment in 3D7/GDV1-GFP-DDON (34-40 hpi, TP2) and HP1 enrichment in 
3D7/GDV1-GFP-DDOFF schizonts at each coding region. r, Pearson correlation coefficient. (C) Fold 
change in HP1 enrichment upon GDV1-GFP-DD overexpression in relation to HP1 enrichment in 
3D7/GDV1-GFP-DDOFF schizonts for each heterochromatic gene. (D) Zoom-in view of the 
enrichment/subtraction tracks at the ap2-g locus. 
 
parasites (Fig. 3, A and C, Table S7). While the vast majority of heterochromatic loci, in 
particular those displaying high HP1 occupancy such as var genes, displayed marginally 
decreased HP1 levels, some genes exhibited as much as 40% reduced HP1 occupancy (Fig. 
3C and Table S7). This group of genes includes ap2-g and most known HP1-associated early 
gametocyte markers including geco (21), pfgexp17 (22) and pfg14_748 (8, 17) (Fig. 3, C and 
D, Table S7). These data are consistent with the microarray results, where GDV1-GFP-DD 
expression activated ap2-g and early gametocyte genes but had no effect on the expression 
of the bulk of heterochromatic genes (Fig. 2, G and H). 
Of note, given the 50-60% sexual conversion rate observed for 3D7/GDV1-GFP-DDON 
parasites (see above), a 30-40% reduction in HP1 occupancy indicates that HP1 may be 
depleted at these loci specifically in sexually committed parasites but single cell approaches 
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are required to confirm this hypothesis. Overall, we suggest that GDV1 destabilises 
heterochromatin and thus allows specific transcription factors to activate expression of ap2-
g and other gametocyte-specific heterochromatic genes, and this may play an important 
role in the positive auto-regulatory feedback loop proposed to reinforce AP2-G expression 
in committed parasites (5, 6, 23). How GDV1 achieves specificity in unlocking specific HP1-
associated genes despite binding heterochromatin genome-wide is a challenging question 
to be addressed in the future.  
Since GDV1 activates sexual commitment, the question arises of how parasites limit GDV1 
expression to prevent sexual conversion in asexual schizonts. A recent study identified a 
multi-exon long non-coding gdv1 antisense RNA (asRNA) that initiates downstream of the 
gdv1 locus and overlaps with the ATG start codon of gdv1 (24), which is a hallmark feature 
of regulatory asRNAs (25). To investigate if the gdv1 asRNA participates in regulating sexual 
commitment we created a gdv1 asRNA loss-of-function mutant in F12 parasites (F12/gdv1-
asKO) (Fig. 4A and Fig. S6). Strand-specific RNA-seq analysis identified a small set of genes 
that were consistently differentially expressed between F12/gdv1-asKO and F12 wild-type 
parasites (17 up- and 23 down-regulated genes) (Fig. 4B, Table S8). Strikingly, and similar to 
F12 parasites expressing ectopic GDV1-GFP-DD (Fig. 2H), ap2-g, dblmsp2 and two early 
gametocyte genes (pfg14_748, PF3D7_1477400) (8, 17) were markedly induced in 
F12/gdv1-asKO parasites, and all except one up-regulated gene are HP1-associated genes 
(Fig. 4B, Fig. S6, Table S8). gdv1 sense transcripts were slightly increased in the F12/gdv1-
asKO population, while gdv1 antisense transcripts were undetectable as expected (Fig. 4, B 
and C, Fig. S6, Table S8).  
These results indicated that the gdv1 asRNA acts as a negative regulator of GDV1 
expression. To confirm this hypothesis, we tagged endogenous GDV1 in these parasites 
(F12/3xHA-GDV1/gdv1-asKO) and observed that indeed almost all parasites expressed 
3xHA-GDV1 (96.7% +/- 2.5 SD) (Fig. S7). Lastly, we show that deletion of the gdv1 asRNA 
locus in a conditional AP2-G mutant resulted in a markedly increased production of 
gametocytes (Fig. S8 and supplementary text). Together, these findings demonstrate a 
central role for the gdv1-asRNA in regulating GDV1-dependent activation of sexual 
commitment. We anticipate this mechanism likely involves inhibiting GDV1 expression by 
interference with gdv1 mRNA transcription, stability or translation, similar to asRNA-
mediated gene regulation in other organisms (26). In conclusion, we identified GDV1-
mediated heterochromatin destabilisation as an epigenetic control strategy regulating 
sexual cell fate decision in malaria parasites. Our discovery of the gdv1-asRNA as a negative 
regulator of sexual commitment is reminiscent of lncRNA-mediated control of 
gametogenesis in yeasts (27, 28). In S. cerevisiae, nutritional stress triggers gametogenesis 
by activating the transcriptional regulator Inducer of Meiosis 1 (IME1) (28). A lncRNA in the 
ime1 promoter and antisense transcription of ime4 are key factors in preventing 
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Fig. 4. A gdv1 antisense RNA antagonises GDV1-dependent sexual commitment.  
(A) gdv1 locus in F12 wild-type and F12/gdv1-asKO parasites. The gdv1 sense transcript (blue), five-
exon gdv1-asRNA (24) (red) and hdhfr resistance marker (brown) are highlighted. (B) Comparison of 
gene expression levels in F12 wild-type and F12/gdv1-asKO early (ES) and late (LS) schizonts. Genes 
de-regulated > 5-fold in both TPs are indicated by circles. (C) UCSC genome browser screenshots of 
RNA-seq coverage plots over the gdv1 locus in F12 wild-type and F12/gdv1-asKO early (ES) and late 
(LS) schizonts. The hdhfr resistance cassette downstream of the gdv1 locus in F12/gdv1-asKO parasites 
and absent in the 3D7 reference genome is indicated by a brown box. (D) Endogenous gdv1 locus in 
F12/3xHA-GDV1/gdv1-asKO parasites and α-HA overview IFA in early schizonts (ES, 32-40 hpi). DIC, 
differential interference contrast. Scale bar, 5 µm. Percentage of 3xHA-GDV1-positive parasites is 
shown at the right (results are the mean of three biological replicates (100 infected RBCs counted per 
sample); error bars indicate SD). 
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IME1 expression under non-inducing conditions (29, 30). These parallels raise the exciting 
possibility that evolutionary divergent unicellular eukaroytes may employ a conceptually 
similar regulatory logic to control entry into the sexual phases of their life cycles. Our study 
contributes to understanding the molecular pathway underlying the formation of malaria 
transmission stages and provides an experimental tool for the mass production of 
gametocytes to support the development of transmission-blocking interventions. 
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Materials and Methods 
Parasite culture, transfection constructs and transgenic cell lines 
P. falciparum 3D7 and F12 parasites were cultured as described (33). Growth synchronization was 
achieved by repeated sorbitol treatments (34). To generate parasite lines 3D7/GDV1-GFP-DD and 
F12/GDV1-GFP-DD expressing ectopic GDV1-GFP-DD, the gdv1 coding sequence (primers 
gdv1_pHGFPDD_BamHI and gdv1_pHGFPDD_NotI) was cloned in frame with gfp-dd into pHcamGFP-
DD using BamHI and SalI. pHcamGFP-DD was obtained by inserting a PCR fragment encoding the FKBP 
destabilizing domain (DD) in frame with gfp into SpeI/SalI-digested pHcamGFP (35). 3D7 and F12 
parasites were transfected with pHcamGDV1-GFP-DD and selected with 4nM WR99210 (WR) as 
described (36). Induction of GDV1-GFP-DD expression was achieved by addition of 312.5 nM Shield-1 
to the culture medium unless otherwise indicated. 
We generated three new mother plasmids (p_gC, pH_gC and pB_gC) for CRISPR/Cas9-based genome 
engineering in P. falciparum using the following cloning steps. First, plasmid pgRNA was obtained by 
Gibson assembly joining the NcoI/PvuII fragment containing the plasmid backbone and U6 single guide 
RNA (sgRNA) expression cassette of pL-6_eGFP (37) with a PCR fragment containing a HindIII-SalI-
EcoRI-BamHI multi-cloning site (MCS) amplified from pET-32a(+) using primers PCR1_F and PCR1_R. 
In a second step, the BsaI site in the ampR gene in pgRNA was eliminated using a Gibson assembly 
reaction by replacing the 207 bp BsaI/FspI ampR fragment with a corresponding 207 bp PCR fragment 
obtained with primers PCR2_F and PCR2_R, the latter of which introduced a silent G to A mutation in 
the BsaI recognition sequence (GGTCTC to GATCTC). This plasmid was named pgRNA2. In a third step, 
the BtgZI recognition site in the U6 sgRNA expression cassette in pgRNA2 was replaced with a BsaI 
recognition sequence to obtain pgRNA3. To achieve this, the BtgZI-digested pgRNA2 plasmid and a 56 
bp fragment obtained by annealing the two complementary oligonucleotides BsaI_F and BsaI_R were 
joined by Gibson assembly. In a forth step, a Cas9 expression cassette was introduced into pgRNA3 
using Gibson assembly to obtain the mother plasmid p_gC. Here, NcoI-digested pgRNA3 was joined 
with three PCR fragments amplified from pUF1_Cas9 (37) encoding (1) the P. falciparum hsp86 
promoter (primers PCR4a_F and PCR4a_R), (2) Streptococcus pyogenes Cas9 (primers PCR4b_F and 
PCR4b_R), and (3) the P. berghei dhfr-ts terminator (primers PCR4c_F and PCR4c_R). In the fifth step, 
a human dihydrofolate reductase (hDHFR) resistance cassette was introduced into p_gC by Gibson 
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assembly to obtain the mother plasmid pH_gC. This was achieved by assembling the BamHI-digested 
p_gC with three PCR fragments encoding (1) the P. falciparum cam promoter amplified from 3D7 
gDNA (primers PCR5a_F and PCR5b_R), (2) the hdhfr gene amplified from pL6_eGFP (primers PCR5b_F 
and PCR5b_R), and (3) the P. falciparum hrp2 terminator amplified from pL6_eGFP (primers PCR5c_F 
and PCR5c_R). The mother plasmid pB_gC is a modified version of pH_gC where the hDHFR cassette 
is replaced with a blasticidin deaminase (BSD) resistance cassette using Gibson assembly. This was 
achieved by assembling BamHI/XhoI-digested pH_gC with three PCR fragments representing (1) the 
cam promoter amplified from pH_gC with primers B1F and B1R; (2) the bsd gene amplified from 
pBcam_3xHA (2) using primers B2F and B2R; and (3) the hrp2 terminator amplified from pH_gC using 
primers B3F and B3R. We also generated pHF_gC and pBF_gC, modified versions of pH_gC and pB_gC, 
respectively, expressing hDHFR fused to the bifunctional negative selection marker yeast cytosine 
deaminase/uridyl phosphoribosyl transferase (hDHFR-yFCU) instead of hDHFR alone. For pHF_gC, 
pH_gC was digested with XhoI and XbaI (cuts within hdhfr) and assembled with four PCR products: (1) 
the 3’ end of hdhfr starting at the XbaI site amplified from pH_gC using primers HF1F and HF1R; (2) 
the 5’ part of yfcu up to the internal BamHI site amplified from pL6-eGFP (37) using primers HF2F and 
HF2R; (3) the 3’ part of yfcu starting at the internal BamHI site amplified from pL6-eGFP (37) using 
primers HF3F and HF3R (note that the separation of the yfcu sequence into two parts was required to 
eliminate the internal BamHI site); and (4) the hrp2 terminator amplified from pH_gC using primers 
HF4F and B3R. For pBF-gC, the BamHI/XhoI-digested pB_gC vector was assembled with two PCR 
products: (1) the cam promoter and bsd coding sequence amplified from pB_gC using primers B1F 
and BF1R; and (2) the yfcu coding sequence and hrp2 terminator amplified from pHF_gC with primers 
HF2F and B3R. The mother plasmid p_gC serves as a template to generate CRISPR/Cas9 knockout 
plasmids (single plasmid approach), and the pH_gC, pB_gC, pHF_gC and pBF_gC mother plasmids are 
used together with a donor plasmid for gene tagging. 
To generate 3D7/AP2-G-GFP-DDglmS parasites we constructed the CRISPR/Cas9 transfection vector 
pH_gC-ap2g-3’-gfp-dd-glmS allowing for marker-free genome editing using a single plasmid. We first 
generated plasmid pH_gC-ap2g-3’ by inserting two annealed complementary oligonucleotides 
(sgt_ap2g3’_F, sgt_ap2g3’_R) encoding the sgRNA target sequence sgt_ap2-g-3’ and appropriate 
single-stranded overhangs into the sgRNA expression cassette in pH_gC using BsaI digestion and T4 
DNA ligase. The sgRNA target sequence sgt_ap2g3’ (agttatagggaatattcaaa) is positioned 60 bp 
downstream of the ap2-g coding sequence and was identified using CHOPCHOP  (38, 39). We then 
generated a second plasmid carrying an ap2g-gfp-dd-glmS donor assembly (pD_ap2g-gfp-dd-glmS) 
using two subsequent cloning steps. First, plasmid pD_ap2g-gfp was generated using Gibson assembly 
joining four PCR fragments encoding (1) the plasmid backbone amplified from pUC19 using primers 
PCRA_F and PCRA_R, (2) a 393 bp ap2-g 5’ homology box (HB) (spanning bps 6904-7296 of the ap2-g 
gene) amplified from 3D7 gDNA using primers PCRB_F and PCRB_R, (3) the gfp coding sequence (plus 
N-terminal GSAG linker) amplified from pH-GFP (7) using primers PCRC_F and PCRC_R, and (4) a 670 
bp ap2-g 3’ HB (spanning the region 60-730 bp downstream of the ap2-g gene) amplified from 3D7 
gDNA using primers PCRD_F and PCRD_R. Second, pD_ap2g-gfp-dd-glmS was constructed using 
Gibson assembly of three PCR fragments representing (1) the ap2-g 5’ HB/pUC19 backbone/ap2-g 3’ 
HB assembly amplified from pD_ap2g-gfp using primers 1F and 1R, (2) the gfp-dd sequence amplified 
from pH-GFP-DD (7) using primers 2F and 2R, and (3) the glmS-246 sequence amplified from pL6-
3HA_glmS-246 (kind gift from Dave Richard) using primers 3F and 3R. The final CRISPR/Cas9 
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transfection vector pH_gC-ap2g-3’-gfp-dd-glmS was then obtained by introducing the EcoRI/HindIII-
digested ap2g-gfp-dd-glmS donor assembly amplified from pD_ap2g-gfp-dd-glmS (primers EcoF and 
HindR) into EcoRI/HindIII-digested pH_gC-ap2g-3’. The pH_gC-ap2g-3’-gfp-dd-glmS construct was 
transfected into 3D7 parasites and 3D7/AP2-G-GFP-DDglmS parasites were selected with 4 nM WR 
and 2.5 mM (D)-+-glucosamine (GlcN) (Sigma Aldrich) for six days and then maintained in absence of 
WR until a stably propagating parasite population was established. Successful editing of the ap2-g 
locus was confirmed by PCR on gDNA. Stabilisation of AP2-G-GFP-DD expression was achieved by 
removing GlcN and adding 1350 nM Shield-1 to the culture medium. 
To disrupt the antisense RNA locus downstream of the gdv1 coding sequence in F12 wild-type and 
3D7/AP2-G-GFP-DDglmS parasites we generated the CRSIPR/Cas9 knockout vectors p_gCH-gdv1-asKO 
and p_gCB-gdv1-asKO, respectively. First, p_gC-gdv1-asKO-pre was created by inserting a hdhfr 
resistance cassette flanked by the 5’ and 3’ HBs into p_gC using Gibson assembly. This was achieved 
by assembling EcoRI/HindIII-digested p_gC with three PCR fragments encoding (1) a 440 bp 5’ HB 
amplified from 3D7 gDNA (spanning the last 93 bp of the gdv1 coding sequence and 347 bp of the 
downstream sequence; primers p_gC-gdv1-asKO_5‘HB_for and p_gC-gdv1-asKO_5‘HB_rev), (2) a 
hdhfr resistance cassette amplified from pH_gC (primers p_gCH-gdv1-asKO_hdhfr_for and p_gCH-
gdv1-asKO_hdhfr_rev), and (3) a 753 bp 3’ HB amplified from 3D7 gDNA (spanning the region 3,554-
4,307 bp downstream of the gdv1 coding sequence; primers p_gCH-gdv1-asKO_3‘HB_for and p_gCH-
gdv1-asKO_3‘HB_rev). To generate the final p_gCH-gdv1-asKO construct, the two complementary 
oligonucleotides (sgt_gdv1-3’_F and sgt_gdv1-3’_R) encoding the sgRNA target sequence sgt_gdv1-3’ 
and appropriate single-stranded overhangs were annealed and inserted into the sgRNA expression 
cassette using BsaI-digested p_gC-gdv1-asKO-pre and T4 DNA ligase. The sgRNA target sequence 
sgt_gdv1-3’ (tgtattactaaagaatgaaa) is positioned 1,639 bp downstream of the gdv1 coding sequence 
and was identified using CHOPCHOP (38, 39). For the p_gCB-gdv1-asKO construct, p_gCH-gdv1-asKO 
was cut with XhoI and EcoRI to release the hdhfr resistance cassette and the 3’ HB. Gibson assembly 
was then used to insert PCR fragments encoding the blasticidin deaminase (bsd) resistance cassette 
amplified from pB_gC (primers p_gCB-gdv1-asKO_for and p_gCB-gdv1-asKO_rev) and the identical 
753 bp 3’HB amplified from 3D7 gDNA (primers p_gCB-gdv1-asKO_3‘HB_for and p_gCB-gdv1-
asKO_3‘HB_rev). The p_gCH-gdv1-asKO construct was transfected into F12 parasites and F12/gdv1-
asKO parasites were selected with 4 nM WR. The p_gCB-gdv1-asKO construct was transfected into 
3D7/AP2-G-GFP-DDglmS parasites grown in presence of 2.5 mM GlcN and 3D7/AP2-G-GFP-
DDglmS/gdv1-asKO parasites were selected with 2.5 µg/ml blasticidin-S-HCl (BSD). Successful 
disruption of the gdv1-asRNA locus and replacement with the hdhfr or bsd resistance cassettes was 
confirmed by PCR on gDNA. Stabilisation of AP2-G-GFP-DD expression was achieved by removing GlcN 
and adding 1350 nM Shield-1 to the culture medium. 
To create the 3D7/3xHA-GDV1 and F12/3xHA-GDV1/gdv1-asKO parasite lines we prepared the 
CRISPR/Cas9 transfection vectors pB_gC-gdv1-5’ and the donor plasmid pFDon_3xha-gdv1. pFDon 
contains an expression cassette for yfcu under control of the hsp86 promoter and was cloned by 
Gibson assembly of four PCR fragments: (1) the pUC18 E. coli plasmid backbone amplified with primers 
D1F and D1R; (2) the hsp86 promoter amplified from pHF_gC using primers D2F and D2R; (3) the yfcu 
coding sequence and hrp2 terminator amplified from pHF_gC using primers D3F and D3R; and (4) the 
MCS amplified from pHF_gC using primers D4F and D4R. To obtain pFDon_3xha-gdv1, three PCR 
fragments were inserted into the pFDon plasmid by Gibson assembly: (1) a 5’ HB spanning 504 bp of 
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the gdv1 upstream region (-505 to -1) amplified from 3D7 gDNA (primers pFDon_GDV1_HA_for and 
pFDon_GDV1_HA_rev); (2) a 93 bp fragment coding for a 3xHA-tag amplified from pBcam_3xHA (2) 
(primers pFDon_GDV1_HA_HAtag_for and pFDon_GDV1_HA_HAtag_rev); and (3) a 3’ HB spanning 
488 bp of the gdv1 coding region (+3 to +491) amplified from 3D7 gDNA. The 3’ HB fragment was 
created in a two-step process. First, a fragment containing three mismatch mutations in the sgRNA 
target sequence sgt_gdv1-5’ (tgaaagtaaaaggtaatagt to tgaaGgtTaaaggCaatagt) was amplified from 
3D7 gDNA (primers pFDon_GDV1_HA_3’HB_mut_for and pFDon_GDV1_HA_3’HB_mut_rev). This 
sequence was then used as template for a second round of amplification adding overhangs for Gibson 
assembly (primers pFDon_GDV1_HA_3’HB_for and pFDon_GDV1_HA_3’HB_rev). To create the 
pB_gC-gdv1-5’ CRISPR/Cas9 plasmid two complementary oligonucleotides (sgt_gdv1-5’_F and 
sgt_gdv1-5’_R) encoding the sgRNA target sequence sgt-gdv1-5’ (tgaaagtaaaaggtaatagt; positioned 
28 bp downstream of the start codon of the gdv1 coding sequence) were annealed and inserted into 
the BsaI site in pB_gC. Equal amounts of both plasmids were transfected into 3D7 wild-type and 
F12/gdv1-asKO parasites and 3D7/3xHA-GDV1 and F12/3xHA-GDV1/gdv1-asKO parasites were 
selected with 5 µg/ml BSD for 10 days and then maintained in absence of drug pressure until stably 
propagating parasite populations were established. Successful editing of the gdv1 locus was 
confirmed by PCR on gDNA. The 3D7/3xHA-GDV1 line was cloned out as described (40). 
All oligonucleotide sequences used for cloning and confirmation of CRISPR/Cas9-based gene editing 
by PCR are provided in Table S9. 
  
Preparation of parasite nuclear extracts 
Nuclei were isolated as described (41). Prior to nuclear protein extraction, nuclei were treated with 
DNase I and RNAse A (20mM Hepes pH 7.4, 10mM NaCl, 5mM MgCl2, 1mM CaCl2, 0.1% NP-40, 1x 
protease inhibitor (Roche Diagnostics), 1x PhosSTOP (Roche Diagnostics), 0.5 U/ml DNase I (Roche 
Diagnostics), 1mg RNase A (Roth)) in a 250 ml reaction for 5min at 37°C. Reactions were adjusted to 
500 ml using 2x high salt extraction buffer (20mM Hepes pH 7.4, 1M NaCl, 6mM EDTA, 2mM EGTA, 
2mM TCEP, 1x protease inhibitor (Roche Diagnostics), 1x PhosSTOP (Roche Diagnostics), 50% Glycerol, 
0.1%NP-40) and nuclear proteins were extracted in 2.5 pellet volumes high salt extraction buffer 
(20mM Hepes pH 7.4, 500mM NaCl, 3mM EDTA, 1mM EGTA, 1mM TCEP, 1x protease inhibitor (Roche 
Diagnostics), 1x PhosSTOP (Roche Diagnostics), 25% Glycerol, 0.1%NP-40) containing 0.02mg/ml 
H3K9me3 peptides (Diagenode) and incubated at 4°C for 1 h. After centrifugation at 20800g at 4°C for 
30min supernatants were immediately used for co-IP experiments. 
 
Co-Immunoprecipitation (co-IP) 
High salt nuclear extract from 3D7/HP1-GFP or 3D7/GDV1-GFP-DDON schizonts was diluted to 250mM 
NaCl using dilution buffer (20mM Hepes pH 7.4, 1mM EDTA, 1mM TCEP, 1x protease inhibitor (Roche 
Diagnostics), 1x PhosSTOP (Roche Diagnostics), 25% Glycerol) and incubated with negative control 
agarose beads (Chromotek) for 30 min at 4°C under constant agitation for lysate pre-clearing. The 
supernatant was split and incubated with GFP-Trap agarose beads (Chromotek) or negative control 
agarose beads (Chromotek) for 1 h at 4°C under constant agitation. The supernatant was recovered 
and beads were washed four times in wash buffer 1 (20mM Hepes pH 7.4, 250mM NaCl, 1mM EDTA, 
1mM TCEP, 0.05% NP-40) and once in wash buffer 2 (20mM Hepes pH 7.4, 250mM NaCl, 1mM EDTA, 
1mM TCEP) . Bound proteins were eluted for 1 h at RT under constant agitation using 2M arginine 
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buffer (2M arginine, pH 4) followed by a second elution in 2% SDS buffer (2% SDS, 20mM Tris-HCl, pH 
8) for 10 min at 95°C. All centrifugation steps were performed at 4°C for 3 min at 500g. Samples were 
analysed by Western blot using mouse mAb a-GFP (Roche Diagnostics #11814460001) or rabbit a-
PfHP1 (7) antibodies.  
 
Capillary liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
For the HP1 co-IP experiments, both the 2M arginine elution and the 2% SDS elution were analysed 
by LC-MS/MS. For the GDV1-GFP-DD co-IP experiments only the 2% SDS elution samples were 
analysed. Proteins in the 2M arginine elution buffer were reduced with 10 mM DTT at 37°C for 1 hr 
and alkylated with 50 mM iodo-acetamide for 15 min at room temperature. Proteins were digested 
with 250 ng endoproteinase LysC (Wako, Neuss, Germany) for two hours at 37°C followed by 500 ng 
trypsin (Worthington, Lakewood, NJ, USA) overnight. The digest was stopped with 1% TFA and 
desalted on a microspin column (The Nest Group, Southborough, MA, USA) according to the 
manufacturer’s recommendations. Proteins eluted with 2% SDS were precipitated with 10% TCA, 
washed twice in ice-cold acetone and air-dried. The protein pellets were dissolved in 30 ml 100 mM 
Tris-HCl (pH 8.0)/6M Urea, containing 10 mM DTT and reduced, alkylated and digested with 250 ng 
endoproteinase LysC as above. The urea concentration was diluted to 2 M with 100 mM Tris-HCl (pH 
8.0) and the sample was further digested with 500 ng trypsin overnight at 37°C. The digest was 
acidified with 1% TFA and the sample was desalted on a MicroSpin cartridge.  
The peptides were dried in a SpeedVac and dissolved in 40 mL 0.1% formic acid and analysed by 
capillary liquid chromatography tandem MS (LC-MS/MS) using a home-packed separating column 
(0.075 mm x 15 cm) packed with Reprosil C18 reverse-phase material (2.4 mm particle size, Dr. Maisch, 
Ammerbuch-Entringen, Germany). The column was connected on line to an Orbitrap Elite FT hybrid 
instrument (Thermo Scientific, Reinach, Switzerland). The solvents used for peptide separation were 
0.1% formic acid in water/0.005% TFA (solvent A) and 0.1% formic acid/0.005% TFA and 80% 
acetonitrile in water (solvent B). 2 ml of peptide digest were injected with a Proxeon nLC capillary 
pump (Thermo Scientific) set to 0.3 ml/min. A linear gradient from 0 to 40% solvent B in solvent A in 
95 min was delivered with the nano pump at a flow rate of 300 nl/min. After 95 min the percentage 
of solvent B was increased to 75% in ten minutes. The eluting peptides were ionized at 2.5 kV. The 
mass spectrometer was operated in data-dependent mode. The precursor scan was done in the 
Orbitrap set to 60,000 resolution, while the fragment ions were mass analyzed in the LTQ instrument. 
A top twenty method was run so that the twenty most intense precursors were selected for 
fragmentation. The MS/MS spectra were searched against a combined P. falciparum 
(www.plasmoDB.org; release 11.1)/human annotated protein database using Proteome Discoverer 
1.4 (Thermo Scientific, Reinach, Switzerland) using the two search engines Mascot and SequestHT 
(Tables S3 and S4). For the search, oxidized methionine and N-terminal protein acetylation were used 
as variable modifications. The identifications were filtered to a peptide false discovery rate of 1%. 
 
Fluorescence microscopy 
IFAs were performed with methanol-fixed or 4% formaldehyde/0.0075% glutaraldehyde-fixed cells 
using the following primary antibodies: mouse mAb a-GFP (Roche Diagnostics #11814460001), 1:100; 
rat mAb a-HA (3F10, Roche Diagnostics #11867423001), 1:100; rabbit a-PfHP1 (7), 1:200; mouse mAb 
a-Pfs16 (kind gift from Robert W. Sauerwein), 1:500. Secondary antibodies: Alexa Fluor 568-
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conjugated a-rabbit IgG (Molecular Probes #A11011), 1:500; Alexa Fluor 488-conjugated a-rabbit IgG 
(Molecular Probes #A11008), 1:500; Alexa Fluor 488-conjugated a-mouse IgG (Molecular Probes 
#A11001), 1:500; Alexa Fluor 488-conjugated a-rat IgG (Molecular Probes #A11006), 1:250; Alexa 
Fluor 568-conjugated a-rat IgG (Molecular Probes #A11077), 1:250. Nuclei were stained with DAPI. 
Images were taken on a Leica DM 5000B microscope with a Leica DFC 345 FX camera, acquired via the 
Leica IM1000 software, and processed using Fiji (42). For each experiment, images were acquired and 
processed with identical settings. 
 
Western Blot 
Parasites were released from infected RBCs by saponin lysis, resuspended in 8M Urea, 5%SDS, 40mM 
Tris pH 6.8, 1% β-Mercaptoethanol, 1x protease inhibitor (Roche Diagnostics) and separated on 
NuPage 4-12% Bis-Tris gels (Novex). Proteins were detected with mouse mAb a-GFP (Roche 
Diagnostics #11814460001), 1:500; rabbit a-PfHP1 (7), 1:5’000; mouse mAb a-PfGAPDH (43), 
1:20’000; rat mAb a-HA (3F10, Roche Diagnostics #11867423001), 1:10’000; mouse mAb a-6xHIS (R&D 
Systems #MAB050R), 1:5’000. 
 
In vitro protein-protein interaction experiments 
A plasmid vector with the following expression cassette was constructed for co-expression of HP1 and 
GDV1: T7 promoter/strep(II)-hp1/T7 promoter/6xhissumo-gdv1/T7 terminator (pStrep-HP1_HS-
GDV1). We used pETA-HS and pETA-Strep as parental vectors, which we previously constructed for 
the expression of N-terminal 6xHis-SUMO-tagged and N-terminally Strep(II)-tagged fusion proteins, 
respectively. pETA-HS was obtained by introducing a sequence encoding a 6xHis stretch followed by 
Saccharomyces cerevisiae SUMO (amplified from gDNA using primers SUMO_F and SUMO_R between 
the NdeI and BamHI sites of pET20(b)+ (Novagen), yielding a vector similar to the one described 
elsewhere (44). pETA-Strep was generated by replacing the NdeI/BamHI fragment in pET20b(+) with 
an annealed double-stranded oligonucleotide (Strep_F and Strep_R) encoding Met-Ala-Ser-Strep(II). 
The co-expression plasmid pStrep-HP1_HS-GDV1 was cloned by Gibson assembly of four PCR products 
representing (1) the backbone of pETA-Strep amplified using the primers SF and SR; (2) the hp1 coding 
sequence (cds) starting at +4 amplified from 3D7 gDNA using primers HP1F and HP1R; (3) the T7 
promoter and the sequence encoding the 6xHis-SUMO tag amplified from pETA-HS with primers HSF 
and HSR; and (4) the gdv1 cds starting at +4 amplified from 3D7 gDNA using primers GDV1F and 
GDV1R. A control vector with the same expression setup was made by replacing the gdv1 cds with a 
fragment encoding amino acids M173 to N311 of the ApiAP2 DNA-binding protein SIP2 (45). This 
fragment was first ligated into pETA-HS (resulting in pETA-HS-SIP2) using the SfoI and XhoI restriction 
sites and the XhoI-digested sip2 PCR product amplified from 3D7 gDNA with primers SIP2F and SIP2R. 
Next, the pStrep-HP1_HS-SIP2 co-expression vector was Gibson assembled using two PCR products 
representing (1) the pStrep-HP1_HS-GDV1 vector omitting the gdv1 cds (amplified using primers 
SHHSF and SHHSR); and (2) the sip2 cds fragment amplified from pETA-HS-SIP2 using primers SIP2F2 
and SIP2R2. After cloning in E. coli DH5alpha and DNA sequencing, the plasmids were transformed 
into Rosetta2(DE3) cells (Novagen) for recombinant protein expression. 
Recombinant proteins were expressed by auto-induction at 25°C (46). Once the cultures were grown 
to saturation, the bacteria were spun down and pellets frozen. Stock solutions for chromatography 
were 3 M arginine phosphate (3 M L-arginine, 1.6 M H3PO4, pH 7.3), 4 M imidazole phosphate (4 M 
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imidazole, 0.888 M H3PO4), 4 M ammonium phosphate (2.8 M (NH4)2HPO4, 1.2 M (NH4)H2PO4). 
Recombinant proteins were purified using the following strategy: (1) nickel affinity purification: 
bacterial pellets were thawed, resuspended in buffer Ni-A (200 mM arginine phosphate, 500 mM 
NaCl, 20 mM imidazole phosphate, 5 mM 6-aminocaproic acid, 0.5 mM TCEP, pH 7.2) and lysed by 
sonication. The lysate was cleared by centrifugation and loaded on a 5 ml HisTrap HP column (GE-
Healthcare). The column was washed with 15 column volumes (CV) of buffer Ni-A and the proteins 
were eluted using five CV-long linear gradient of Ni-A to Ni-B (Ni-A with 400 mM imidazole phosphate). 
Both the Strep(II)-HP1/HisSUMO-GDV1 complex and HisSUMO-SIP2 eluted in the same range of the 
gradient. (2) StrepTactin affinity purification: the nickel column elution obtained from the GDV1/HP1 
lysate was loaded on a 5 ml StrepTrap HP column (GE Healthcare), washed with ten CV of buffer Strep-
A (200 mM arginine phosphate, 300 mM ammonium phosphate, 30 mM NaOH, 5 mM 6-aminocaproic 
acid, 1 mM EDTA, 0.5 mM TCEP, pH 7.4) and eluted using buffer Strep-B (400 mM arginine phosphate, 
300 mM ammonium phosphate, 5 mM 6-aminocaproic acid, 1 mM EDTA, 2.5 mM desthiobiotin, 0.5 
mM TCEP, pH 7.4). To purify Strep(II)-HP1 without interaction partner, the nickel column flow through 
obtained from the SIP2-HP1 control lysate was used and purified using the same conditions. (3) 
Hydrophobic interaction chromatography: the salt concentration of the StrepTactin column elutions 
were adjusted to 0.75 M ammonium phosphate and loaded on a 1 ml Phenyl HP column (GE 
Healthcare). The column was washed using ten CV of buffer HIC-A (400 mM arginine phosphate, 750 
mM ammonium phosphate, 5 mM 6-aminocaproic acid, 1 mM EDTA, 0.5 mM TCEP, pH 7.2) and the 
proteins were eluted using a 25 CV-long linear gradient of buffer HIC-A to HIC-B (400 mM arginine 
phosphate, 5 mM 6-aminocaproic acid, 1 mM EDTA, 50 % (w/v) ethylene glycol, 0.5 mM TCEP, pH 7.2). 
The Strep(II)-HP1/HisSUMO-GDV1 complex was concentrated using an Amicon spin filter (Millipore) 
with a 10 K cut-off. Protein samples were analysed by SDS/polyacrylamide gel electrophoresis 
followed by Coomassie staining or Western blot analysis. 
All oligonucleotide sequences used for cloning of expression vectors are provided in Table S9. 
 
Gametocyte conversion, differentiation and sex ratios 
To quantify sexual conversion rates of 3D7/GDV1-GFP-DD parasites, synchronous 3D7/GDV1-GFP-
DDOFF cultures were split at 8-16 hours post-invasion and one half was maintained in the absence of 
Shield-1 and one half was cultured in the presence of Shield-1 (3D7/GDV1-GFP-DDON). After re-
invasion, parasites were fixed at 38-46 hpi either with methanol (Fig. 2B) or 4% 
formaldehyde/0.0075% glutaraldehyde (Fig. S2) and a-Pfs16 IFAs combined with DAPI staining was 
performed to quantify sexual conversion rates (proportion of stage I gametocytes among all infected 
RBCs). To assess gametocyte differentiation, cultures were treated with 50 mM N-acetyl-D-
glucosamine (GlcNAc) for the first four days after re-invasion to eliminate asexual parasites (47) and 
then with normal culture medium for another 4-6 days when mature stage V gametocytes were 
observed in Giemsa-stained thin blood smears. 
To quantify male and female gametocytes synchronous 3D7/GDV1-GFP-DDOFF cultures were split at 
8-16 hours post-invasion and one half was maintained in the absence of Shield-1 while the other half 
was cultured in the presence of Shield-1 (3D7/GDV1-GFP-DDON). After re-invasion, parasites were 
treated with 50 mM GlcNAc as above. Gametocytaemia was determined four days after re-invasion 
by visual inspection of Giemsa-stained blood smears and used to calculate the sexual conversion rate 
(gametocytaemia observed on day four in relation to the total parasitaemia observed on day one after 
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re-invasion). Eleven days after re-invasion male and female gametocytes were quantified by 
inspection of Giemsa-stained blood smears as described elsewhere (48) (for each population three 
individual blood smears were scored blindly). 
To assess 3xHA-GDV1 expression under growth conditions that either suppress or induce sexual 
commitment, 3D7/3xHA-GDV1 parasites were split at 24-30 hours post-invasion and pulsed with 
defined minimal fatty acid medium (RPMI-1640 medium, 25 mM HEPES, 24 mM sodium bicarbonate, 
100 mM hypoxanthine, 0.39% fatty acid-free BSA (Sigma-Aldrich), 30 mM oleic acid, 30 mM palmitic 
acid), either supplemented with 2 mM choline (suppresses sexual commitment) or lacking choline 
(induces sexual commitment), respectively (16). Twelve hours after pulsing relative 3xHA-GDV1 
expression levels were determined by Western blot and IFAs were performed to determine the 
proportion of parasites expressing 3xHA-GDV1 in haemozoin-positive parasites (1n-4n). Sexual 
conversion rates were determined as described above by visual inspection of Giemsa-stained blood 
smears after GlcNAc treatment. 
To quantify sexual conversion rates of 3D7/AP2-G-GFP-DDglmS and 3D7/AP2-G-GFP-DDglmS/gdv1-
asKO parasites, synchronous cultures were split at 24-32 hours post-invasion and one half was 
maintained in the presence of glucosamine/absence of Shield-1 and one half was cultured in the 
absence of glucosamine/presence of Shield-1. Sexual conversion rates were determined as described 
above by a-Pfs16 IFAs on methanol-fixed thin smears. 
 
Chromatin immunoprecipitations, high throughput sequencing and data analysis 
3D7/GDV1-GFP-DDOFF parasites were synchronized twice 18 hours apart to obtain a six hour growth 
window (18-24 hpi). At 28-34 hpi cultures were split and one half was maintained in the absence of 
Shield-1 and one half was cultured in the presence of Shield-1 (3D7/GDV1-GFP-DDON). Paired samples 
of 3D7/GDV1-GFP-DDOFF and 3D7/GDV1-GFP-DDON parasites were harvested at three consecutive 
time points (TPs) two (30-36 hpi, TP1), six (34-40 hpi, TP2) and ten (38-44 hpi, TP3) hours after addition 
of Shield-1  by crosslinking with 1% formaldehyde for 15 min at 37ºC. The crosslinking reaction was 
quenched by 0.125 M glycine. Nuclei were isolated by releasing parasites from infected RBCs using 
0.05% saponin followed by lysis in CLB (20 mM Hepes, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 0.65% 
NP-40, 1 mM DTT, 1x protease inhibitor (Roche Diagnostics)). Nuclei were washed and snap-frozen in 
CLB supplemented with 50% glycerol. Nuclei were resuspended in sonication buffer (50 mM Tris pH 
8, 1% SDS, 10 mM EDTA, 1x protease inhibitor (Roche Diagnostics)) and sonicated for 20 cycles of 30 
sec ON/30 sec OFF (setting high, BioruptorTM Next Gen, Diagenode). Fragment sizes ranged from 100-
600 bp as determined by de-crosslinking a 50 ml aliquot and running the purified DNA on a 1% agarose 
gel. ChIPs were performed under rotation overnight at 4°C in incubation buffer (5% Triton-X-100, 750 
mM NaCl, 5 mM EDTA, 2.5 mM EGTA, 100 mM Hepes pH 7.4) by combining sonicated chromatin (500 
ng DNA content) with either 1 mg mouse mAb a-GFP (Roche Diagnostics #11814460001) or 1 mg 
rabbit a-PfHP1 (7) in the presence of 10 ml protA and 10 ml protG Dynabeads (Life Technologies, 
#10008D and #10009D). Beads were washed for 5 min at 4°C while rotating with 400 ml of the 
following wash buffers: 2x wash buffer 1 (0.1% SDS, 0.1% DOC, 1% Triton-X100, 1 mM EDTA, 0.5 mM 
EGTA, 20 mM Hepes pH 7.4), 1x wash buffer 2 (0.1% SDS, 0.1% DOC, 1% Triton-X100, 500 mM NaCl, 1 
mM EDTA, 0.5 mM EGTA, 20 mM Hepes pH 7.4), 1x wash buffer 3 (250 mM LiCl, 0.5% DOC, 0.5% NP-
40, 1 mM EDTA, 0.5 mM EGTA, 20 mM Hepes pH 7.4), 2x wash buffer 4 (1 mM EDTA, 0.5 mM EGTA, 
20 mM Hepes pH 7.4). The immunoprecipitated chromatin was eluted in 200 ml elution buffer (1% 
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SDS, 0.1 M NaHCO3) while rotating for 20 min at RT and de-crosslinked (1% SDS, 0.1 M NaHCO3, 1 M 
NaCl) in a 45°C shaking heat-block overnight. In parallel, 30 ml of sonicated input chromatin was de-
crosslinked under the same conditions. The DNA was purified using QIAquick MinElute PCR columns 
(Qiagen) and eight separate a-GFP ChIPs or four separate a-PfHP1 ChIPs were combined. 
To prepare sequencing libraries 1 ng of input DNA, 1 ng a-GFP ChIP DNA or 5 ng a-HP1 ChIP DNA were 
end repaired, extended with 3′ A-overhangs and ligated to barcoded NextFlex adapters (Bio Scientific, 
#514122) as described (49). Libraries were amplified using an optimized KAPA protocol (50) using 
KAPA HiFi HotStart ready mix (KAPA Biosystems, KM2602), NextFlex primer mix (Bio Scientific, 
#514122) and the following PCR program: 98°C for 2 min; four cycles of 98°C for 20 sec, 62°C for 3 min; 
62°C for 5 min. Amplified libraries were size-selected for 225-325 bp (mono-nucleosomes + 125 bp 
NextFlex adapter) using 2% E-Gel Size Select agarose gels (Invitrogen, #G6610-02) and amplified by 
PCR for ten cycles using the above conditions. Libraries were purified and adapter dimers removed by 
Agencourt AMPure XP beads purification using a 1:1 library:beads ratio (Beckman Coulter, #A63880). 
ChIP-seq libraries were sequenced on the Illumina NextSeq 500 system to generate 75 bp single-end 
reads (NextSeq 500/550 High Output v2 kit). Reads were mapped against the P. falciparum 3D7 
reference genome from PlasmoDB v26 (www.plasmodb.org) using BWA samse (v0.7.12-r1039) and 
filtered to mapping quality ≥15 (SAM tools v1.2). Only uniquely mapped reads (between 3.7 and 11.5 
million reads) were used for further analysis. 
To visualize ChIP-seq data in the UCSC Genome browser, all libraries were normalized to the amount 
of mapped reads per million (RPM). Bedgraph files were generated using bedtools (v2.20.1). For log2 
ratio tracks HP1 or GDV1-GFP-DD ChIP values were divided by input values and log2-transformed. For 
substraction tracks ChIP values obtained from 3D7/GDV1-GFP-DDOFF parasites were substracted from 
those obtained from 3D7/GDV1-GFP-DDON parasites. Within the UCSC genome browser tracks were 
smoothened (10-16) and the windowing function was set as ‘mean’. To assess HP1 and GDV1-GFP-DD 
coverage of individual genes, tags were counted for each coding region and offset by +1 to avoid 
division by zero while calculating fold change in coverage. Coding region counts were normalized to 
the number of reads per kb per million mapped reads (RPKM). Genes with very low mapability (input 
RPKM<5) were excluded from further analysis. ChIP-seq enrichment values (ChIP/input) were 
calculated over each coding region.  
 
Microarray experiments and data analysis 
3D7/GDV1-GFP-DDOFF parasites were synchronized twice 16 hours apart to obtain an eight hour 
growth window (16-24 hpi). After re-invasion parasites were synchronised again at 0-8 hpi. At 4-12 
hpi the culture was split and one half was maintained in the absence of Shield-1 and one half was 
cultured in the presence of Shield-1 (3D7/GDV1-GFP-DDON). For both populations, total RNA was 
isolated in the same cell cycle (generation 1) from trophozoites (T1; 24-32 hpi), early schizonts (ES1; 
32-40 hpi), late schizonts (LS1; 40-48 hpi), and after re-invasion (generation 2) from early ring stages 
(ER2; 8-16 hpi), late ring stages (LR2; 16-24 hpi), trophozoites (T2; 24-32 hpi), early schizonts (ES2; 32-
40 hpi). Corresponding samples of F12/GDV1-GFP-DDOFF and F12/GDV1-GFP-DDON parasites were 
prepared accordingly. RNA extraction and cDNA synthesis was carried out as described (51). Cy5-
labelled test cDNAs were hybridised against Cy3-labelled cDNA reference pool consisting of total RNA 
obtained from 3D7 wild-type parasites harvested at five consecutive TPs along intra-erythrocytic 
parasite development (7). Equal amounts of Cy5- and Cy3-labelled samples were hybridised on a 
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P. falciparum 8×15K Agilent gene expression microarray (GEO platform ID GPL15130) for 16 hours at 
65°C in an Agilent hybridisation oven (G2545A) (52). Slides were scanned using the GenePix scanner 
4000B and GenePix pro 6.0 software (Molecular Devices). The raw microarray data representing 
relative transcript abundance ratios between each test sample and the reference pool (Cy5/Cy3 log2 
ratios) were subjected to lowess normalization and background filtering as implemented by the Acuity 
4.0 program (Molecular Devices). Flagged features and features with either Cy3 or Cy5 intensities 
lower than two-fold the background were discarded. Log2 ratios for multiple probes per gene were 
averaged. Transcripts showing expression values at all seven consecutive paired time points were 
included for downstream analysis. We performed paired two-class Significance Analysis of 
Microarrays (SAM) (53) to identify genes with significant differential expression between 3D7/GDV1-
GFP-DDOFF and 3D7/GDV1-GFP-DDON or F12/GDV1-GFP-DDOFF and F12/GDV1-GFP-DDON parasites, 
respectively (q-value (fdr) cut-off <0.15; mean fold change cut-off >1.5). Heatmaps were generated 
using Java Treeview (54). Scatterplots were generated using Microsoft Excel. The processed 
microarray data are listed in Table S5 (3D7/GDV1-GFP-DD) and S6 (F12/GDV1-GFP-DD). 
 
RNA-seq library preparation, high throughput sequencing and data analysis 
F12 and F12/gdv1-asKO parasites were synchronized twice 16 hours apart to obtain an eight hour 
growth window. Parasites were harvested at 32-40 hpi and at 40-48 hpi. Total RNA was isolated using 
Ribozol (Amresco) according to the manufacturer’s manual and further purified using the RNeasy Plus 
Mini Kit (Qiagen) for removal of gDNA. Residual gDNA was digested with TURBO DNA-freeTM DNaseI 
(Ambion) and the RNA was quantified by NanoDrop. Total RNA was polyA-selected using the Oligotex 
mRNA Mini Kit (Qiagen, #70022) according to manufacturer’s instructions. Subsequently, 2 mg of 
polyA-selected total RNA equivalent were fragmented by alkaline hydrolysis (5x fragmentation buffer: 
200 mM Tris-acetate pH 8.2, 500 mM potassium acetate, 150 mM magnesium acetate) for 1 min 45 
sec at 85°C in a 150 ml volume and precipitated as previously described (55), followed by two TURBO 
DNase treatments (Ambion, #AM2238) to remove possible remnants of genomic DNA. Further library 
preparation for strand-specific RNA-seq was carried out as described (50). In short, first-strand cDNA 
synthesis was performed with AT-corrected random N9 primers (76% AT) in presence of 0.2 mg 
Actinomycin D (Thermo 446 Fisher Scientific) to prevent DNA-dependent second-strand cDNA 
synthesis. To maintain the strand-specific information during second-strand synthesis dTTPs were 
replaced with dUTPs. Resulting double-stranded cDNAs (1.9-3.2 ng) were end-repaired and extended 
with 3’ A-overhangs. After ligation of NextFlex adapters (Bio Scientific, #514122), libraries were 
treated with USER enzyme (NEB, #M5505L) to specifically degrade the dUTP-containing second strand 
and subsequently amplified by PCR (98°C for 2 min; 4 cycles of 98°C for 20 sec, 62°C for 3 min; 62°C 
for 5 min) using KAPA HiFi HotStart ready mix (KAPA Biosystems, #KM2602) and NEXTflex primer mix 
(Bio Scientific, #514122). Next, libraries were size-selected for 300-400 bp fragments using 2% E-Gel 
Size Select agarose gels (Invitrogen, #G6610-02) and amplified for another 12 cycles using the same 
conditions as above. Subsequent depletion of adapter dimers and library purification was performed 
using Agencourt AMPure XP beads (Beckman Coulter, #A63880) in a 1:1 library beads ratio.  
Strand-specific RNA-seq libraries were sequenced on the Illumina NextSeq 500 system to generate 75 
bp single-end reads (TruSeq SR Cluster Kit v2), which were mapped against the P. falciparum 3D7 
transcriptome from PlasmoDB v26 using BWA samse (version 0.7.12-r1039). Reads were filtered for 
mapping quality ≥15 (samtools version 1.2) and only uniquely mapped reads (between 1.6 and 4.7 
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million reads) were used for further analysis. After separating the reads according to the strand they 
mapped to (sense strand FLAG16, antisense strand FLAG0), sense and antisense transcript abundance 
was assessed by counting the respective tags for each transcript except for transcripts originating from 
the mitchochondrial and apicoplast genomes. Resulting tag counts were offset by +1 and normalized 
to the number of reads per kb per million mapped reads (RPKM). RPKM ratios were calculated when 
at least one of the two samples per time point had a RPKM value ≥ 3. To visualize RNA-seq data in the 
UCSC Genome browser, 75 bp reads were additionally mapped against the annotated P. falciparum 
3D7 genome (PlasmoDB v26), filtered as described above and split into reads mapping to the sense 
strand (FLAG16) and antisense strand (FLAG0), respectively. RNA-seq libraries were normalized to the 
number of mapped reads per million (RPM) and bedgraph files were generated (bedtools v2.20.1). 
After uploading the tracks to the UCSC genome browser, tracks were smoothened (5) and the 
windowing function was set as ‘mean’. 
 
Reverse transcription quantitative PCR (RT-qPCR) 
F12 and F12/gdv1-asKO parasites were synchronized twice 16 hours apart to obtain an eight hour 
growth window. Parasites were harvested at 40-48 hpi. Total RNA was isolated using Ribozol 
(Amresco) according to the manufacturer’s manual and further purified using the RNeasy Plus Mini 
Kit (Qiagen) for removal of gDNA. Residual gDNA was digested with TURBO DNA-freeTM DNaseI 
(Ambion) and the RNA was quantified by NanoDrop. All samples were tested negative for 
contaminating gDNA by qPCR. 2 mg total RNA was reverse-transcribed using the RETROscript Kit 
(Ambion). qPCR reactions were performed at primer concentrations of 0.5 mM using Power SYBR® 
Green PCR Master Mix (Applied Biosystems) on a StepOnePlusTM Real-Time PCR System (Applied 
Biosystems) in a reaction volume of 20 ml. All reactions were run in triplicate yielding virtually identical 
Ct values. Cycling conditions were: 95°C for 10 min, followed by 40 cycles of 95°C/15 sec and 60°C/1 
min. Product-specific amplification was ensured by melting curve analysis for each reaction. Relative 
transcript levels were calculated by normalization against the house-keeping gene encoding 
eukaryotic translation initiation factor 2-alpha kinase (pk4, PF3D7_0628200). All primer sequences are 
listed in Table S9. 
 
Supplementary materials  
 
SUPPLEMENTARY TEXT 
Deletion of the gdv1 asRNA locus in F12 parasites resulted in a marked increase in ap2-g transcript 
levels (Fig. 4B, Fig. S6 and Table S8). Hence, to be able to knock-out the gdv1 asRNA in 3D7 parasites 
we first had to modify the ap2-g locus such that AP2-G expression is prevented under default culture 
conditions. To achieve this in a most robust way we placed expression of AP2-G under control of two 
conditional expression systems. Using a single CRISPR/Cas9-based gene editing step we tagged AP2-
G with a C-terminal GFP-DD tag and at the same time inserted a glmS riboswitch element into the 3’ 
untranslated region (Fig. S8). The glmS riboswitch allows regulating gene expression at the level of the 
mRNA; in presence of the amino sugar glucosamine (GlcN) the glmS ribozyme structure mediates self-
cleavage of the mRNA leading to its degradation (56-58). As expected, parasites did not express AP2-
G-GFP-DD and failed to produce gametocytes when cultured in absence of Shield-1 and presence of 
GlcN. In presence of Shield-1 and absence of GlcN AP2-G-GFP-DD expression was detectable by IFA in 
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the nuclei of some parasites and gametocytes were produced at a rate of 11.0% (+/- 0.3 SD) (Fig. S8). 
Having established this conditional AP2-G loss-of-function mutant we next deleted the gdv1 asRNA 
locus in these parasites (3D7/AP2-G-GFP-DDglmS/gdv1-asKO). 3D7/AP2-G-GFP-DDglmS/gdv1-asKO 
parasites still failed to produce gametocytes when AP2-G-GFP-DD expression was prevented in 
absence of Shield-1 and presence of GlcN. However, compared to the 3D7/AP2-G-GFP-DDglmS control 
line 3D7/AP2-G-GFP-DDglmS/gdv1-asKO parasites displayed a substantially increased sexual 
conversion rate of 39.3% (+/- 2.8 SD) when AP2-G-GFP-DD expression was stabilised, showing that the 
gdv1-asRNA antagonises the GDV1-dependent induction of gametocyte conversion. 
 
SUPPLEMENTARY FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S1. GDV1 co-localises and interacts with HP1. (A) a-GFP (green) and a-HP1 (red) co-localisation 
IFAs in 3D7/GDV1-GFP-DDON trophozoites (T, 24-32 hpi), early schizonts (ES, 32-40 hpi) and late 
schizonts (LS, 40-48 hpi). Scale bar, 2.5 mm. White frames refer to the magnified views in the 
rightmost images (scale bar, 0.5 mm). DIC, differential interference contrast. Results are 
representative of three biological replicate experiments. (B) Flow chart of the purification approach 
used to demonstrate direct protein-protein interaction between GDV1 and HP1 co-expressed in E.coli 
as HisSumo-tagged GDV1 and Strep(II)-tagged HP1. Co-expression of a HisSUMO-tagged N-terminal 
fragment of the heterochromatin-associated ApiAP2 factor PfSIP2 (45) and Strep(II)-tagged HP1 was 
used as negative control. Samples highlighted in blue are shown in the Coomassie-stained 
polyacrylamide gel shown in panel C. (C) Coomassie-stained SDS-polyacrylamide gel. Lane 1: protein 
size standard. Lanes 2, 3: supernatants (SN) of bacterial lysates show co-expression of the respective 
fusion proteins GDV1/HP1 (lane 2) and SIP2/HP1 (lane 3) (asterisks). Lanes 4, 5: elution samples 
obtained after Ni2+ affinity purification (HIS E) of the GDV1/HP1 SN (lane 4) or the SIP2/HP1 SN 
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(lane 5). Strep(II)-tagged HP1 co-purified specifically with HisSUMO-GDV1 (lane 4) but not with 
HisSUMO-SIP2 (lane 5). Lanes 6, 7: the Ni2+ column elution of the GDV1/HP1 sample (containing both 
HisSUMO-GDV1 and Strep(II)-HP1) and Ni2+ column flow through of the SIP2/HP1 negative control 
sample(containing Strep(II)-HP1) were further purified using StrepTactin affinity purification followed 
by hydrophobic interaction chromatography (HIC). Analysis of the HIC eluates (HIC E) show that 
HisSUMO-GDV1 co-purified with Strep(II)-HP1 (lane 6). (D) a-HP1 and a-HIS Western blot confirm the 
identities of HisSUMO-GDV1 and Strep(II)-HP1 in the HIC elution samples. 
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Fig. S2. GDV1 over-expression induces sexual commitment.  
(A, B) Overview images of IFAs performed on formaldehyde/glutaraldehyde-fixed cultures 38-46 
hours after re-invasion (day 2) using a-Pfs16 antibodies, highlighting the large proportion of stage I 
gametocytes (green) in 3D7/GDV1-GFP-DDON (A) compared to 3D7GDV1-GFP-DDOFF (B) parasites. 
Nuclei were stained with DAPI. Scale bars, 15 mm (20x magnification) and 5 mm (40x magnification). 
(C) Proportion of male and female gametocytes in 3D7/GDV1-GFP-DDOFF and 3D7GDV1-GFP-DDOFF 
populations. Results represent the mean of three technical replicates (error bars represent SD). Total 
number of scored gametocytes is shown above the bars. 
 
 
 
 
 
 
 
Fig. S3. Generation of the 3D7/3xHA-GDV1 line using CRISPR/Cas9 and expression of 
endogenous 3xHA-GDV1.  
(A) Schematic maps of the gdv1 locus (PF3D7_0935400) in 3D7 parasites (top), the pFDon_3xha-gdv1 
donor and pB_gC-gdv1-5’ CRISPR/Cas9 transfection vectors (center), and the modified gdv1 locus 
after CRISPR/Cas9-based genome editing in 3D7/3xHA-GDV1 parasites (bottom). The gdv1 sense  
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transcript and multi-exon antisense transcript (24) are indicated by undulated arrows in blue and red, 
respectively. The nucleotide positions of the sgt_gdv1-5’ sgRNA target sequence is indicated 
(chromosome 9 coordinates). The pFDon_3xha-gdv1 donor plasmid contains a 3xha sequence (red) 
flanked on either side by a homology box (HB) (orange) for homology-directed repair. The pB_gC-
gdv1-5’ plasmid contains expression cassettes for SpCas9 (grey), the sgRNA (purple) and the bsd 
resistance marker (brown). Successful gene editing results in the expression of a N-terminally tagged 
3xHA-GDV1. PCR primer binding sites used to confirm successful gene editing are indicated by 
arrowheads. (B) PCR on gDNA from 3D7/3xHA-GDV1 and 3D7 wild-type parasites. Primers gdvHA_F 
and gdvHA_R bind to chromosomal sequences outside the HBs and amplify a 1455 bp or 1362 bp 
fragment from the edited or wild-type gdv1 locus, respectively. The gdvHA_F/HA_R and 
HA_F/gdvHA_R primer combinations are specific for the edited locus and amplify 795 bp and 765 bp 
fragments, respectively. (C) a-HA (green) and a-HP1 (red) co-localisation IFAs in 3D7/3xHA-GDV1 
trophozoites (T, 24-32 hpi) and early schizonts (ES, 32-40 hpi). Scale bar, 2.5 mm. White frames refer 
to the magnified views in the rightmost images (scale bar, 0.5 mm). DIC, differential interference 
contrast. Results are representative of two biological replicate experiments. (D) Representative a-HA 
(red) IFAs of 3D7/3xHA-GDV1 parasites cultured in presence or absence of 2 mM choline. Nuclei were 
stained with DAPI. Scale bar, 2.5 mm. DIC, differential interference contrast. 
Chapter 5
 
 
156 
 
 
 
Fig. S4. Induction of GDV1-GFP-DD expression triggers a gametocyte-specific transcriptional 
response.  
The heatmap shows the temporal gene induction profiles of all genes with (1) higher transcript 
levels in 3D7/GDV1-GFP-DDON compared to the 3D7 reference pool (positive log2 Cy5/Cy3 ratio), 
and (2) greater than 2-fold higher transcript levels in 3D7/GDV1-GFP-DDON vs 3D7/GDV1-GFP-
DDOFF (log2 fold change >1) in any two of the seven consecutive TPs. HP1-associated genes 
identified previously (2) and in this study (Table S7) are highlighted by red boxes. Early gametocyte 
genes identified in previous studies (7, 8, 17) are highlighted by orange boxes. FC, fold change; 
gen., generation. T1/ES1/LS1, trophozoites, early schizonts, late schizonts in generation 1; 
ER2/LR2/T2/ES2, early ring stages, late ring stages, trophozoites, early schizonts in generation 2. 
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Fig. S5. Increased GDV1 occupancy at heterochromatic domains at all three TPs in 3D7/GDV1-GFP-
DDON compared to 3D7/GDV1-GFP-DDOFF parasites.  
ChIP-seq ratio tracks display relative enrichment (ChIP/input) of GDV1-GFP-DD (blue) or HP1 
(green) along chromosome 12 in 3D7/GDV1-GFP-DDON parasites cultured in the presence of Shield-
1 for two (TP1, 30-36 hpi), six (TP2, 34-40 hpi) or ten hours (TP3, 38-44 hpi) and in the matching control 
populations grown in the absence of Shield-1 (3D7/GDV1-GFP-DDOFF). 
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Fig. S6. Generation of the F12/gdv1-asKO parasite line using CRISPR/Cas9.  
(A) Schematic maps of the gdv1 locus (PF3D7_0935400) in F12 parasites (top), the p_gCH-gdv1-asKO 
CRISPR/Cas9 transfection vector (center), and the modified gdv1 locus after CRISPR/Cas9-based 
genome editing in F12/gdv1-asKO parasites (bottom). The gdv1 sense transcript and multi-exon 
antisense transcript (24) are indicated by undulated arrows in blue and red, respectively. The 
nucleotide positions of the sgt_gdv1-3’ sgRNA target sequence is indicated (chromosome 9 
coordinates). The p_gCH-gdv1-asKO plasmid contains expression cassettes for SpCas9 (grey), the 
sgRNA (purple) and the hdhfr resistance marker (brown) flanked by two homology boxes (HB) (orange) 
for homology-directed repair. PCR primer binding sites used to confirm successful gene editing are 
indicated by arrowheads. (B) PCR on gDNA from F12/gdv1-asKO and F12 wild-type parasites. Primers 
gdvF and gdvR bind to chromosomal sequences outside the HBs and amplify a 3751 bp or 4818 bp 
fragment from the edited or wild-type gdv1 locus, respectively. The gdvF/hdhfrF and hdhfrR/gdvR 
primer combinations are specific for the edited locus and amplify 1452 bp and 2069 bp fragments, 
respectively. (C) RT-qPCR data confirming the increase in ap2-g and dblmsp2 transcript levels in 
F12/gdv1-asKO compared to F12 wild-type parasites (results are the mean of three biological 
replicates; error bars represent SD). actin (PF3D7_1264200)/glu-tRNA-l.(PF3D7_1331700), control 
genes. (D), RT-qPCR showing the absence of gdv1 asRNA in F12/gdv1-asKO parasites. Values represent 
GDV1 induces sexual commitment of malaria parasites
 
  
159 
expression levels relative to the house-keeping gene encoding eukaryotic translation initiation factor 
2-alpha kinase (pk4, PF3D7_0628200). glu-tRNA-l. (PF3D7_1331700), control gene. Results are the 
mean of three biological replicates (error bars represent SD). n.d., not detectable. 
 
 
 
 
 
Fig. S7. Generation of the F12/3xHA-GDV1/gdv1-asKO line using CRISPR/Cas9 and expression of 
endogenous 3xHA-GDV1. 
(A) Schematic maps of the gdv1 locus (PF3D7_0935400) in F12/gdv1-asKO parasites (top), the 
pFDon_3xha-gdv1 donor and pB_gC-gdv1-5’ CRISPR/Cas9 transfection vectors (center), and the 
modified gdv1 locus after CRISPR/Cas9-based genome editing in F12/3xHA-GDV1/gdv1-asKO 
parasites (bottom). The gdv1 sense transcript is indicated by an undulated arrow in blue. The 
nucleotide positions of the sgt_gdv1-5’ sgRNA target sequence is indicated (chromosome 9 
coordinates). The pFDon_3xha-gdv1 donor plasmid contains a 3xha sequence (red) flanked on either 
side by a homology box (HB) (orange) for homology-directed repair. The pB_gC-gdv1-5’ plasmid 
contains expression cassettes for SpCas9 (grey), the sgRNA (purple) and the bsd resistance marker 
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(brown). Successful gene editing results in the expression of a N-terminally tagged 3xHA-GDV1. PCR 
primer binding sites used to confirm successful gene editing are indicated by arrowheads. (B) PCR on 
gDNA from F12/3xHA-GDV1/gdv1-asKO and F12 wild-type parasites. Primers gdvHA_F and gdvHA_R 
bind to chromosomal sequences outside the HBs and amplify a 1455 bp or 1362 bp fragment from the 
edited or wild-type gdv1 locus, respectively. The gdvHA_F/HA_R and HA_F/gdvHA_R primer 
combinations are specific for the edited locus and amplify 795 bp and 765 bp fragments, respectively. 
(C) a-HA (green) and a-HP1 (red) co-localisation IFAs in F12/3xHA-GDV1/gdv1-asKO trophozoites (T, 
24-32 hpi), early schizonts (ES, 32-40 hpi) and late schizonts (LS, 40-48 hpi). Scale bar, 2.5 mm. White 
frames refer to the magnified views in the rightmost images (scale bar, 0.5 mm). DIC, differential 
interference contrast. Results are representative of two biological replicate experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. S8. Generation of the 3D7/AP2-G-GFP-DDglmS and 3D7/AP2-G-GFP-DDglmS/gdv1-asKO 
parasite lines using CRISPR/Cas9.  
(A) Schematic maps of the ap2-g locus (PF3D7_1222600) in 3D7 parasites (top), the pD_ap2-g-gfp-dd-
glmS donor and pH_gC-ap2g-3’ CRISPR/Cas9 transfection vectors (center), and the modified ap2-g 
locus after CRISPR/Cas9-based genome editing in 3D7/AP2-G-GFP-DDglmS parasites (bottom). The 
nucleotide positions of the sgt_ap2g-3’ sgRNA target sequence is indicated (chromosome 12 
coordinates). The pD_ap2-g-gfp-dd-glmS donor plasmid contains a gfp-dd-glmS fusion sequence 
flanked on either side by a homology box (HB) (orange) for homology-directed repair. The pH_gC-
ap2g-3’ plasmid contains expression cassettes for SpCas9 (grey), the sgRNA (purple) and the hdhfr 
resistance marker (brown). Successful gene editing results in the expression of a C-terminally tagged 
AP2-G-GFP-DD fusion protein that is under control of the glmS riboswitch system (56). PCR primer 
binding sites used to confirm successful gene editing are indicated by arrowheads. (B) Schematic maps 
of the gdv1 locus (PF3D7_0935400) in 3D7/AP2-G-GFP-DDglmS parasites (top), the p_gCB-gdv1-asKO 
CRISPR/Cas9 transfection vector (center), and the modified gdv1 and ap2-g loci after CRISPR/Cas9-
based genome editing in 3D7/AP2-G-GFP-DDglmS/gdv1-asKO parasites (bottom). The gdv1 sense 
transcript and multi-exon antisense transcript (24) are indicated by undulated arrows in blue and red, 
respectively. The nucleotide positions of the sgt_gdv1-3’ sgRNA target sequence is indicated 
(chromosome 9 coordinates). The p_gCB-gdv1-asKO plasmid contains expression cassettes for SpCas9 
(grey), the sgRNA (purple) and the bsd resistance marker (brown) flanked by two homology boxes (HB) 
(orange) for homology-directed repair. PCR primer binding sites used to confirm successful gene 
editing are indicated by arrowheads. (C) PCR on gDNA from 3D7/AP2-G-GFP-DDglmS/gdv1-asKO, 
3D7/AP2-G-GFP-DDglmS and 3D7 wild-type parasites. Primers apF and apR bind to chromosomal 
sequences outside the ap2-g HBs and amplify a 2584 bp or 1263 bp fragment from the edited or wild-
type ap2-g locus, respectively. Primers gdvF and gdvR bind to chromosomal sequences outside the 
gdv1 HBs and amplify a 3751 bp or 4818 bp fragment from the edited or wild-type gdv1 locus,
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respectively. The apF/gfpR and apR/gfpF primer combinations are specific for the edited ap2-g locus  
and amplify 882 bp and 1876 bp fragments, respectively. The bsdR/gdvF and bsdF/gdvR primer 
combinations are specific for the edited gdv1 locus and amplify 1378 bp and 2322 bp fragments, 
respectively. (D) Endogenous ap2-g locus in the 3D7/AP2-G-GFP-DDglmS line and a-GFP IFA showing 
AP2-G-GFP-DD expression in a late schizont (LS, 40-48 hpi) from a 3D7/AP2-G-GFP-DDglmS culture 
grown in presence of Shield-1 and absence of glucosamine (GlcN). DIC, differential interference 
contrast. Scale bar, 2.5 mm. Results are representative of three biological replicates. (E) Sexual 
conversion rates in 3D7/AP2-G-GFP-DDglmS and 3D7/AP2-G-GFP-DDglmS/gdv1-asKO parasites 
cultured either in presence of GlcN/absence of Shield-1 (AP2-G-GFP-DD expression prevented) or 
absence of GlcN/presence of Shield-1 (AP2-G-GFP-DD expression permitted) (results are the mean of 
three biological replicates (>200 infected RBCs counted per sample); error bars indicate SD).  
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Supplementary tables 
 
Table S1. Potential HP1-interacting proteins identified by LC-MS/MS in the eluates of three 
independent Co-IP experiments. Gene IDs and annotations have been retrieved from PlasmoDB 
(www.plasmodb.org). This table lists all proteins detected in all three HP1-GFP Co-IP eluates (Co-IP 
Exp#1-3) and undetected in all negative control eluates. Note that for each experiment the sequence 
coverage and number of unique peptides indicated derive from either the 2 M arginine or subsequent 
2% SDS elution samples, whichever displayed the higher number of unique tryptic peptides detected 
(see also Table S3). Cov, % sequence coverage; Pep, number of unique tryptic peptides detected. 
 
  Co-IP Exp#1 Co-IP Exp#2 Co-IP Exp#3 
GeneID Description Cov Pep Cov Pep Cov Pep 
PF3D7_1220900 heterochromatin protein 1 (HP1) 77.82 30 65.79 23 71.43 24 
PF3D7_0935400 gametocyte development protein 1 (GDV1) 43.91 19 9.68 6 22.20 10 
PF3D7_0818200 14-3-3 protein (14-3-3I) 43.89 7 17.94 3 10.31 3 
PF3D7_1451200 conserved Plasmodium protein, unknown function 17.42 24 14.10 14 15.43 21 
PF3D7_1441400 FACT complex subunit SSRP1, putative (FACT-S) 11.46 5 9.49 4 7.91 3 
PF3D7_0517400 FACT complex subunit SPT16, putative (FACT-L) 1.14 1 8.41 8 3.24 3 
PF3D7_1023900 
chromodomain-helicase-DNA-
binding protein 1 homolog, 
putative (CHD1) 
0.45 1 0.45 1 5.26 12 
PF3D7_1357400 conserved Plasmodium protein, unknown function 1.70 2 3.56 3 3.48 3 
PF3D7_1456000 transcription factor with AP2 domain(s) (ApiAP2) 2.91 4 0.80 1 3.20 3 
 
Table S2. Potential GDV1-interacting proteins identified by LC-MS/MS in the eluates of three 
independent Co-IP experiments. Gene IDs and annotations have been retrieved from PlasmoDB 
(www.plasmodb.org). This table lists all proteins detected in all three GDV1-GFP-DD Co-IP eluates (Co-
IP Exp#1-3) and undetected in all negative control eluates (see also Table S4). Cov, % sequence 
coverage; Pep, number of unique tryptic peptides detected. 
 
  Co-IP Exp#1 Co-IP Exp#2 Co-IP Exp#3 
GeneID Description Cov Pep Cov Pep Cov Pep 
PF3D7_0505800 small ubiquitin-related modifier, putative (SUMO) 54 5 46 4 37 2 
PF3D7_1220900 heterochromatin protein 1 (HP1) 50.38 14 28.95 9 23.31 6 
PF3D7_0935400 gametocyte development protein 1 (GDV1) 32.89 19 23.54 10 18.36 9 
PF3D7_1211800 polyubiquitin (PfpUB) 44.62 1 21 1 21 1 
PF3D7_1451200 conserved Plasmodium protein, unknown function 15.82 24 20.81 29 5.72 7 
PF3D7_1023900 
chromodomain-helicase-DNA-
binding protein 1 homolog, 
putative (CHD1) 
10.16 30 8.74 23 5.44 13 
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PF3D7_1027800 60S ribosomal protein L3, putative 3.11 1 3.11 1 3.11 1 
PF3D7_1447000 40S ribosomal protein S2, putative 2.94 1 3.31 1 3.31 1 
 
Table S3-S8, please download online. 
 
Table S3. Mass spectrometry results of the HP1-GFP co-IP experiments. This file lists all proteins and 
peptides identified by Mascot and Sequest HT searches of the results obtained from LC-MS/MS 
analysis of protein elutions 1 (E1_Arg) and 2 (E2_SDS) obtained after HP1-GFP co-IP (HP1 Co-IP) or 
negative control IPs (neg. control). The experiments have been performed in three biological 
replicates (#1-3). The file contains 12 worksheets. (xlsx format). 
 
Table S4. Mass spectrometry results of the GDV1-GFP-DD co-IP experiments. This file lists all proteins 
and peptides identified by Mascot and Sequest HT searches of the results obtained from LC-MS/MS 
analysis of protein elutions (E_SDS) obtained after GDV1-GFP co-IP (GDV1 Co-IP) or negative control 
IPs (neg. control). The experiments have been performed in three biological replicates (#1-3). The file 
contains 6 worksheets. (xlsx format). 
 
Table S5. Processed microarray data obtained from 3D7/GDV1-GFP-DD parasites. Columns A-B: 
Gene ID and gene annotation. Column C: HP1 target genes previously identified by ChIP-on-chip (2) 
and in this study (Table S7). Column D: known early gametocyte markers (7, 8, 17). Columns E-K: 
Cy5/Cy3 log2 ratios for all transcripts and seven TPs harvested from 3D7/GDV1-GFP-DDOFF parasites. 
Columns L-R: Cy5/Cy3 log2 ratios for all transcripts and seven TPs harvested from 3D7/GDV1-GFP-
DDON parasites. Column S-Y: fold change in gene expression (log2) in 3D7/GDV1-GFP-DDON compared 
to 3D7/GDV1-GFP-DDOFF parasites for each of the seven paired TPs. Column Z: mean fold change in 
gene expression in 3D7/GDV1-GFP-DDON compared to 3D7/GDV1-GFP-DDOFF parasites across all seven 
TPs. Column AA: SAM significance q-values (% fdr). Column AB: significantly up-regulated (u) or down-
regulated (d) genes. T1/ES1/LS1, trophozoites, early schizonts, late schizonts in generation 1; 
ER2/LR2/T2/ES2, early ring stages, late ring stages, trophozoites, early schizonts in generation 2. (xlsx 
format). 
 
Table S6. Processed microarray data obtained with F12/GDV1-GFP-DD parasites. Columns A-B: Gene 
ID and gene annotation. Column C: HP1 target genes previously identified by ChIP-on-chip (2) and in 
this study (Table S7). Column D: known early gametocyte markers (7, 8, 17). Columns E-K: Cy5/Cy3 
log2 ratios for all transcripts and seven TPs harvested from F12/GDV1-GFP-DDOFF parasites. Columns 
L-R: Cy5/Cy3 log2 ratios for all transcripts and seven TPs harvested from F12/GDV1-GFP-DDON 
parasites. Column S-Y: fold change in gene expression (log2) in F12/GDV1-GFP-DDON compared to 
F12/GDV1-GFP-DDOFF parasites for each of the seven paired TPs. Column Z: mean fold change in gene 
expression in F12/GDV1-GFP-DDON compared to F12/GDV1-GFP-DDOFF parasites across all seven TPs. 
Column AA: SAM significance q-values (% fdr). Column AB: significantly up-regulated (u) or down-
regulated (d) genes. T1/ES1/LS1, trophozoites, early schizonts, late schizonts in generation 1; 
ER2/LR2/T2/ES2, early ring stages, late ring stages, trophozoites, early schizonts in generation 2. (xlsx 
format). 
 
Table S7. GDV1-GFP-DD and HP1 ChIP-seq enrichment values. ChIP/input enrichment values were 
calculated over each coding region of the Pf_3D7_v3 reference genome in 3D7/GDV1-GFP-DDON and 
3D7/GDV1-GFP-DDOFF parasites at TPs 1-3 (30-36 hpi, 34-40 hpi, 38-44 hpi). Columns A-B: Gene ID and 
gene annotation. Column C: chromosome number. Columns D-E: Nucleotide positions at the start and 
end of each gene. Column F: HP1-associated genes (HP1 ChIP/input >1 in 3D7/GDV1-GFP-DDOFF 
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control parasites at TP3). Column G: known early gametocyte markers (7, 8, 17). Columns H-M: GDV1-
GFP-DD ChIP/input values for each population and TP. Columns N-P: fold change in GDV1-GFP-DD 
occupancy between parasites cultured in the presence or absence of Shield-1 for each TP. Columns 
Q-R: HP1 ChIP/input values for both populations at TP3. Column S: log2 fold change in HP1 occupancy 
between parasites cultured in the presence or absence of Shield-1 for TP3. (xlsx format). 
 
Table S8. Processed RNA-seq data of sense transcripts obtained from F12 wild-type and F12/gdv1-
asKO parasites. Columns A-B: Gene ID and gene annotations. Column C: HP1 target genes previously 
identified by ChIP-on-chip (2) and in this study (Table S7). Columns D-E: RPKM values for early 
schizonts (32-40 hpi) of F12 wild-type and F12/gdv1-asKO parasites. Column F: fold change (FC) in 
transcript abundance in F12/gdv1-asKO compared to F12 wild-type early schizonts (32-40 hpi). 
Columns G-H: RPKM values for late schizonts (40-48 hpi) of F12 wild-type and F12/gdv1-asKO 
parasites. Column I: fold change (FC) in transcript abundance in F12/gdv1-asKO compared to F12 wild-
type late schizonts (40-48 hpi). Column J: Genes consistently up-regulated (up) or down-regulated 
(down) in both time points in F12/gdv1-asKO compared to F12 wild-type parasites. Genes with RPKM 
values < 3 in both samples per time point are highlighted in grey and were excluded from downstream 
analyses. (xlsx format) 
 
Table S9. Oligonucleotides used in this study. 
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Summary 
Underlying the development of malaria parasites within erythrocytes, and the resulting 
pathogenicity, is a hardwired program that secures proper timing of gene transcription and 
production of functionally relevant proteins. How stage-specific gene expression is 
orchestrated in vivo remains unclear. Here, using the assay for transposase accessible 
chromatin-sequencing (ATAC-seq), we identified ~4000 regulatory regions in P. falciparum 
intraerythrocytic stages. The vast majority of these sites is located within 2 kb upstream of 
transcribed genes and their chromatin accessibility pattern correlates positively with 
abundance of the respective mRNA transcript. Importantly, these regions are sufficient to 
drive stage-specific reporter gene expression and DNA motifs enriched in stage-specific sets 
of regulatory regions interact with members of the P. falciparum AP2 transcription factor 
family. Collectively, this study provides initial insights into the in vivo gene regulatory 
network of P. falciparum intraerythrocytic stages and should serve as a valuable resource 
for future studies.  
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Introduction 
Malaria, caused by infection with parasites of the Plasmodium genus, remains a major 
health and economic burden [1]. The parasite’s life cycle is intriguingly complex, requiring 
adaptation to several different host cell environments and transmission between the 
human host and the mosquito vector. The approximately 48 hr intraerythrocytic 
development of P. falciparum is responsible for most disease symptoms. It involves the 
invasion, remodelling, consumption, and rupture of human red blood cells while the 
parasite replicates by schizogony, giving rise to 16-32 new parasites [2]. Underlying this 
development and the pathogenicity of the parasite is a gene expression program that 
secures proper timing of gene transcription and production of functionally relevant 
proteins. However, despite being a fundamental eukaryotic process and a potential target 
of drug-based intervention, our understanding of gene expression regulation in Plasmodium 
is still in its infancy [3].  
During the intraerythrocytic development cycle (IDC), the majority of genes is transcribed 
in a “just-in-time” manner, with peak mRNA abundances correlating with the need for the 
products they encode for [4]. Although post-transcriptional and translational control 
mechanisms operate in this stage as well [5, 6], the initial production of mRNAs, dictated by 
transcriptional and epigenetic mechanisms, remains a major and rate limiting step in the 
gene expression process during the blood-stage cycle. In P. falciparum, epigenetic 
regulation of gene expression is most evident in heterochromatin-mediated gene silencing 
of, for example, antigenic variation genes, the selection of erythrocyte invasion pathways, 
and control of gametocyte conversion rate (for review see [7]). This type of regulation is, 
however, limited to genes located in subtelomeric regions and a few chromosome-internal 
heterochromatic islands [8, 9], while the largest part of the parasite genome is in a 
transcriptionally permissive, euchromatic state. 
These observations collectively point to an important role for transcriptional control 
mechanisms in stage-specific gene expression regulation, including the action of trans-
acting transcription factors (TFs) that bind to specific DNA sequences and stimulate or 
inhibit the assembly and/or activity of the RNA polymerase II pre-initiation complex. Such 
sequence-specific TFs are, however, relatively low in numbers, constituting roughly 1% of 
all protein-coding genes [10, 11] compared to ~3% in yeast or 6% in human. Despite general 
scarcity of sequence-specific TFs, the relevance of the Apicomplaxan AP2 family of TFs in 
Plasmodium has become evident over the past decade, mainly through the use of knock-
out or knock-down experiments [12-21]. While these functional genomic approaches have 
been very powerful to dissect the function of TFs outside of the IDC, they could only suggest 
the essentiality of AP2 factors during the IDC. Furthermore, rather little is known about DNA 
elements that act in concert with these specific TFs. Most of our current understanding on 
cis-regulatory DNA elements stems from deletion analyses of promoters (e.g. [22-24]), 
in silico DNA motif predictions (e.g. [25-28]), and protein binding microarray studies 
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defining the in vitro sequence preference of recombinant ApiAP2 domains (Campbell et al., 
2010). Although these studies have certainly been valuable and some of the DNA motif 
predictions could indeed be confirmed by ChIP-sequencing experiments (Kaneko et al., 
2015; Santos et al., 2017), we still lack an accurate, genome-wide overview of cis-regulatory 
DNA elements and their activity in vivo.  
The binding of specific trans-factors to the DNA is associated with the eviction and/or 
destabilization of nucleosomes thereby creating a more “accessible” chromatin 
environment. As a first attempt to explore open chromatin structures in P. falciparum, 
formaldehyde-assisted isolation of regulatory elements (FAIRE-seq) has been has been 
employed [29]. While this study reported increased accessibility at active promoter regions, 
the resolution of the data was not sufficient to improve the identification of regulatory 
elements. In a previous study, we applied MNase-sequencing to profile the nucleosome 
landscape and provided proof of principle that the chromatin environment of a predicted 
regulatory element is depleted of nucleosomes and this signature could be used to predict 
active regulatory elements [30]. As a completion of these efforts, here we set out to identify 
gene regulatory elements in vivo and on a genome-wide scale by directly profiling 
chromatin accessibility using the assay for transposase accessible chromatin-sequencing 
(ATAC-seq [31]). We combined ATAC-seq and directional RNA-sequencing (RNA-seq) on 
eight tightly synchronized P. falciparum IDC stages to profile gene regulatory events. 
Furthermore, we combined bioinformatics, biochemical, and reporter gene assays to 
characterize these cis-regulatory elements and their interactions with transcription factors. 
Collectively, this study represents a major step towards dissection of the transcriptional 
regulation network of this deadly pathogen and provides a valuable resource for future 
studies aiming to characterize or use gene regulatory elements. 
 
Results 
ATAC-seq identifies accessible chromatin regions in the AT-rich Plasmodium genome 
To identify and profile transcription factor binding events, we performed ATAC-seq on 
synchronized P. falciparum 3D7 parasites at eight consecutive time points during their IDC 
(from 5 to 40 hr post invasion [hpi]). Considerable signal was detected in coding sequences 
(Figure S1A, purple track “t40 all”) and in subtelomeric regions of the genome (data not 
shown). We reasoned that this was likely due to the sequence bias of the enzyme [32], in 
combination with the distinctly higher GC-content of these sequences as compared to the 
AT-rich intergenic regions [33]. To correct for such biases as well as biases introduced during 
library preparation and sequencing, we performed the same assay on naked, genomic DNA 
(gDNA). This control library also showed a distinctly higher read count in the GC-richer 
coding sequences (Figure S1A, bottom gray track “gDNA all”) and subtelomeric regions.  
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Figure 1: ATAC-seq detects chromatin accessibility during intraerythrocytic development of 
P. falciparum. 
A) UCSC genome browser screenshot of a 66,700 bp region on chromosome 7 displaying chromatin 
accessibility profiles from eight time points (t05 - t40 hours post invasion [hpi]) as a ratio of normalized 
ATAC-seq tag count over background transposition in naked, genomic DNA (ATAC-seq/gDNA). Black 
bars below t40 track depict the peak regions as identified by MACS2 peak calling. Coding sequences 
are indicted as blue (positive strand) or red (minus strand) bars. GC%, the mean percentage of GC 
nucleotides, smoothened over 5bp windows. B) Heatmap depicting the Pearson correlation of RPKM 
values in peak regions from the above dataset (REPLICATE1) and an independent eight time point 
ATAC-seq dataset (REPLICATE2) demonstrating a high degree of reproducibility. C) The distribution of 
accessible regions among different genomic regions. Peaks were called on accessibility profiles of 
individual time points (t05-t40) and merged, yielding 4035 accessible regions. Intergenic regions were 
categorized based on the direction of transcription of the flanking coding regions (divergent, green; 
convergent, orange; tandem, pink). D) Peaks located in divergent and tandem intergenic regions were 
assigned to the closest downstream gene and the distance between the ATAC peak summit and the 
ATG or TSS was calculated. The line depicts the smoothened distribution of distances (kernel density 
estimate). See also Figure S1 and Table S1. 
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Furthermore, in the chromatin context, Tn5 transposition is known to give rise to (sub-) 
nucleosomal fragments (<150 bp) as well as fragments corresponding to mono-, di- and tri-
nucleosomes as a result of transposition in the vicinity of TF binding sites and in linker 
regions between nucleosomes, respectively (Buenrostro et al., 2013). We therefore 
reasoned that selecting reads with a size between 50 and 150bp could increase the signal-
to-noise ratio for the detection of TF binding sites. Indeed, compared to the other insert 
sizes, a higher proportion of 50-100 bp and 100-150 bp fragments mapped to intergenic, 
putative regulatory regions (Figures S1A and S1B) and to binding sites of an AP2 
transcription factor (AP2-I [17], Figure S1B and next paragraph). Based on the above 
observations we decided to use only fragments with a size between 50 and 150bp and 
corrected the derived read counts with the read counts detected in the gDNA control library 
in all follow-up analysis (Figure 1A). Finally, the robustness of the data was assessed by 
preparing a replicate ATAC-seq dataset (replicate 2), which showed a high degree of 
correlation with the first dataset (Pearson correlation of 0.88 and higher; Figures 1B and 
S1C). Accordingly, our ATAC-seq approach enables robust and accurate identification of 
accessible chromatin regions despite AT-richness of the P. falciparum genome. 
 
Dynamic chromatin accessibility in 5’ intergenic regions highlights TF-binding events  
Next, we identified local regions of increased accessibility for all eight time points of the IDC 
using the model-based analysis of ChIP-seq 2 (MACS2) algorithm for peak calling [34]. The 
number of identified accessible regions reflects the overall transcriptional output at the 
given stage of development [35-37], with ~500 regions in ring stages to ~3000 in late 
trophozoite/early schizonts (Figure S1D). After merging the peaks for all time points, a total 
4035 regions were identified that show increased accessibility during one or more stages of 
the IDC (Table S1), 92% of which were also confirmed by the peaks called on the replicate 
ATAC-seq dataset (Data not shown). Ninety percent of the accessible regions locate to 
intergenic regions containing one or two putative promoter regions (Figure 1C). Within 
these regions, the majority of peaks locate up to 2 kb upstream of the ATG and, when a 
transcription start site (TSS) was known [30], within 1.5 kb upstream of the TSS (Figure 1D). 
In addition, these ATAC peaks captured 95% of the AP2-I binding sites detected by ChIP-seq 
(Figures 2A and 2B; [17]). Interestingly, two different clusters of AP2-I binding sites could be 
discriminated based on their accessibility profile during the IDC. A cluster of 64 regions 
(linked to 50 genes) becomes accessible in late trophozoites/early schizonts and a cluster of 
105 regions (linked to 100 genes) that becomes accessible in mature schizonts and shows 
increased accessibility in t05 rings (Figures 2C and 2D). This subdivision is also evident at the 
molecular level with genes in cluster 1 being enriched for processes related to chromatin 
organization and cell cycle progression, while cluster 2 genes are clearly involved in host cell 
invasion (Table S2). Collectively, these results demonstrate that ATAC-seq detects dynamic 
chromatin accessibility in promoter regions of P. falciparum genes during the IDC and that 
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Figure 2: ATAC-seq predicts transcription factor binding events detected earlier by ChIP-sequencing. 
A) UCSC genome browser screenshots of three genomic regions with PfAP2-I transcription factors 
binding sites. Normalized ATAC-seq coverage is plotted as ratio over coverage in gDNA control. Data 
of the three PfAP2-I ChIP-seq replicates from [17], generated in the P. falciparum Dd2 line, were 
mapped against the P. falciparum 3D7 genome. Turquoise bars are PfAP2-I peaks from [17]. B) 
Overlap between PfAP2-I peaks and ATAC peaks from t40 time point (165 out of 2771 peaks overlap 
with 169 out of 177 PfAP2-I peaks) plotted as Venn diagram. C) Heatmap of non-gDNA corrected 
ATAC-seq accessibility profiles over PfAP2-I peaks (midpoint +/- 5 kb) that overlap with merged ATAC 
peaks (n = 169). Profiles were clustered using Pearson correlation calculated for the middle 100 bp 
window into 2 clusters by k-means clustering. D) Median accessibility profiles for the two clusters of 
ATAC peaks defined in (C) with the 50th and 90th percentile as a dark- and light-colored shades. 
Accessibility is calculated as proportion-of-sum of quantile normalized RPKM values over the time 
points. See also Table S2. 
 
it can capture TF binding events. In addition, it demonstrates that data from ATAC-seq 
performed at multiple developmental stages can provide valuable temporal resolution to 
TF ChIP-seq data performed at a single time point.  
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Chromatin accessibility patterns are predictive for gene expression dynamics  
To assess the relationship between chromatin accessibility and gene expression, we 
prepared directional RNA-seq libraries from the same parasite cultures as used for ATAC-
seq. Overall, the chromatin accessibility pattern and the transcript abundance pattern of 
the downstream gene are positively correlated (see examples in Figure 3A). To quantify this 
correlation, accessible regions were assigned to the closest downstream located gene, 
yielding 3210 accessible region - gene pairs (accessible regions and/or genes with low signal 
and hence potentially noisy patterns were excluded; STAR Methods). Chromatin 
accessibility patterns during the IDC, which were highly reproducible between the replicates 
(Figure S1E, median correlation of r=0.84), were then used to group accessible regions by 
means of k-means clustering. Alignment with the assigned genes revealed a high degree of 
similarity between chromatin accessibility patterns and relative abundance of 
corresponding mRNAs (Figure 3B). In fact, the majority of the genes showed a clear positive 
correlation between chromatin accessibility and relative mRNA abundance (Pearson 
correlation > 0.6, Figure 3C), demonstrating that chromatin accessibility is highly predictive 
of the gene expression pattern for the majority of genes. Moreover, this observation 
suggests that the gene regulatory events governing the IDC of P. falciparum are mainly 
activating events.  
 
ATAC-seq regions are sufficient for regulating stage-specific gene expression 
To study the potential of the identified accessible regions to drive stage-specific gene 
expression, parasite lines were generated with different accessible regions cloned upstream 
of the minimal kahrp promoter [38] and a gfp-luciferase (gfp-luc) reporter gene (Figures 4A, 
S2A and S2B). The region upstream of PF3D7_1372200 (hrpIII) has been characterized 
before and functioned as positive control [23] while the accessible regions upstream of 
PF3D7_0719000, PF3D7_1200700 and PF3D7_1222700 were selected based on their stage-
specific accessibility and RNA abundance profiles (Figure S2C, blue framed rectangle). In 
addition, for PF3D7_0719000 and PF3D7_1200700 we created control parasite lines with a 
neighboring, not-accessible intergenic region cloned upstream of the minimal kahrp 
promoter (Figure S2C, red framed rectangle; for PF3D7_1222700 integration of the negative 
control construct could not be achieved). Remarkably, for all tested accessible regions, the 
temporal expression profile of the reporter gene matched the RNA expression profiles of 
the respective downstream located genes and was clearly above the background detected 
in the control lines (Figure 4B and S2C). This demonstrates that intergenic regions displaying 
dynamic chromatin accessibility are sufficient to induce stage-specific expression of the 
downstream located gene. 
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Figure 3: Chromatin accessibility positively correlates with mRNA abundance of the downstream 
gene. 
A) UCSC genome browser screenshot (chr3: 110,000-125,500) of ATAC-seq chromatin accessibility 
profiles (top) and corresponding RNA-seq profiles (bottom; only reads mapping to the sense-strand 
are displayed). B) Heatmaps displaying relative chromatin accessibility and mRNA abundance profiles 
of the downstream gene through eight stages of intraerythrocytic development. Relative accessibility 
in ATAC-seq peaks located in divergent or tandem intergenic regions was calculated as a proportion-
of-sum of quantile normalized RPKM values over the time points and clustered by k-means using the 
1-Pearson correlation distance metric. The relative transcript abundances of the downstream located 
genes, expressed as proportion-of-sum of sense strand RPKM values over the time points, were 
plotted in the same order. Color scales range from the 20th to the 80th percentile for both datasets. C) 
Observed (red line) and 1000 randomized distributions (1000 gray lines with mean of all 
randomizations as black line) of Pearson correlation coefficients between relative chromatin 
accessibility and mRNA abundance of the downstream gene (as in (B)) plotted as smoothened kernel 
density distribution. 
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Figure 4: Accessible regions are sufficient in driving stage-specific reporter gene expression. 
A) Schematic representation of the DNA constructs inserted into the cg6 locus of attB(+) 3D7 
P. falciparum parasites using the site-specific integration system [58]. Accessible regions detected by 
ATAC-seq (light blue) were cloned upstream of the minimal kahrp promoter (yellow) followed by the 
gfp/luciferase fusion gene (green). B) Barplots showing the relative gfp/luciferase (gfp/luc) transcript 
abundance determined by RT-qPCR for ring, trophozoite and schizont stages from parasites carrying 
the reporter construct without accessible region (only the kahrp minimal promoter, yellow), with the 
accessible region of PF3D7_1372200 (hrpIII, positive control) or with selected accessible region 
located upstream of PF3D7_0719000, PF3D7_1200700 or PF3D7_1222700. For the latter three 
constructs with novel putative regulatory sequences, reporter gene expression was measured in 
biological duplicate. Relative gfp/luc transcript abundance was determined based on a standard, 
reference dilution series (see Methods). The relative abundances in replicate 2 were scaled to the 
average of replicate 1. The raw data are depicted in Figure S2. Transcript abundance (RPKM) of the 
respective gene as determined by RNA-seq is indicated as blue line for eight time points (t05-t40).  
See also Figure S2. 
 
Specific sequence motifs are associated with dynamics of accessible regions 
The ATAC-seq data revealed different patterns of accessibility over the IDC that showed an 
overall positive correlation with mRNA abundance. We reasoned that these were likely 
caused by the presence of different DNA motifs in promoter regions that are bound by 
specific transcription factors in a stage-specific manner. To identify DNA motifs that could 
perform this function, we first performed an exhaustive de novo motifs search using 
GimmeMotifs and seqGL (STAR Methods; [39, 40]). These de novo predicted motifs were 
combined with previously predicted Plasmodium motifs [41] and known vertebrate, 
invertebrate, and plant motifs from the CIS-BP database [42], yielding a comprehensive 
library of putative cis-regulatory sequences. Next, we identified gene sets with clear stage-
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specific accessibility/expression profiles by selecting all accessible regions that positively 
correlated with transcript abundance (Pearson correlation > 0.6; n = 2118 regions; see Table 
S1) and clustered those considering both their accessibility as well as transcript abundance 
patterns over the IDC into eight clusters using k-means clustering (Figure 5A).  
To identify motifs associated with specific accessibility/expression patterns, we used an 
ensemble of different regression and classification methods, as implemented in 
GimmeMotifs (van Heeringen and Veenstra, 2011), and searched for motifs from the above 
library that were consistently enriched in accessible regions of a specific cluster (p < 0.01, in 
at least two out of three runs; Table S3). After manually removing eight low-information 
content motifs (Figure S3A and Table S3), we clustered the remaining motifs yielding 41 
non-redundant motifs (Figures 5B, Figure S3B and Table S3, for redundancy filtering see 
[39]). Interestingly, for all ATAC/RNA-seq co-clusters we observe enrichment of at least one 
predicted AP2 motif (in total 16 motifs predicted for 13 different AP2 proteins, blue font in 
Figure 5B), suggesting that the corresponding AP2 transcription factor is likely relevant in 
regulating these genes. Additionally, we detected motifs similar to the G-box element 
upstream of heat shock genes (motif vertebrate.C2H2_ZF_M6240 [22]). Importantly, in 
addition to these previously predicted motifs we identify 13 de novo motifs with potential 
regulatory capacity in P. falciparum (indicated with red font in Figure 5B). 
 
DNA-pull down combined with quantitative proteomics reveals cis-trans regulatory 
interactions 
We selected four motifs and identified their protein interactors by performing DNA pull-
downs using short oligos representing actual accessible sequences containing the selected 
motifs and native nuclear extracts from non-synchronous, asexual P. falciparum 3D7 
cultures. To identify proteins that specifically bind to the motif, but not to a control oligo 
with a scrambled motif, we analyzed pull-down and control samples by quantitative tandem 
mass-spectrometry. (See Table S4 for the complete list of motifs and identified proteins.)  
First, we tested the CA-repeat motif predicted for protein PF3D7_0802100, which formed a 
“motif group” with similar motifs predicted for other AP2 proteins (PF3D7_0420300, 
PF3D7_1305200 and PF3D7_1456000, Figure S3B). The DNA pull-down confirmed the 
specific recruitment of PF3D7_0802100 and PF3D7_0420300 to the ACACACAT motif when 
compared to a scrambled control motif (ATCAAACC), but not the other two factors (Figure 
6A). Next, we tested three de novo motifs (031, 028, and 050). All these motifs captured at 
least one ApiAP2 transcription factor (Figures 6B-D). The ApiAP2 factor PF3D7_0420300 was 
consistently identified among the interactors of the TTATTACAC motif (de_novo_motif_031, 
Figures 6B and S4A). Remarkably, this motif is more similar to the sequence preference of 
the second AP2 domain of this factor (TTATTACAC versus GTGTTACA [41]), potentially 
suggesting that this factor can bind to two different regulatory elements (CACACACA see 
above and TRTTACAC) using different AP2 domains.  
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Figure 5: DNA motifs enriched in stage-specific ATAC regions. 
A) Co-clustering of ATAC-seq and RNA-seq data, limited to peak-to-gene pairs with Pearson correlation 
> 0.6 (n = 2118; see Table S1). Accessibility and transcript abundance are expressed as proportion-of-
sum of (qn)RPKM values over the time points and clustered by k-means using the 1-Pearson 
correlation distance metric into eight clusters. Color scales range from the 20th to 80th percentile per 
dataset. B) Heatmap of significance estimates for differential motif enrichment (expressed as –
log10(P-value)). Each column relates to a cluster generated by co-clustering the ATAC-seq and RNA-
seq data by k-means cluster (see (A)). Each row refers to a motif or a ‘motif group’, with logo and 
name listed on the right. Asterisks indicate that the motif is a representative from a group of similar 
motifs (see Figure S3B and Table S3). Predicted binding sites for ApiAP2 transcription factors are 
reported in blue font with PlasmoDB geneID (name, if know in brackets). When a cluster contains one 
or more predicted Plasmodium motifs, these are reported in brackets behind the representative 
motif. See also Figure S3, Table S1 and Table S3. 
 
 
For the second de novo motif (028), we tested three different probes and, interestingly, 
partially overlapping sets of chromatin-related factors were enriched together with the 
transcription factor AP2-I in each of them (Figured 6C and S4B and S4C). These included 
bromodomain proteins (BDP) 1, -2 and -3 (PF3D7_1475600); HMGB3; and a SWIB/MDM2 
domain-containing protein (SWIB, PF3D7_0611400), but also two conserved unknowns 
(PF3D7_0306100 and PF3D7_1124300), NOP5 and IspD. This suggests that AP2-I is sufficient 
to recruit these chromatin factors to target gene promoters, in line with the current study 
of (Santos et al., 2017). Notably, in two of the three pull-downs another AP2-factor, SIP2, 
was enriched with the motif-containing oligos (Figures S4B and S4C). SIP2 has first been 
predicted to bind to a motif very similar to AP2-I (Figure S4B and S4C, [41]) but later shown 
to a bind a longer sequence, named SPE2 (NVTGCA-4(5)-VGTGCR) upstream of subtelomeric 
var genes [12]. By chance sequences similar to a full SPE2 motif can be found in both of 
these oligos, including some flanking sequences (Table S5), explaining the binding of SIP2 to 
these two, but not the first oligo. Hence, SIP2 to is likely not a genuine interactor of 
de_novo_motif_028. Lastly, we tested de_novo_motif_050 (GAGCTCAA) using DNA probes 
from two different genomic regions. In this case, we observed a moderate, but consistent, 
interaction with the ApiAP2 factor PF3D7_0613800 (Figures 6D and Figure S4D). This motif 
is different from the predicted binding sites of the domains 1 and 2 of PF3D7_0613800 [41] 
and might be recognized by its third domain for which sequence preference has not been 
defined.  
Collectively, these experiments indicate that the motifs predicted from the stage-specific 
regulatory elements indeed interact with specific transcription factors. In addition, they 
point to a delicate interplay between DNA elements, transcription and chromatin modifying 
factors in regulating intraerythrocytic development of malaria parasites. 
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Figure 6: DNA pull-downs identify potential cis-trans regulatory interactors. 
Scatter plots displaying the quantitative proteomic analysis of duplicate DNA pull-downs with label 
swap using (A) 58-60bp DNA probes with the CA-repetitive motif (ACACACAT) and three de novo 
predicted motifs; (B) de_novo_motif_031, TTATTACAC; (C) de_novo_motif_028, GCACWWT 
NNKTGCW; (D) de_novo_motif_050, GAGCTCAA). The same probes with a scrambled motif were used 
as controls. The statistically significant outliers (black diamond, intensity-based FDR < 5%) are the 
potential interactors to the motif. Red font indicates that the interaction was confirmed using a probe 
from a different genomic region but containing the same motif. Green dots are candidate DNA-binding 
factors derived from Table 4 of [10]. Earlier predicted binding sites for the identified AP2 factors are 
show in relation to the motif used in the pull down below each plot. See also Figure S4, Table S4.  
 
 
Discussion 
Here we present high-resolution temporal chromatin accessibility data during 
intraerythrocytic development of P. falciparum. ATAC-seq, used in this study (Figure 1), 
clearly supersedes other chromatin-based technologies such as FAIRE-seq [29, 43], MNase-
seq [30], or ChIP-seq [44] in identifying active regulatory sites on a global scale, both in 
terms of the number of sites identified as well as in terms of spatial resolution of the data. 
Furthermore, ATAC-seq shows a nearly complete overlap with ChIP-seq profiles of a TF, AP2-
I (Figure 2, [17]). While due to the bias of the transposase against AT-rich sequences and 
stringent filtering we might not detect all regulatory events, we identified an accessible 
region for at least 60% of all P. falciparum genes and about 70% of the genes expressed 
during the IDC (comprising about 85% of all genes; Otto at al., 2010), providing a valuable 
resource for future studies that could range from targeted gene studies to predicting 
functional consequences for SNPs or other mutations in non-coding regions.  
Notably, the coupling between accessible regions and genes in our analysis was based on 
the assumption that most genes in the P. falciparum genome are regulated by the nearest 
regulatory elements. While this assumption might not always be correct, it is remarkable 
that temporal accessibility and mRNA abundance profiles strongly correlate for the majority 
of the genes (Figure 3), suggesting functional interactions between these regulatory 
elements and the nearby genes. Furthermore, the DNA sequence of all four tested 
accessible regions was sufficient in dictating a stage-specific expression pattern to a 
reporter gene that is similar to that of the respective endogenous gene (Figure 4). Although 
our data does not exclude the existence of distant enhancers, at least the majority of 
identified regions in this dataset likely operates at close distance to their target gene. The 
scarcity of distant regulatory sequences in P. falciparum is also supported by the fact that 
long distance interactions identified so far in chromosome conformation studies in this 
parasite were restricted to centromeres, ribosomal DNA loci and subtelomeric regions [45, 
46]. Collectively, our data together with earlier studies (e.g. [15, 17, 19, 23, 44, 47]), suggest 
that most P. falciparum genes have a compact regulatory unit like other unicellular 
eukaryotes (i.e. yeast,) with minimal promoter(s) and upstream regulatory element(s) 
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located within one or two kilobases of the target gene. However, our data, in combination 
with future high-resolution chromosome conformation studies, might reveal distant 
enhancers, if they exist.  
The marked positive correlation between chromatin accessibility and mRNA abundance 
(Figure 3) also supports the notion that activating, rather than repressive, regulatory events 
drive gene expression in the IDC of P. falciparum. Alternatively, ATAC-seq might 
preferentially detect activator bound chromatin regions. Yet ATAC-seq has been shown to 
detect non-transcription-related DNA-binding events (e.g. CTCF binding to insulator 
elements, [31]) and bivalent promoters (co-occurrence of activating and repressive histone 
markings) in other organisms [48, 49]. Also, thus far, only two transcription factors, AP2-G2 
and AP2-Sp, have been postulated to have repressive properties during blood stage 
development of P. berghei [16, 18, 19]. Regardless of the presence and specific functions of 
a few transcriptional repressors, our data suggest that a cascade of transcription activating 
events is mainly responsible for the stage-specific expression during blood stage 
development of P. falciparum. 
Since their discovery, the AP2 gene family has been regarded as the major family of putative 
transcription factors in Plasmodium. However, even with these 27 putative transcription 
factors the proportion of transcription factors to the total number of genes remains to be 
low (~50-60 among ~5800 genes compared to, for example, 169 per ~6000 genes in yeast 
[50]). Therefore, to our surprise, besides AP2s, we did not consistently detect any other 
protein family in our DNA pull downs that could function as a sequence-specific DNA-
binding factor. Hence, despite the existence of few other types of DNA-binding factors in 
Plasmodium (including C2H2-type [51], Myb-type [52], and HMGB-domain proteins [53]), 
so far all evidence suggests that the AP2 family can be regarded as the major TF family in 
Plasmodium, leaving researchers puzzled how such a small number of factors can govern 
such a delicate gene expression program. Combinatorial action of multiple transcription 
factors has been suggested to increase the regulatory potential of these factors in directing 
development of malaria parasites (e.g. [28, 54]). Such cooperative interaction between AP2-
I and other stage-specific transcription factors could explain the different accessibility 
patterns observed for the AP2-I binding sites (Figures 2D). Yet we did not find any DNA 
motifs, other than the AP2-I binding site (GTGCA), strongly enriched in these clusters that 
could serve as a binding site for such factor (data not shown). Alternatively, post-
translational modifications of DNA-binding domains from TFs [55] or protein-protein 
interactions between TFs and cofactors could affect TF sequence specificities and or 
recruitment of TFs to specific chromatin regions [56]. To this end, we (Figure 6C) and others 
[17, 57] detected a strong interaction between AP2-I and an epigenetic complex involving, 
among others, two acetylated histone binding proteins (BDP1 and BDP2). However, if and 
how these proteins contribute to stage- and/or sequence-specific binding patterns of       
AP2-I or enhanced binding of AP2-I to acetylated chromatin regions remains to be 
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determined. Furthermore, nearly half of the AP2 TFs has more than one AP2 domains. Our 
pull-down data suggests that in fact some of the AP2-factors could interact with different 
regulator elements using different domains (Figure 6). Eventually, it seems conceivable, that 
the limited number of sequence-specific transcription factors encoded by the Plasmodium 
genome use the combination of the above mechanisms to achieve the precision of 
regulation required to drive the gene expression program underlying blood stage 
development. Collectively, our work provides the in depth global view of the in vivo 
transcriptional regulatory events during intraerythrocytic development of P. falciparum. It 
also highlights some intricate details of the interplay between transcription factors and cis-
regulatory elements that controls gene transcription, bringing us a big step closer to 
understand and fight this deadly parasite.  
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Star Methods 
CONTACT FOR REAGENT AND RESOURCE SHARING 
Requests for resources and reagents should be directed to the Lead Contact, Richárd Bártfai 
(r.bartfai@science.ru.nl). 
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
 
Parasite culture conditions 
Parasites were cultured in RPMI medium supplemented with 10% human serum, 0.2% NaHCO3 and 
2.5% or 5% human O+ red blood cells. Parasite lines were maintained in a shaking semi-automated 
37 °C incubator in 10ml total volume and 5% hematocrit. For the ATAC-seq and RNA-seq parasite 
collections, the cultures were kept in T75 culture flasks with 20ml total volume and 2.5% or 1.25% 
hematocrit. For these collections the T75 flasks were placed in candle jars in a steady 37 °C incubator, 
as in [30]. For the collections of parasite RNA for RT-qPCR and parasite nuclei for the generation of 
nuclear protein extract, 20 or 50 ml parasite cultures with 2.5% hematocrit were kept in T75 or T175 
flasks in a steady 37 °C incubator with gas composition of 3% O2, 4% CO2 and 93% N2.  
 
Parasite and bacterial strains 
See Table S5 for details on parasite and bacterial strains used in this study.  
 
METHOD DETAILS 
 
Parasite culture synchronizations and collections 
For combined ATAC-seq and RNA-seq collections, cultures were selected for var2csa expression, 
expanded and synchronized as follows. VAR2CSA panning was performed as in [60]. Petri dishes (150 
× 15 mm, BD biosciences Falcon 351058) were coated overnight with Chondroitin sulfate A (0.05% 
CSA in PBS) and blocked with 1% Casein/PBS solution for at least one hour and rinsed twice with RPMI. 
Parasite cultures were centrifuged, resuspended in RPMI with 10% human serum, transferred to the 
CSA-coated petri dishes and incubated for 30 min at 37 °C in a candle jar. Afterwards, unbound 
parasites and non-infected erythrocytes were removed by gentle RPMI washes. Bound parasites were 
extensively resuspended in complete medium to detach them from CSA. Fresh blood was added to 
these parasites and they were put back in culture medium as described above in the shaking 
incubator. This selection was repeated four times before expansion. Before and during expansion of 
the culture, parasites were synchronized by sorbitol treatment and a Percoll gradient centrifugation. 
For the sorbitol treatment, parasites were spun down and the parasite pellet was gently resuspended 
in 6-7 pellet volumes of 5% D(-)-sorbitol (Merck, #107758) and incubated for 10 min at 37 °C while 
shaking. Parasites were spun down and new medium and fresh blood were added to 5% hematocrit. 
For percoll gradients, parasite cultures were spun down, resuspended in fresh medium to 10% 
hematocrit and an equal volume of 63% Percoll (GE Healthcare, #17-0891-01) in PBS was gently 
layered below the culture. The schizont interface was collected after spinning the gradient and fresh, 
Plasmodipur filtered RBCs (EuroProxima, the Netherlands) were added a 1.5 h later which was then 
set as time point zero (0 hours post invasion (hpi)) resulting in a synchronicity window of 7 h (i.e. 7h 
difference between the first and last invasion). Medium was changed every ten hours but not less 
than ten hours before collection. Cultures were mixed with every medium change and after 20 hpi 
kept at 1.25% hematocrit. Parasites were collected from 5 hpi onwards every 5 hours and ATAC-seq 
and RNA-seq collections were performed from the same synchronized culture. Giemsa stained blood 
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smears were made at each time point to monitor parasite growth and staging (See Figure S5 for 
representative microscope images and Table S6 with counts of parasite stages per time point).  
For collections of parasites carrying the attP(+)_minkahrp expression constructs, site-specific 
integration was first confirmed and parasites were synchronized using sorbitol treatments and Percoll 
gradient centrifugations as described above. For each parasite line ring, trophozoite and schizont 
stages were collected (PF3D7_0719000 replicate 1 synchronized to a ~8 h window, collected 12 hpi, 
25 hpi, 39 hpi; PF3D7_0719000 replicate 2 synchronized to a ~10 h window, collected 10.3 hpi, 25 hpi, 
40.5 hpi; PF3D7_1200700 replicate 1 synchronized to a ~12 h window, collected 14 hpi, 23 hpi, 38 hpi; 
PF3D7_1200700 replicate 2 synchronized to a ~10 h window, collected 12.25 hpi, 23 hpi, 39.5 hpi;  
PF3D7_1222700 replicate 1 synchronized to a ~5 h window, collected 5 hpi, 25 hpi, 35 hpi; 
PF3D7_1222700 replicate 2 synchronized to a ~8 h window, collected 6.25 hpi, 24.5 hpi, 41 hpi; 
PF3D7_1372200 synchronized to a ~12 h window, collected 12 hpi, 23 hpi, 36 hpi; kharpminimal 
promoter only synchronized to a ~5 h window, collected 5 hpi, 25 hpi, 35 hpi; PF3D7_0719000negative 
replicate 1 synchronized to a ~5 h window, collected 8 hpi, 25 hpi, 38.75 hpi; PF3D7_0719000negative 
replicate 2 synchronized to a ~7 h window, collected 10 hpi, 25.5 hpi, 39 hpi; PF3D7_1200700negative  
replicate 1 synchronized to a ~9 h window, collected 12 hpi, 24 hpi, 41 hpi; PF3D7_1200700negative  
replicate 2 synchronized to a ~10 h window, collected 12.5 hpi, 25 hpi, 41hpi). 
 
ATAC-seq library preparation 
Native parasite nuclei were isolated as in [36]. In short, after lysis of RBCs by 0.05% saponin treatment 
and separating nuclei from parasite debris using a cell lysis buffer (CLB: 10 mM Tris-HCL pH8.0, 10 mM 
NaCl, 3 mM MgCl2, 0.2% NP-40) with 0.25 M sucrose cushion. A 10 μl sized nuclei pellet was 
resuspended with a cut-off pipet tip in 337.5 μl CLB and for ATAC-seq replicate 1 69 μl of nuclei was 
used for t05 to t20 and 23 μl of nuclei was used for t25 to t40 (these volumes were based on previous 
tests using a dilution series of nuclei). For ATAC-seq replicate 2 we had to optimize the amount of 
nuclei again due to the use of a kit from a different lot and this led us to use 466 μl of nuclei for t05 
and t10 and 155 μl for t15 and t20. Nuclei were brought to 10.5 μl in CLB and used in a 25 μl ATAC 
reaction based on (Lara-Astiaso et al., 2014) with 2 μl Tn5 transposase and 12.5 μl TD buffer (Nextera 
DNA Library Prep Kit, #FC-121-1030, Illumina, USA). Reactions were incubated for 1 h in a 37 °C heat 
block. Nuclei were kept in suspension by gently tapping the tube every 10 minutes. The reaction was 
stopped by addition of 5 μl clean up buffer (900 mM NaCl, 300 mM EDTA), 2 μl 5% SDS and 2 μl 
proteinase K (Sigma-Aldrich #P6556) and incubated for 30 min at 40 °C. Tagmentated DNA fragments 
were isolated using 2.4 sample volume of Agencourt AMPure XP beads (Beckman Coulter, #A63882, 
Inc. USA). Half of the isolated DNA was used for library preparation (the other half was stored as back-
up) starting with a size selection using 0.85x volumes of AMPure XP beads to enrich for fragments of 
500 bp and smaller. Size-selected fragments were amplified using the KAPA HiFi HotStart ready-mix 
(KAPA Biosystems, #KK2602, US) and Nextera index primers (Nextera DNA Sample Preparation Index 
Kit, #FC-121-1012) under the following conditions: 98 °C for 2 min; 16 cycles of 98 °C for 20 s, and 62 
°C for 3 min; 62 °C for 5 min. Libraries were purified using 1x volumes Agencourt AMPure XP beads. 
The fragment size distribution of the libraries was evaluated in a High-Sensitivity Bioanalyzer run 
(Agilent, #5067-4626, US) and the size selection was repeated when there was a large proportion of 
fragments longer than 500 bp (replicate 1 t05, t15, t30, t35, t40). To control for sequence bias, the 
same ATAC protocol was applied to genomic DNA from synchronous wild type 3D7 P. falciparum ring 
stage parasites using 547.0 ng or 60.8 ng of input DNA. All ATAC-seq libraries were KAPA quantified 
(KAPA Library Quantification Kit, #KR0405). 
 
RNA-seq library preparation 
Parasite cultures were immediately placed on ice and washed once with ice-cold PBS. Pelleted cultures 
were resuspended in RLT buffer (Qiagen, #74106) supplemented with 1% β-mercaptoethanol and 
snap-frozen in liquid nitrogen. Total RNA was extracted using the RNeasy Mini Kit (Qiagen, #74106; 
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including RNA clean-up and two on-column DNase treatments) and RNA concentration was measured 
using the Qubit™ RNA HS Assay Kit (Invitrogen, #Q32852). RNA was then polyA-selected using the 
Oligotex mRNA Mini Kit (Qiagen, #70022) according to manufacturer’s instructions. Subsequently, 
2000 ng of polyA-selected total RNA equivalent were fragmented by alkaline hydrolysis (40 mM Tris 
acetate pH 8.2, 100 mM potassium acetate,30 mM magnesium acetate) for 1 min 45 s at 85 °C in a 
150 µl volume and precipitated as previously described in (Hoeijmakers et al., 2013). Next, polyA-
selected RNA was cleaned from remaining genomic DNA (detected by qPCR) by two additional TURBO 
DNase treatments (Ambion, #AM2238). Strand-specific RNA-seq was performed as in [30]. 
Accordingly, first strand cDNA synthesis was performed with AT-corrected Random N9 primers (76% 
AT) in the presence of 0.2 µg Actinomycin D (Thermo Fisher Scientific #11805017). During second 
strand synthesis dTTPs were substituted with dUTPs to preserve strand-specific information. Next, 10 
ng of each double stranded cDNA library was end repaired, extended with 3’ A-overhangs, barcoded 
with NextFlex adapters (Bio Scientific, #514122) and treated with USER enzyme (NEB, #M5505L) to 
specifically degrade the dUTP-containing second strand. Libraries were amplified by PCR (98°C for 2 
min; 4 cycles of 98 °C for 20 s, 62 °C for 3 min; 62 °C for 5 min) using KAPA HiFi HotStart ready mix 
(KAPA Biosystems, #KM2602) and NEXTflex primer mix (Bio Scientific, #514122) and subsequently gel 
size-selected for 300 - 400 bp using 2% E-Gel Size Select agarose gels (Invitrogen, #G6610-02). After 
an additional eight cycles of amplification (see above), libraries were purified and adapter dimers 
depleted using 1x volume of Agencourt AMPure XP beads (Beckman Coulter, #A63880). 
 
Parasite transfection 
Parasite transfections were performed as in [61] using a BTX electroporation system. Synchronized 
ring stage 3D7 P. falciparum attB(+) parasites were pelleted by centrifugation and 100% hematocrit 
packed cells were mixed with 75 μg of the pINT and 75 μg of the desired attP(+)_minkahrp plasmid in 
cytomix (120 mM KCl, 0.15 mM CaCl2·2H2O, 5mM MgCl2·6H2O, 25 mM HEPES, 2 mM EGTA, 10mM 
K2HPO4, 10mM KH2PO4) in 450 μl total volume in a 2 mm electroporation cuvette (BTX, #45-0125). 
After transfection, parasites were resuspended in warm culture medium and cultured at 2.5% 
hematocrit in the presence of 2.6 nM WR99210 (Jacobus Pharmaceutical Company, Inc.), 2.5 µg/ml 
Blasticidin S HCl (Gibco, #R210-01) and 250 µg/ml Geneticin (Gibco, #11811-031). After seven days, 
culturing was continued without Geneticin. When the parasite cultures became blood-smear, positive 
site-specific integration of the attP-containing plasmid into the parental line was confirmed by 
performing PCR using the primer combinations ‘p1_for’/ˈp1_rev’ and ˈp2_forˈ/ˈp2_revˈ (Table S7) on 
extracted genomi c DNA (Qiagen, #51106). Genomic DNA of the non-transfected parental 3D7 line 
was used as negative control (Figure S2a and b). Afterwards parasites were cultured at a three week 
on/off schedule of 2.6 nM WR99210 and 2.5 µg/ml Blasticidin S HCl.  
 
Plasmid DNA cloning 
To examine the regulatory potential of the identified accessible several parasite lines were generated: 
four parasite lines with an integrated plasmid containing an accessible region detected by ATAC-seq 
upstream of a minimal kahrp promoter and a gfp-luc reporter gene (Figure 4a, Figure S2a), two 
parasite lines with a not-accessible, control region instead of the accessible region (a third line did not 
show successful integration) and one parasite with an integrated plasmid containing the minimal 
promoter followed by the reporter gene. To generate these parasites, we applied the Bxb1 integrase-
mediated site-specific attP/attB integration system from [58] which results in directional integration 
of an attP-site containing plasmid into the cg6 locus of a parental attB site-containing P. falciparum 
line. To generate the specific attP-plasmids, the pDC2 plasmid [58] was modified on several points. 
(All primers used for cloning, integration checking and RT-qPCR are listed in Table S7). The orientation 
of the 5’cam-snf7-gfp-3’hsp86 cassette was reversed using the primers ˈ5'Pfcam-Fˈ and ˈ3'hsp86-Rˈ, 
PstI/ApaI digestion and ligation by the T4 ligase (Promega, #M1804) resulting in plasmid pOM1. The 
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snf7-gfp element was replaced by the gfp-luc sequence from the MV163 plasmid [62] using the primers 
ˈGFPLuc-F’ and ˈGFPLuc-Rˈ, AvrII/XhoI digestion and ligation by the T4 ligase resulting in plasmid 
pOM2. Finally, the 5’cam was replaced by the kahrp minimal promoter [38] using the primers ˈkahrp-
Fˈ and ˈkahrp-Rˈ, digestion by AvrII/AgeI and T4 ligation resulting in plasmid attP(+)_minkahrp. 
Accessible or control regions located upstream of the genes PF3D7_0719000, PF3D7_1200700 and 
PF3D7_1222700 or the accessible region upstream of PF3D7_1372200 were amplified and inserted 
upstream of the kahrp minimal promoter using their respective primers listed in Table S7 and 
BglII/NotI digestion and ligation by the T4 ligase. These accessible regions were selected because they 
showed clear, distinct, stage-specific accessibility patterns; the downstream gene showed a matching 
gene expression pattern; we favored accessible regions located in tandem intergenic regions (i.e. 
containing a single promoter) for clarity of the assignment between genes and accessible regions; and 
we excluded ATAC regions and parts of the peak that overlapped with a TSS. 
 
RNA extraction, cDNA synthesis and qPCR 
Total RNA was extracted as described in ˈRNA-seq library preparationˈ and was checked for genomic 
DNA contamination by qPCR. If needed, the sample was additionally treated once or twice with TURBO 
DNase (Ambion, #AM2238). For each sample 500 to 1000 ng of total RNA was mixed with random 
hexamer primers (0.5 μg, Roche #11034731001), OligodT12-18 (0.5 μg, Invitrogen #18418012) and 
dNTPs (0.5 mM in the final volume of 20 μl, Invitrogen 10297-018) and incubated for 5 min at 
70 °C. First strand synthesis was performed for 1 h at 42 °C in First Strand Buffer (Invitrogen) 
supplemented with DTT (10 mM), Superscript III (200 units, Invitrogen, #18080044) and RNasin 
Plus RNase inhibitor (40 units, Promega, #N261B), after which superscript III was inactivated by 
incubation at 70 °C for 15 min. For all samples, a negative control reaction was performed in which 
Superscript III was replaced by water (RT minus control) under identical conditions. For each 
parasite line the same amount of RNA was used as template from the different time points.  
To measure the relative gfp-luciferase (gfp-luc) transcript abundance, a qPCR was performed using 
SYBRgreen supermix (BioRad) and primers which were mixed according to the manufacturer’s 
instructions. The qPCR was preformed using the CFX96 Real Time Systems C1000 Touch Thermal 
Cycler (Bio-Rad) with the following program: 95 °C for 3 min, (94 °C for 10 s, 52 °C for 30 s, 68 °C for 
30 s) 39 cycles, 95 °C for 1 min, 65 °C for 1 min and a gradient from 65 °C to 94.5 °C with a 0.5 °C 
increase every 10 s. Primers specific for gfp-luc served to assess the relative abundance of the reporter 
transcript (ˈGFP-1ˈ, ˈGFPLucˈ, ˈLuc-1ˈ. ˈLuc-2ˈ) and primers for blasticidin and actin (ˈBSD-1ˈ, ˈBSD-2ˈ, 
ˈactinˈ) controlled for successful cDNA synthesis (results not shown). All -RT controls reported ‘not 
detectable’ (NA) or in Cq values in the range of the H2O control, which was included for all primer 
pairs (results not shown). The relative gfp-luc transcript abundance was measured against a standard 
dilution series prepared from P. falciparum 3D7 attB(+) genomic DNA and pOM2 plasmid DNA mixed 
in a close to 1 molar ratio (10-fold dilution series of genomic DNA ranging from 5 pg – 5000 pg, 10-
fold dilution series of plasmid DNA ranging from 0.005pg - 5pg). As different standard series were 
used for the positive replicate 1 and replicate 2, the data of replicate 2 was scaled to the average of 
replicate 1 for Figure 4. The raw data for each replicate are depicted in Figure S2B. 
 
Nuclear protein extract generation and DNA pull-down  
For collections, asynchronous asexual P. falciparum 3D7 cultures were put on ice immediately and 
filtered over Plasmodipur filters (EuroProxima, Netherlands) to remove human white blood cells. 
Infected RBCs were washed once in PBS and resuspended in PBS with Protease Inhibitor Cocktail (PI 
at 1:100, Roche, #04693132001) and 0.05% saponin to a maximum of 6.25% hematocrit for a 
maximum of 15 minutes. Nuclei were isolated over a double sucrose gradient in CLB with PI (PI at 
1:50, bottom layer of 0.25 M sucrose, top layer 0.1 M sucrose) and resuspended in CLB with 20% 
glycerol, pelleted by centrifugation, snap-frozen and stored at -80 °C until the generation of the 
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nuclear protein extract. Nuclear protein extract was generated as in [30] with two rounds of extraction 
in High Salt Extraction Buffer (50 mM HEPES pH7.5, 20% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 1 mM 
DTT, 0.4% NP-40, PI). Protein concentration was measured using a Qubit fluorometer (Qubit™ Protein 
Assay Kit, ThermoFisher Scientific, #Q33212). Nuclear protein extract was snap-frozen in aliquots and 
stored at -80 °C. Right before the pull-down, nuclear protein extracts were diluted to 0.909 mg/ml 
protein concentration in 50 mM HEPES pH7.5, 10% glycerol, 150 mM NaCl, 1.5 mM MgCl2, 1 mM DTT, 
0.125% NP-40, PI at 1:25, 9 ng/μl yeast tRNA (Sigma-Aldrich, #R5636), 9 ng/μl poly(dI:dC) (Sigma-
Aldrich, #P4929) and 9 ng/μl poly(dA:dT) (Sigma-Aldrich, #P0883). Diluted extracts were spun once at 
17000 x g for 25 minutes at 4°C to remove precipitates.  
DNA pull downs were performed as in (Hubner et al., 2015; Kensche et al., 2016). Probes for DNA pull 
downs (ordered from Integrated DNA Technologies, US; Table S7) were dissolved in TE (10 mM Tris, 
0.1 mM EDTA, pH 8.0) to 200 μM. 1000 pmoles of biotinylated forward probe was annealed to 1500 
pmoles of reverse probe in annealing buffer (10 mM HEPES pH 8.0, 0.05 M NaCl, 1 mM EDTA, in DNase 
free water). For each pull-down, 50 pmoles of dsDNA probe was coupled to 10 μl of washed sepharose 
beads slurry (GE Healthcare, #17511301) in DNA Binding Buffer (DBB: 10 mM HEPES pH 8.0, 1 M NaCl, 
10 mM EDTA, 0.05% NP-40 in DNase free water) in a total volume of 350 μl while rotating at RT for at 
least 1 h. Excess probes were removed by two washes with 500 μl DBB and two with 500 μl Protein 
Binding Buffer* (PBB*: 50 mM HEPES pH 8.0, 150 mM NaCl, 0.1% NP-40, 1 mM DTT, PI at 1:25). After 
the last wash, PBB* was removed almost completely for each reaction and 550 μl of diluted nuclear 
protein extract with 500 μg protein content was added and incubated for 1.5 h while rotating at 4 °C. 
Reactions were spun at 400 x g and supernatants were discarded. Beads (with probes and bound 
proteins) were then washed by once with 1 ml PBB*, twice with 1 ml PBB (PBB* without PI) and twice 
with 1 ml Wash Buffer (WB: 50 mM HEPES pH 8.0, 150 mM NaCl). After the last wash with PBB and 
the washes with WB, supernatants were removed as much as possible. Disulfide bonds were reduced 
by incubating the beads with 5 mM TCEP (Sigma-Aldrich, #C4706-2G dissolved to 100 mM in mass-
spec grade Milli-Q and stored at -20 °C) in 100 mM TEAB (Sigma-Aldrich, #T7408-100 ml) for 1 h in a 
37 °C shaking heat block. Beads were briefly spun down and incubated with 10mM (final 
concentration) of MMTS (Thermo Scientific, #23011, dissolved to 200 mM in isopropanol and stored 
at -20 °C) to alkylate disulfide bonds in a 37 °C shaking heat block for 10 min. Beads were briefly spun 
down and 0.4 μg Trypsin/LysC (dissolved to 0.4 μg/ul in Resuspension buffer (50 mM acetic acid 
(pH<3), Promega, #V5072) was added and incubated for 1 h in a 37 °C shaking heat block. Beads were 
spun for 1 min at 200 x g at RT and supernatants were collected in a new Eppendorf tube. 50 μl of 100 
mM TEAB was added to the beads and these were incubated for another 5 min in a 37 °C shaking heat 
block and supernatants were added to the previously collected supernatants. Trypsin digestion in the 
supernatants was continued by overnight incubation in a 37 °C waterbath. Each probe was tested 
twice per experiment and peptides were labelled by dimethyl labelling (Boersema et al., 2009). 
NaBH3CN (Merck, #818053) and CH2O were used for ‘light’ labels and NaBD3CN (Sigma-Aldrich, 
#190020-1G) and CD2O for the ‘heavy’ labels. Labelling reactions were incubated for 1 h at RT while 
shaking and labelling was stopped by addition of 16 μl of 1% ammonia. Reactions of wild-type and 
mutated probes with different labels were then pooled and acidified by addition 10 μl of 100% 
trifluoroacetic acid (TFA, Biosolve BV, the Netherlands, #20234131). Samples were then cleaned and 
concentrated on C18 stage tips (Rappsilber et al., 2007) and stored at 4 °C until measurement. 
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
 
ATAC-seq data Analysis  
The ATAC-seq libraries were sequenced for 75 bp, paired-end on a NextSeq500 system (Illumina) using 
NextSeq500/550 HighOutput kit V2 (75 cycles) reagents (Illumina). Raw fastq reads were first 
evaluated using FastQC before continuing ([63]  and reads obtained from the two gDNA control 
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libraries were combined after sequencing. Paired-end libraries were mapped with BWA-mem (version 
0.7.10; [64]) against the P. falciparum 3D7 reference genome (PlasmoDB release 26; [65, 66]) and 
filtered for mapping quality >= 30 ((samtools version 1.3.1; [67]). Duplicate reads were removed using 
Picard tools (version 1.139; (BroadInstitute)) and reads mapping to the apicoplast and mitochondrial 
DNA were removed as well as supplementary alignments (FLAG 2048). Finally, an in silico size selection 
was performed to select for read pairs with insert sizes between 50 and 150 bp (or different when 
indicated) and these libraries were used for further analysis (between 5.9 and 9.7 million reads for 
replicate 1; between 3.6 and 6.4 million per library for replicate 2; 36.9 million for the merged gDNA 
control library). For visualization, these libraries were converted to bedgraph files using bedtools 
genomecov (version 2.20.1; (Quinlan and Hall, 2010)) with the option ‘-pc’ for paired end data and 
scaled per million reads (RPM). Alternatively, for genomic DNA-corrected tracks, the coverage in each 
of the t05 to t40 libraries (with an offset of +0.1) was divided by the coverage in the gDNA library (with 
an offset of +0.1). Bedgraph files were visualized in the UCSC genome browser [70]. 
Downstream analyses were performed using the data from ATAC-seq replicate 1. Peak calling we used 
the MACS2 subcommands ‘macs2 pileup’, ‘macs2 bdgcmp’ and finally ‘macs2 bdgpeakcall’ (MACS2 
release 2.7; (Liu, 2016)). Because some MACS2 subcommands cannot handle paired end data, we first 
binned the libraries based on the insert size in steps of 5 bp. Next, the start site of reads aligning to 
the positive strand were shifted with +4 bp and those aligning to the minus strand with -5 bp to 
represent the center of the Tn5 transposon binding event as in [31]. Then a pileup track for each 
(binned) ATAC library was calculated by MACS2 pileup with --extsize set to half the mean insert size. 
The pileup tracks of the binned libraries were then summed, scaled per million of reads and a 
pseudocount of 0.1 was added to every position. Regions of local enrichment were identified with 
macs2 bdgcmp using the gDNA pileup track as background and scored in qvalues (-m qpois). Finally, 
macs2 bgpeakcall was used to identify regions with qvalue below 0.001 (-c 3.0). To prevent calling 
many small ‘peaks’ we allowed regions to be merged when they were within the maximum insert size 
of 150 bp (-g 150) and we set the minimum length of a peak to 100 bp (-l 100).  
Peaks for all time points were merged and the highest scoring summit was selected as summit for the 
merged peak (4035 merged peaks in total). Peaks with a summit located in a coding region (209 
merged peaks) or more than 3kb away from the first/last gene on each chromosome (71 merged 
peaks) were removed from further analyses. To assign the remaining 3755 intergenic peaks to genes 
we only selected peaks in intergenic regions flanking the 5’ of a gene. For this purpose, intergenic 
regions (IGs) were categorized based on the flanking coding sequences: ‘tandem IGs’ are flanked by 
two genes both in 5’-> 3’ or in 3’<-5’ orientation; ‘divergent IGs’ have a downstream gene with 3’<-5’ 
orientation and an upstream gene in 5’->3’ orientation; ‘convergent IGs’ have a downstream gene in 
5’<-3’ orientation and the upstream gene in 3’->5’ orientation (see Figure 1c). Peaks with their summit 
located in ‘tandem IGs’ and ‘divergent IGs’ (3647 peaks) were assigned to the closest downstream 
gene using bedtools closest (version 2.20.1; (Quinlan and Hall, 2010)). To calculate accessibility per 
stage, tags were counted for each of the merged peaks in tandem or divergent IGs. Tag counts were 
offset by +1 and normalized to the number of reads per kb per million mapped reads (RPKM). For each 
peak the maximum RPKM value was determined across the stages and peaks with the lowest 10% of 
maximum values were removed. To correct for signal intensity differences among the time points we 
normalized the data on quantiles (using the normalized.quantiles command from the R package 
preprocessCore version 1.36.0; (Bolstad, 2017)). Then, for each peak we calculated the proportion of 
signal per time point compared to the summed signal over all time points. This proportion-of-sum 
value was used to calculate the accessibility pattern in each peak region over the time course (t05 – 
t40).  
 
Directional RNA-sequencing  
Strand-specific RNA-seq libraries were sequenced on the Illumina NextSeq 500 system to obtain 75 
bp single-end reads (NextSeq500/550 HighOutput kit V2 (75 cycles) reagents (Illumina)). Reads were 
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evaluated using FastQC ([63] and mapped against the annotated P. falciparum 3D7 transcriptome from 
PlasmoDB release 26 [65, 66]  using BWA samse (version 0.7.12-r1039; [72]). Single-end reads were 
filtered to mapping quality ≥15 (samtools version 1.2; [67]) and only uniquely mapped reads (between 
9.2 and 11.6 million per library) were used for further analysis. To visualize RNA-seq data in the UCSC 
Genome browser, 75bp reads were additionally mapped against the annotated P. falciparum 3D7 
genome from PlasmoDB version 26 [65, 66], filtered for uniquely mapped reads and mapping quality ≥ 
15. Reads were separated according to the strand they mapped to (sense strand FLAG16, antisense 
strand FLAG0) and normalized to the number of mapped reads per million (RPM). Bedgraph files were 
generated (version 2.20.1; [69]) and visualized in the UCSC genome browser [70]. 
To assess RNA abundance per gene, reads mapped against the transcriptome were separated based 
on alignment to the sense (FLAG 16) or antisense strand (FLAG 0) respectively. Only reads aligning to 
the sense strand of each transcript were used for further analysis. Tags were counted for all transcripts 
(excluding mitchochondrial RNA and apicoplast RNA) and offset by +1. Transcript counts were 
normalized to the number of reads per kb per million mapped reads (RPKM) and the maximum RPKM 
value was determined per transcript. Low abundant transcripts with their maximum RPKM value 
across the stages were discarded (lowest 10 percentile). Relative transcript abundance to assess 
stage-specific expression patterns over the time course (t05 – t40) was calculated by dividing the 
RPKM value of each time point through the sum of RPKM values of all time points (proportion of sum).  
 
Comparison of ATAC-seq and RNA-seq data 
To compare accessibility and transcript abundance patterns, accessibility (proportion-of-sum) was 
clustered using the web-based Morpheus tool from the Broad Institute (BroadInstitute) into eight 
clusters by k-means clustering with the 1-pearson correlation coefficient as distance metric and 
20.000 iterations. Relative transcript abundances (proportion-of-sum) of the downstream gene were 
then plotted in the same order. Accessibility and mRNA abundance profiles were visualized on a 
heatmap using color scale covering the 20th to 80th percentile of values. The Pearson correlation 
coefficient was calculated for each peak-to-transcript pair. Randomized correlations were calculated 
for 1000 shuffled peak-to-transcript matches.  
For co-clustering of accessibility and transcript abundance patterns, peak-to-transcript matches were 
first filtered for a Pearson correlation coefficient above 0.6. The resulting matrix of accessibility and 
transcript abundance data (n = 2118 matches) was uploaded in Morpheus and again clustered into 8 
k-means with the same settings as before.  
 
Comparison with AP2-I ChIP-sequencing data 
For visualization purposes, the AP2-I ChIP-sequencing data from Santos and co-workers was mapped 
against the P. falciparum 3D7 genome with settings as in [17]. In short, reads were trimmed with 
Trimmomatic (version 0.36; [74]), mapped with BWA-mem (version 0.7.10 [64]) against the P. 
falciparum 3D7 genome (PlasmoDB release 26 [65, 66]) and filtered for not being the primary 
alignment (FLAG 256), being a duplicate (FLAG 1024), being a supplementary alignment (FLAG 2048) 
and for mapping quality of 30 and higher. The MACS2 callpeak command was used to generate 
bedgraph files of the ChIP and input libraries (settings --m 5 50 --extsize 250 --call-summits -B -q 0.05 
-g 2.2e7). These bedgraph files were used to make log2 ChIP-over-input tracks that were uploaded in 
the UCSC genome browser. Bedtools intersect (version 2.20.1; [69]) was used to define the overlap 
between the ATAC-seq peaks with the trimmed AP2-I peaks (in 3D7 coordinates) reported in [17]. Fluff 
was used to generate the heatmap of accessibility over the AP2-I peaks that overlap with ATAC-seq 
peaks [75]. We used the build-in Gene Ontology tool of PlasmoDB with default settings to identify 
enriched GO terms [65].  
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Motif identification and enrichment analyses  
For de novo motif identification, we used gimme motifs from the GimmeMotifs package (v0.11.0; [39]). 
Numerous de novo motif searches were performed on individual time points and using different 
number of clusters ranging from 4 to 16 in regions of 200 or 300 bp around the summit. The 
background consisted of either shuffled peak regions or the other clusters. Searches were performed 
for large (6 - 15 bp) or xl (6 - 20 bp) motifs. Motifs identified in these various searches were clustered 
using gimme cluster (-t 0.9) yielding a non-redundant list of de novo motifs. To identify motifs 
differentially enriched in one of the 8k means co-clusters of the ATAC-seq and RNA-seq data compared 
to other co-clusters, we run an ensemble of different regression and classification methods, as 
implemented in GimmeMotifs [39]. As input motif library we used the clustered de novo motifs, 
predicted Plasmodium motifs [41, 76], and motifs from plants, vertebrates and invertebrates reported 
in CISBP [42], motifs from each subgroup were first clustered with gimme cluster at -t 0.9). Gimme 
maelstrom was ran three times and we selected motifs that had a P value=< 0.01 in at least two runs. 
From this list we manually removed eight low information content motifs. The remaining 70 motifs 
were grouped based on their similarities by gimme cluster (-t 0.9), resulting in 41 ‘motif groups’.  
 
Mass spectrometry and MS data analysis 
Loaded C18 stage tips were rehydrated with 25 μl buffer A (0.1% formic acid) and peptides were eluted 
in PCR tubes using 30 μl buffer B (80% acetonitrile, 0.1% formic acid). Acetonitrile was evaporated by 
a 15 min vacuum spin at room temperature and samples were reconstituted to 12 μl with buffer A of 
which 5 μl measured on a QExactive or Orbitrap Fusion mass spectrometer (Thermo Fisher Scientific). 
In both cases, the sample was separated over a 30cm C18-reverse phase column (1.8μm Reprosil-Pur 
C18-AQ, dr. Maisch 9852) and eluted using an Easy-nLC 1000 (Thermo Fisher Scientific). For the 
QExactive, elution was preformed over a 94 min gradient (5.6% acetonitrile/0.1% formic acid - 25.6% 
acetonitrile/0.1% formic acid) and directly injected into the mass spectrometer. Data on the QExactive 
was acquired in TOP10 data-dependent acquisition mode with dynamic exclusion enabled for 20 s. 
Resolution for MS was set at 70.000 at m/z = 400 and for MS/MS at 17.5000. For the Fusion, elution 
was performed over a 114 min gradient (7.2% Acetonitrile/0.1% formic acid- 25.6% acetonitrile/0.1% 
formic acid) and directly injected into the mass spectrometer. Data on the Fusion was acquired in 
data-dependent top speed mode in a 3 s cycle with dynamic exclusion set at 60 s. Resolution was set 
at 120.000. 
Raw MS spectra were analyzed as in [30] using MaxQuant (version 1.5.3.30, [77]). In short, standard 
settings were applied with the following modifications. Multiplicity was set at 2, adding a mass of 
28.03 Da (light-labelled) or 36.08 Da (heavy-labelled) to the peptides N-terminus and lysine 
residues. Trypsin/P was set as the specific digestion mode with maximum 2 missed cleavages. 
Analyses were run with re-quantify set to ‘match from and to’. MMTS (added mass of 45.99 Da) 
was specified as fixed modification of cysteines. The match-between-runs option was activated 
(with 0.7 min match time window and 20 min alignment time window) and calculation of iBAQ 
values was enabled. Peptide masses were searched against the Plasmodium falciparum 3D7 
annotated proteome (PlasmoDB release 9.3 [65, 66]) with the entire human proteome included in 
the contaminants list using the integrated Andromeda search engine. Mass tolerance was set at 
4.5 ppm for precursor ions and 20 ppm for fragment ions, and peptides and proteins were 
accepted with an 0.01 FDR cut-off. Protein quantification was set to minimally require a single 
peptide-ratio, but a more stringent downstream filtering on minimally 2 peptides (of which at 
least 1 unique) was applied for generation of scatterplots and determination of significance. 
Downstream analyses were performed using the Perseus software package (version 1.4.0.20, [78]). 
Normalized H/L-ratios were log2-transformed and intensity values were log10-transformed. 
Significant outliers were determined using the intensity-based Significance B option (two-sided 
Benjamini-Hochberg test) with a FDR cut-off set to 0.05. The protein list was filtered for reverse 
hits, proteins that are only identified by site and potential contaminants. In addition, proteins 
Chapter 6
 
 
192 
required a minimum of 2 peptides of which at least 1 unique in order to be considered as a hit in 
both the forward and reverse experiment. Data was plotted in R and significant outliers were 
labelled. Candidate TFs were retrieved from table 4 in [10] and highlighted as well.  
 
DATA AND SOFTWARE AVAILABILITY 
 
The accession number for the ATAC-seq and RNA-seq data reported in this paper is NCBI Sequence 
Read Archive, SRA: GSE104075. 
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Supplementary material 
SUPPLEMENTARY FIGURES 
 
 
 
Figure S1 related to figure 1: ATAC-seq data processing and reproducibility. 
A) UCSC genome browser screenshot of the region on chromosome 7 (333,700 - 400,399bp) showing  
libraries of t40 and gDNA without (‘all’) and after in silico selection for the indicated insert size ranges.  
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Coding sequences are indicted as blue (positive strand) or red (minus strand) bars. GC%, the mean  
percentage of GC nucleotides, smoothened over 5 bp. B) Barplots depict the proportion of reads 
located in coding sequences (top plot) or in AP2-I peaks (bottom plot) for t40 and gDNA ATAC-seq 
libraries without (‘all’) and after in silico selection for the indicated insert size ranges. C) UCSC genome 
browser screenshot as in Figure 1A showing the gDNA-corrected ATAC-seq profiles for the two 
replicates over eight timepoints of blood stage development. D) Barplot of the number of peaks as 
called by MACS2 at each point. E) Heatmaps of relative chromatin accessibility in the two ATAC-seq 
datasets for the regions and clustering depicted in Figure 3B. Relative accessibility was calculated as a 
proportion-of-sum of qnRPKM values over the time points and clustered by k-means using the 1-
Pearson correlation distance metric. Color scales range from the 20th to the 80th percentile for both 
datasets.  
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Figure S2 related to figure 4: Reporter constructs containing gpf/luc gene under the control of 
accessible or control regions. 
A) Schematic representation of recombinant cg6 locus (black) in the attB-containing parental 
P. falciparum 3D7 parasite line [58] after integration with an attP-containing plasmid carrying the 
gfp/luc gene (green) under the control of the kahrp minimal promoter (yellow) with or without 
accessible or control region (light blue/ orange). The attB plasmid backbone is indicated as a pink line, 
the attP integration plasmid backbone is blue. The position of primer pairs (p1 forward and reverse 
covering the accessible region and kahrp promter or p2 forward and reverse covering the gfp/luc gene 
and plasmid backbone) used to confirm the generated parasite lines (see B) are indicated above the 
drawing. Location of amplicons (a1-4) measured by RT-qPCR (see C) are indicated below. The drawing 
is not to scale. B) Confirmation of insertion of the DNA constructs to the cg6 locus by PCR. Genomic 
DNA from attB-site containing parental parasites served as negative control. C) (next page) UCSC 
genome browser screenshots showing gDNA-corrected ATAC-seq tracks and directional RNA-seq 
tracks (left and middle panel) for all eight time points. In the ATAC-seq secreenshots, the cloned 
accessible regions upstream of PF3D7_0719000, PF3D7_1200700, PF3D7_1222700 and 
PF3D7_1372200 are shaded in grey with a blue rectangle. Selected control regions are highlighted 
with a dark orange rectangle. In the RNA-seq screenshots the relevant gene is shaded in grey. Black 
bars represent the called ATAC-seq peaks. Red and blue bars are genes encoded on minus and plus 
strand. Right panel: Relative gfp/luc transcript abundance measured by qRT-PRC (average of amplicon 
a1 to a4) for ring, trophozoite and schizont stages from parasites containing the accessible (or control) 
region assigned to the PF3D7_0719000, PF3D7_1200700, PF3D7_1222700 or PF3D7_1372200 gene 
upstream of the minimal kahrp promoter. Note that the replicate 2 schizont sample for 
PF3D7_1222700 has been collected at a later time point, explaining the higher reporter gene 
expression observed.The relative gfp/luc transcript abundance was assessed by taking the average of 
the four different primer pairs (see A, a1-4). ‘x’ epicts missing value. 
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Figure S3 related to figure 5: Identification of putative DNA motifs. 
A) List of eight repetititive and/or low-information content motifs excluded from further analysis. B) 
Motif groups generated by clustering similar motifs found to be differential enrichted (P=< 0.01 from 
rank aggregation test) for one or more ATAC/RNA-clusters. Representative motifs used in Figure 5 are 
indicated with red fonts.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4 related to figure 6: DNA pull downs for identification of potential protein interactors.  
(See page 202) 
Duplicate DNA pull downs with label swap perfomed using 60bp DNA probes with the (A) 
de_novo_motif_031 (TTATTACAC); (B-C) de_novo_motif_028 (GCACWWTNNKTGCW) or (D) 
de_novo_motif_050 (GAGCTCAA). The same probes with a scrambled motif were used as controls. 
The statistically significant outliers (black diamond, intensity-based FDR <5%) are the proteins that 
interact with the motifs. Red font indicates that the interaction was confirmed using a probe from a 
different genomic region but containing the same motif. # and *indicate that the protein was 
significantly enriched in either the forward or reverse experimintent at an FDR of 0.05 or 0.1, 
respectively. Green dots mark candidate DNA-binding factors derived from Table 4 of [10]. 
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Figure S5 related to parasite culture synchronizations and collections: Representative images of 
Giemsa smears from time-course experiment (replicate1). 
For each time point in the time-course experiment Giemsa stained blood smears were prepared. The 
two images show the representative parasite morphologies from each time point.  
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SUPPLEMENTARY TABLES 
Table S1-S4, S6 and S7, please download online. 
Table S1. Genome cooridnates of ATAC peaks. Related to Figure 1, Figure S1 and Figure 5. 
Table S2. Fluff heatmap clustering AP2-I peaks using ATAC-seq data. Related to Figure 2. 
Table S3. Result of the motif enrichment analysis and associated position weight matrices. Related 
to Figure 5 and Figure S3. 
Table S4. Proteins identified in DNA pull downs. Related to Figure 6 and Figure S4. 
Table S5. Parasite and bacterial strains. Related to STAR Methods. 
 
Parasite Strains 
Name Description Culture medium 
P. falciparum 3D7 wild-type P. falciparum strain (Walliker et al., 1987) normal medium 
P. falciparum 3D7 attB(+) 
P. falciparum 3D7 strain with 
attB site in cg6 locus (Nkrumah 
et al., 2006) 
medium supplemented with 
2.6nM WR99210 
P. falciparum 3D7 
attB::attP_minkahrp 
P. falciparum 3D7 attB(+) after 
transfection and confirmed 
genomic integration of plasmid 
attP_minkahrp  
medium supplemented with 
2.6nM WR99210, 2.5µg/ml 
Blasticidin S HCl (Gibco, R210-01) 
and 250µg/ml Geneticin for 7 days 
after transfection 
P. falciparum 3D7 
attB::attP_minkahrp_ 
PF3D7_1372200 
P. falciparum 3D7 attB(+) after 
transfection and confirmed 
genomic integration of plasmid 
attP_minkahrp_ 
PF3D7_1372200 
medium supplemented with 
2.6nM WR99210, 2.5µg/ml 
Blasticidin S HCl (Gibco, R210-01) 
and 250µg/ml Geneticin for 7 days 
after transfection 
P. falciparum 3D7 
attB::attP_minkahrp_ 
PF3D7_1200700 
P. falciparum 3D7 attB(+) after 
transfection and confirmed 
genomic integration of plasmid 
attP_minkahrp_ 
PF3D7_1200700 
medium supplemented with 
2.6nM WR99210, 2.5µg/ml 
Blasticidin S HCl (Gibco, R210-01) 
and 250µg/ml Geneticin for 7 days 
after transfection 
P. falciparum 3D7 
attB::attP_minkahrp_ 
PF3D7_0719000 
P. falciparum 3D7 attB(+) after 
transfection and confirmed 
genomic integration of plasmid 
attP_minkahrp_ 
PF3D7_0719000 
medium supplemented with 
2.6nM WR99210, 2.5µg/ml 
Blasticidin S HCl (Gibco, R210-01) 
and 250µg/ml Geneticin for 7 days 
after transfection 
P. falciparum 3D7 
attB::attP_minkahrp_ 
PF3D7_1200700negative 
P. falciparum 3D7 attB(+) after 
transfection and confirmed 
genomic integration of plasmid 
attP_minkahrp_ 
PF3D7_1200700negative 
medium supplemented with 
2.6nM WR99210, 2.5µg/ml 
Blasticidin S HCl (Gibco, R210-01) 
and 250µg/ml Geneticin for 7 days 
after transfection 
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P. falciparum 3D7 
attB::attP_minkahrp_ 
PF3D7_0719000negative 
P. falciparum 3D7 attB(+) after 
transfection and confirmed 
genomic integration of plasmid 
attP_minkahrp_ 
PF3D7_0719000negative  
medium supplemented with 
2.6nM WR99210, 2.5µg/ml 
Blasticidin S HCl (Gibco, R210-01) 
and 250µg/ml Geneticin for 7 days 
after transfection 
 
Bacterial strains 
Name Carried plasmid Plasmid elements Comment 
STBL3_pDC2 pDC2 [56] 
pDC2_3’hsp86-gfp-snf7-
5’pfcam-5’pcdt-bsd-3’hrp2-attP-
ampR 
attP-containing plasmid 
STBL3_pOM1 pOM1 
pOM1_5’pfcam-gfp-snf7-
3’hsp86-5’pcdt-bsd-3’hrp2-attP-
ampR 
expression cassette of pDC2 
reverted and including ApaI site 
STBL3_pOM2 pOM2 pOM2_5’pfcam-gfp-luc-3’hsp86-5’pcdt-bsd-3’hrp2-attP-ampR 
snf7-gfp in pOM1 replaced by gfp-
luc 
XL10-
Gold®_attP_mi
nkahrp 
attP_min 
kahrp 
pOM2_5’pfkahrp-gfp-luc-
3’hsp86-5’pcdt-bsd-3’hrp2-attP-
ampR 
pOM2 with 5’pfcam replaced by 
kahrp minimal promoter 
XL10-
Gold®_attP_mi
nkahrp_ 
PF3D7_137220
0 
attP_ 
minkahrp
_PF3D7_ 
1372200 
pOM2_ATAC_1372200-
5’pfkahrp-gfp-luc-3’hsp86-
5’pcdt-bsd-3’hrp2-attP-ampR 
attP_minkahrp with accessible 
region upstream of 
PF3D7_1372200 (or replaced by 
the accessible or control region 
located upstream of 
PF3D7_1372200,  
PF3D7_0719000 or 
PF3D7_1222700) 
DH5a_pINT pINT [56] pINT-3‘hsp86-neoII-5’hsp86-5’PcDT-bxb1myc-3’hrp2-amp 
plasmid for expression of 
mycobacteriophage bxb1 
integrase 
 
Table S6. Parasite staging for time-course experiments (replicate 1 and 2). Related to STAR 
Methods. 
Table S7. Primers and oligos used for cloning, integration PCR, RT-qPCR and DNA pull down 
experiments. Related to Star Methods. 
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New insights into chromatin regulation of Plasmodium parasites 
In recent years, significant progress has been made in identifying components of 
P. falciparum’s epigenetic machinery such as post-translational histone modifications 
(histone PTMs), numerous ‘reader’, ‘writer’ and ‘eraser’ enzymes and long non-coding RNAs 
(lncRNA) [1-10]. Components of the transcriptional machinery such as homologues of most 
general transcription factors (TFs) and RNA polymerase II (Pol II) subunits have been 
identified [11, 12], specific TFs discovered [13, 14] and regulatory sequences located or 
predicted (e.g. [15-17]). Several studies revealed crucial roles of epigenetic mechanisms in 
key biological processes such as antigenic variation and regulation of gametocyte 
conversion (chapter 2) as well as the roles of several specific TFs during parasite 
development [15, 18-25]. Yet, our knowledge about most epigenetic components and/or 
TFs is still very limited. Accordingly, we are far from understanding their precise function 
and how they interact to control chromatin-based processes such as gene expression 
throughout Plasmodium’s life cycle.  
In the following paragraphs, I will discuss our findings from chapter 3 to 6 and place them 
into the context of the state-of-the-art as well as highlight their contribution to our 
understanding of chromatin regulation in malaria parasites.  
 
Histone variants and their role in chromatin biology of malaria parasites 
Up until now, our knowledge about the function of individual components of P. falciparum’s 
epigenetic machinery is limited. The generation of genome-wide profiles can help to link 
epigenetic components such as histone variants, histone PTMs and their readers to genomic 
features. If profiled at consecutive time points, their dynamics can additionally reveal their 
relation to biological processes, such as gene expression or replication and hence help to 
predict their functionality in these processes. 
Chapter 3 describes the genome-wide analysis of histone variant PfH3.3 and completes our 
knowledge about the histone variants in the epigenetic landscape of P. falciparum. This 
study revealed that PfH3.3-variant nucleosomes primarily occupy euchromatic coding 
(~76% A+T) and subtelomeric repetitive sequences (~73% A+T), the GC-richest sequences 
in the extremely AT-biased P. falciparum genome (~81% A+T, [26]). Remarkably, intergenic 
regions, which exhibit a different base pair composition (~86% A+T) are marked by 
PfH2A.Z/PfH2B.Z double-variant nucleosomes and centromeres (~97% A+T) by PfCenH3 
probably as PfCenH3/PfH2A.Z/PfH2B.Z triple-variant nucleosomes [27-29]. Together the 
genome-wide profiles of all four P. falciparum histone variants support the idea that the 
individual histone variants and their combinations index functional distinct genomic 
domains in a base-composition dependent manner throughout the intraerythrocytic cycle 
(Chapter 3, [27-29]). Yet, P. falciparum has by far the most AT-biased genome and of the 
human-infecting species only closely related species from the same subgenus (Laverania) 
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such P. reichenowi (~81%) [30] and P. gaboni (~79%) [31] have a so extremely skewed 
genome composition. Accordingly, our observation that variant-nucleosomes index the 
genome in an AT-dependent manner might be a P. falciparum or Laverania-specific 
adaptation due to their evolving low-complexity genomes [32]. Thus, whether our 
observation is relevant to less AT-rich genomes of the human-infecting species P. malariae 
(~76%) [33], P. ovale curtisi/wallikeri (~71%) [33], P. knowlesi (~63%) [34] and P. vivax 
(~57.7%) [35] or to malaria model organisms such as the rodent-infecting species P. yoelii, 
P. berghei and P. chabaudi (~76-79%) [36] remains to be deciphered. Yet, GC-content 
differences in genomic regions such as intergenic regions versus coding sequences also 
occur in less extremely biased Plasmodium genomes just not as distinct as in 
P. falciparum [35].  
As in other eukaryotes, also in P. falciparum variant-containing nucleosomes (likely) possess 
unique biophysical properties and provide distinct sites for PTMs, which serve as scaffold to 
recruit specific ‘reader’, ‘writer’ and ‘eraser’ proteins, and contribute to the regulation of 
chromatin-based processes [6, 37]. For instance, during asexual blood stage development, 
the histone tails of PfH2A.Z and PfH2B.Z are heavily acetylated compared to their canonical 
counterparts [4]. At intergenic regions, which contain regulatory sequences, 
PfH2A.Z/PfH2B.Z incorporation could potentially lead to reduced nucleosome stability/ 
increased chromatin accessibility, which in turn promotes transcription more efficiently 
and/or be necessary for pre-initiation complex (PIC) recruitment.  Interestingly, during 
blood stage development, these PfH2A.Z/PfH2B.Z-containing regions are dynamically 
marked by various histone modifications which correlate with transcriptional activity of the 
downstream located gene such as H3K9ac and H4K8ac or are incorporated in a stage-
dependent manner such as H3K4me3 [27, 28, 38, 39]. In contrast to PfH2A.Z and PfH2B.Z, 
the histone tail of PfH3.3 is almost identical to its counterpart PfH3 (chapter 3).  Yet, PfH3.3 
is mainly incorporated in coding sequences, depleted of the histone variants 
PfH2A.Z/PfH2B.Z and mostly devoid of the PTMs H3K4me3 and H3K9ac. Instead H2BK112ub 
co-occurs with PfH3.3-marked coding regions and correlates with gene transcription (my 
unpublished observation). Thus, the few differing amino acids between PfH3.3 and PfH3 
(only eight in the entire sequence) seem to be sufficient to give each of them unique 
features and functions, potentially through different biophysical properties or distinct sites 
for PTMs. For instance, S10ph (as several other PTMs) has been solely detected for PfH3 
[40] and its deposition might be hampered in PfH3.3 by the adjacent amino acid substitution 
[41]. Further PTM crosstalk and/or recruitment of specific reader complexes could hence 
promote unique functions of histone variants in processes such as transcription initiation 
and elongation or gene silencing (e.g. S10ph stimulates Gcn5 to acetylate H3K14 [42] 
whereas the double modification H3K9me3/S10ph associates with facultative 
heterochromatin at differentiated postmitotic cells [43])  
Chapter 7
 
 
210 
Next to its incorporation into coding sequences, PfH3.3 also occurs at the active and poised 
but not the inactive var gene promoter. Interestingly, the active/poised state of a certain 
var gene is maintained over multiple parasite generations. Thus, PfH3.3 may serve as an 
epigenetic memory mark in the process of antigenic variation (chapter 3). However, how 
exactly PfH3.3 incorporation contributes to the complex process of antigenic variation [44] 
has not been unraveled. Our efforts to tackle this question by generating conditional PfH3.3 
knock-down lines failed, potentially due to the interference of the knock-down tag with the 
proper function of PfH3.3. Yet, alternative approaches like conditional knock-down based 
on the glmS ribozyme [45] or the TetR-aptamer system [46] could circumvent this problem, 
and hence shed light on the unique function of PfH3.3. For instance, reduced PfH3.3 levels 
may lead to an increased var gene switching rate and hence confirm its function as memory 
mark in var gene regulation.  
 
Heritable gene-silencing in malaria parasites 
In Plasmodium parasites, in contrast to their vertebrate hosts, HP1-mediated gene silencing 
seems to be the main mechanism of heritable silencing since the facultative 
heterochromatic mark H3K27me3 is absent in P. falciparum [4, 47] and the relevance of 
reported asymmetric DNA methylation [7] has not been established. Yet, other PTMs have 
been reported to (potentially) contribute to transcriptional repression but may not be 
involved in heritable gene silencing (e.g. H3K36me2 [47]), or just relevant for a subset of 
heterochromatic genes (e.g. H3K36me3 [48]).  
Chapter 4 describes a very comprehensive ChIP-seq study we performed to identify the 
genome-wide binding sites of HP1 across different malaria species with the aim to expand 
our knowledge about conserved or species-specifically silenced genes across six different 
Plasmodium species. Additionally, we investigated variantly silenced genes across four 
P. falciparum and two P. knowlesi strains as well as the role of HP1-mediated silencing in 
life cycle progression. Our results for P. falciparum were in line with previous findings, which 
showed that multi-gene family members (often involved in parasite pathogenicity) and few 
individual genes are targets of HP1-mediated gene silencing in P. falciparum schizont 
stages [49-51]. In our study, we also extended this knowledge to five additional species. 
Additionally, by exploring different parasite strains of the same species, we revealed that 
many heterochromatic genes are silenced in a strain-specific manner. Most of these genes 
were also variantly expressed in P. falciparum isogenic parasite strains [52] and field 
isolates [53]. Hence, variant HP1-mediated gene silencing may serve as a mechanism to 
increase the adaptive capacity, for instance, to host immune responses but also to 
erythrocytes with different surface receptor repertoires. Previously, it has been shown that 
P. falciparum parasites can use several alternative pathways to invade human erythrocytes, 
for instance, when cultured with blood of human donors lacking certain surface receptors 
or with erythrocytes with a restricted surface receptor repertoire due to enzyme 
Discussion
 
 
211 
treatment [54]. Thus, genome-wide HP1 profiles generated from parasites cultured in 
different blood types or differently treated erythrocytes may reveal the epigenetic changes 
underlying alternative invasion pathways.  Indeed, genome-wide HP1 profiles of two 
P. knowlesi clones adapted to different host cells (Macaque versus human blood cells) 
revealed a dozen of genes which were clearly differently marked by HP1. Subsequent 
culturing of the human blood-adapted parasite strain in Macaque blood and vice versa as 
performed previously [55] could reveal whether this host cell adaptation has been purely 
due to epigenetics. In that case, genes important for the adaption to human erythrocytes 
but unbeneficial for Macaque erythrocytes might be silenced again whereas genes 
important for the adaption to Macaque erythrocytes would be derepressed and vice versa. 
In addition, genome-wide HP1 profiles from independent P. knowlesi strains or isolates 
could reveal other variantly silenced genes, which could help to uncover epigenetically 
regulated processes in P. knowlesi. 
Most strikingly, we discovered that heterochromatin is strictly maintained during asexual 
proliferation but is extensively remodeled during sexual differentiation of P. falciparum 
parasites. This appears to be crucial for the activation of key gametocyte-specific genes and 
the adaptation of the erythrocyte remodeling machinery. Interestingly, heterochromatic 
domains mainly expand leading to an increased number of silenced genes in gametocytes 
compared to asexual parasites. More recently generated H3K9me3 ChIP-seq data [56] 
showed that these heterochromatic domains expand even further in P. falciparum oocysts 
and salivary gland sporozoites, implying that an additional subset of genes gets silenced 
during development in the mosquito vector. Thus, our observation suggests that asexually 
proliferating blood stages have the most accessible chromatin structure with almost 80% of 
the genome being transcriptionally active during blood stage development [26, 57] and that 
the percentage of active genes decreases in succeeding life cycle stages. A reset of the 
heterochromatic state could potentially occur during liver stage schizogony, which would 
also be in line with a previous study, suggesting that the mosquito passage may be a 
prerequisite for the reset of the epigenetic state of virulence genes in P. chabaudi [58]. 
However, further analysis will be needed to investigate when partial or complete resetting 
of heterochromatin occurs and expansion of our study and the study of Gomez-Diaz and co-
workers by HP1 and/or H3K9me3 ChIP-seq on other life cycle stages such as mature liver 
schizonts and first generation merozoites could clearly contribute to clarify this open 
question. ChIP-seq analysis of stages which are very difficult to collect in large numbers, 
such as P. falciparum liver stages, could be a particular challenge. However, further 
processes in the ChIP-seq technology to reduce the starting material and/or improving the 
signal-to-noise ratio could overcome these challenges. Drop-ChIP [59], for instance, uses a 
droplet-based microfluidics system [60] to barcode digested chromatin from single cells 
before immunoprecipitation, which decreases the background noise caused by unspecific 
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binders. However, further improvements regarding the low sequencing depth/resolution 
due to the limited number of valid sequencing reads from individual cells, would be needed.  
The above described gradual expansion of heterochromatic domains results in an increased 
number of silenced genes throughout life cycle progression, which are likely unbeneficial or 
even incompatible with the stage-specific requirements. At the same time, few genes, 
which have been silenced in asexual stages, get de-repressed in these succeeding life cycle 
stages, likely in an active manner. For instance, ap2-g, the gene encoding the master 
regulator of gametocyte commitment [21, 23, 61]. Thus, independent mechanisms could be 
responsible for activating and/or silencing these different genes.  
 
Epigenetic regulation of commitment to gametocytogenesis  
The ap2-g locus is usually silenced in the vast majority of asexual parasites and only 
transcribed in a small parasite sub-population, which committed to develop to gametocytes 
[21, 23]. Interestingly, the proportion of these committed parasites/the gametocyte 
conversion rate can be modulated through environmental conditions such as host 
lysophophatidylcholine (LysoPC) levels as recently shown for P. falciparum [62]. In 
chapter 5 we aimed to decipher the mechanism upstream of AP2-G expression, which 
resets ap2-g heterochromatinization in P. falciparum [61]. Interestingly, we revealed 
GDV1 [63] as upstream activator of sexual differentiation. The expression of GDV1 itself is 
regulated by a long non-coding gdv1 antisense RNA and absence of this lncRNA increased 
GDV1 expression levels. Increased GDV1 levels, in turn, lead to reduced HP1 occupancy at 
a particular set of genes including ap2-g, dblmsp2 and early gametocyte markers [21, 61, 
63, 64] and consequently also to increased transcript levels of these genes. Thus, increased 
GDV1 levels induce AP2-G expression resulting in increased gametocyte conversion rates in 
a parasite population. Interestingly, the second highly induced gene dblmsp2 encodes a 
merozoite surface protein, which has previously been shown to be only expressed in a small 
percentage of schizonts [65, 66], which are likely committed, and the expressed protein 
DBLMSP2 may solely be anchored to the surface of committed merozoites [67]. 
Interestingly, DBLMSP2 has been shown to be bound by unspecific IgM, which seems to 
mask parasites from the adaptive host immune system (IgG) [67, 68]. Thus, its expression 
in committed parasites may contribute to successful transmission and survival of malaria 
parasites. Notably, orthologues of GDV1 have not been identified in all malaria species, for 
instance, not in the rodent-infecting species examined in chapter 4, which raises the 
question how HP1 removal of the ap2-g locus could occur in these species. Do other 
proteins undertake the function of GDV1 in rodent species, and if yes which one(s)? The 
identification of PbHP1 interacting proteins may reveal interesting candidate proteins. Also, 
two key question remained open in regard to GDV1-induced gene activation in 
P. falciparum: How does GDV1 remove/destabilize HP1 at few selected loci? And which 
upstream events modulate gdv1 antisense RNA transcription, GDV1 stability or activity? 
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LysoPC found in human serum represses sexual differentiation [62]. Accordingly, reduced 
levels of LysoPC and hence of its metabolite PC leads to increased gametocyte commitment 
rates [62]. But how is this linked to reduced gdv1 antisense RNA and/or increased GDV1 
transcript abundance (the latter has been detected after LysoPC depletion, [62]) and thus 
in varying gametocyte commitment rates? Unveiling this missing link will not only be a 
further milestone in understanding the mechanisms of gametocyte commitment in 
P. falciparum and likely in other species with GDV1 orthologues but will also extent our 
knowledge about the connection of external signals and/or parasite metabolism and 
epigenetic gene regulation.  
 
Regulation of euchromatic genes in malaria parasites 
From previous studies we learned that in P. falciparum heterochromatin mediated gene 
silencing is of major importance ([69], chapters 2, 4 and 5) and controls, depending on the 
species, ~4%-16% of all genes during blood stage development (chapter 4). Yet, during the 
asexual blood stage cycle, the largest part of the parasite genome is in a transcriptionally 
permissive, euchromatic state, and encompasses roughly 92% of all genes in P. falciparum 
[49, 51]. In P. falciparum, typical characteristics of euchromatin are PfH2A.Z/PfH2B.Z-
double variant nucleosomes at intergenic regions, ‘active’ PTMs such as H3K9ac, H3K4me3, 
H4K8ac and H2BK112ub which correlate with gene expression and/or promoter strength 
and general high acetylation levels of the tails of the histones H3 and H4 (unpublished data, 
[38, 51, 70, 71]). Yet, how exactly epigenetic marks and their ‘reader’, ‘eraser’ and ‘writer’ 
proteins interact to contribute to transcription regulation in malaria parasites has not been 
deciphered. Additionally, also in P. falciparum, binding of specific in trans-acting 
transcription factors (TFs) [13, 14] to regulatory DNA sequences (e.g. [16, 17, 72]) likely 
stimulates or inhibits the assembly and/or activity of the preinitiation complex (PIC) at the 
core (or minimal) promoter [11, 12] as shown for other eukaryotes [73]. Yet, an accurate, 
genome-wide overview of cis-regulatory DNA elements is still lacking for P. falciparum. Up 
until now, we do not know how and which specific in trans-acting TFs and cis-regulatory 
elements interact to produce the typical ‘just-in-time’ transcription pattern during blood 
stage development in P. falciparum [74] and to which extent and/or how epigenetic 
mechanisms contribute to ‘just-in-time’ transcription.  
In chapter 6 we aimed to decipher the gene regulatory networks in P. falciparum during 
blood stage development. By applying ATAC-seq [75], we generated a genome-wide 
overview of accessible chromatin regions throughout the asexual blood stage cycle. The 
vast majority of these regions were found in euchromatic intergenic regions located within 
one or two kilobases upstream of the next downstream located gene. Based on previous 
observations, which suggested a close proximity of regulatory elements and their target 
genes (e.g. [15, 16, 20]), we assigned each accessible region to the nearest downstream 
located gene. Indeed, for the vast majority of genes, chromatin accessibility dynamics and 
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transcript abundance pattern strongly positively correlated. Additional in vivo studies 
showed on the basis of examples that these identified accessible regions were sufficient to 
dictate stage-specific gene expression to a reporter gene similar to the expression pattern 
of the respective endogenous gene. Motif screening within accessible regions clustered 
according to their stage-specific accessibility/expression profile of the assigned gene 
uncovered ‘stage-specific’ Plasmodium [17, 76] and de novo motifs. Subsequently, a set of 
identified motifs was used for DNA-pull-downs combined with quantitative proteomics. 
Specific TFs were found among the motif interacting proteins, suggesting that the 
discovered cis-trans regulatory interactions are likely involved in the ‘just-in-time’ 
transcription regulation during blood stage development. Expanding this analysis to the 
remaining motifs will definitively reveal further cis-trans regulatory interactions during 
asexual proliferation. In addition, applying the same methodology to other life cycle stages 
such as gametocytes, could highly contribute to unravel yet unknown stage-specific gene 
transcription regulatory mechanisms. 
Furthermore, our data suggest that i) gene expression in P. falciparum is predominantly 
regulated by cis-regulatory elements, which are in close proximity to the target gene and ii) 
gene expression in P. falciparum is primarily regulated by transcription activating events. 
Distant enhancers as key regulators of gene expression as observed in many metazoan [77] 
are hence rather unlikely.  In line with this, long distant interactions were restricted to 
centromeres, telomeres, ribosomal rDNA genes and virulence gene clusters in previous 
chromosome conformation studies [78, 79].  The largely activating nature of transcription 
regulating events is supported by previous TF data. So far, TFs have been shown to primarily 
act as activators (e.g. AP2-G [21, 23], AP2-O [15, 25] AP2-I [24]) except for AP2-Sp, which 
may act as both by activating sporozoite genes in P. berghei oocysts [80] and potentially 
repressing female gametocytes-specific genes in P. berghei gametocytes or asexual blood 
stages [22] and AP2-G2, which has been identified as transcriptional repressor in P. berghei 
gametocytes [20, 22].   
However, how these stage-specific cis-trans regulatory interactions between cis-regulatory 
elements and TFs are related and/or coupled to epigenetic mechanisms has not been 
deciphered yet. What is the role of histone PTMs and histone variants at and/or next to 
accessible regions/TF binding sites? In many eukaryotes H3.3/H2A.Z double variant 
nucleosomes are particularly unstable and additional acetylation of H3.3 at K122, which 
occurs near the histone-DNA interphase [81], is assumed to contribute to their 
destabilization at promoter and enhancer elements, thereby facilitating TF binding [82]. 
PfH2A.Z/PfH2B.Z-double variant nucleosomes found at promoter regions in P. falciparum 
[28] are also rather labile and their heavy acetylation or PTMs such as the recently detected 
H3K112ac [40] might function in a similar way.  In addition, certain PTMs or ncRNAs next to 
TF binding sites could modulate TF binding affinity or recruit TFs as shown for other 
eukaryotes [73, 83]. Thus, further investigations of the transcription regulatory network and 
Discussion
 
 
215 
the establishment of the link between TF binding events and epigenetic mechanisms will 
remain one of the major encounters of future malaria research. 
Conclusion and Outlook 
By combining our novel findings, and integrating them into the latest state-of-the-art 
regarding gene transcription regulation in P. falciparum, the following, yet incomplete, 
picture emerges:  
During blood stage development, the vast majority of genes is expressed in a ‘just-in-time’ 
manner with peak mRNA abundances correlating with the need for the products they 
encode for [74]. This ‘just-in-time’ gene expression is regulated by stage-specific TF binding 
to cis-regulatory elements, which are in close proximity to the respective target genes, and 
lead to largely transcription activating cis-trans regulatory interactions (chapter 6). The role 
of the chromatin composition at these cis-regulatory elements is still elusive but may 
influences TF binding by nucleosome stability (e.g. H2A.Z/H2B.Z double-variant 
nucleosomes) and/or the presence of specific PTMs. In contrast, members of multi-gene 
families implicated in parasite virulence and immune evasion as well as few individual genes 
including ap2-g are heritably silenced via HP1 during asexual proliferation (chapter 2 and 
4). Nonetheless, the chromatin state of some of these genes can change during asexual 
proliferation, for instance, in case of the var gene family members. Time after time, a 
heritably silenced var gene is activated, while the previously activated one is silenced, and 
remains active for multiple generations (chapter 2). The incorporation of the histone variant 
H3.3 into the var gene promoter likely contributes to the propagation of this active state to 
the next generations (chapter 3). Frequently, few parasites escape the asexual proliferation 
cycle and commit to gametocytogenesis (chapter 5, [84]). This cell fate decision is likely 
stochastic, but also responsive to environmental factors [62, 84] and linked to gdv1 levels 
or activity by a yet unknown mechanism. Decreased gdv1 antisense RNA levels induce GDV1 
expression and derepress ap2-g (chapter 5). This leads to transcription of the TF AP2-G, 
which in turn induces a cascade of downstream regulatory events leading to sexual 
differentiation [21, 23]. These downstream regulatory events are accompanied by extensive 
chromatin remodeling. Early gametocyte markers, which have been heritably silenced in 
asexual parasites, get activated and expressed in gametocytes (chapter 4). At the same 
time, heterochromatic domains expand and lead to silencing of previously active genes, 
which are potentially needed for proper erythrocyte remodeling during asexual 
proliferation (chapter 4). Yet, the link between heterochromatin formation and AP2-G 
induced gametocytogenesis remains to be deciphered. Moreover, heterochromatic 
domains are even further extended in oocysts and salivary gland sporozoites (chapter 4, 
[56]), giving the impression that heterochromatin continuously spreads from asexual blood 
stages to liver stages. But why and how, remains to be unveiled.  
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Taken together, these new insights gained in chapter 3 to 6 contribute to our understanding 
of the process of gene regulation in Plasmodium parasites. Still, many questions remain 
unanswered, for instance, what is the precise function of other epigenetic components, 
regulatory sequences and specific TFs? What role do epigenetic mechanisms play in malaria 
parasites during transcription regulating and other chromatin-based processes such as DNA 
replication? How do individual TFs interact to form a regulatory network and which 
regulatory events occur during, for instance, asexual proliferation, stage transition or 
response to external stimuli? Thus, understanding these individual mechanisms, linking 
them and integrating the gained knowledge into a comprehensive model of chromatin 
regulation/transcription regulation in malaria parasites is one of the major challenges for 
the upcoming years.  
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SUMMARY 
 
Malaria is one of the deadliest infectious diseases claiming close to half a million human 
lives annually despite extensive elimination efforts. The causal agent are single-celled 
parasites of the genus Plasmodium. The life cycle of these parasites involves a mosquito 
vector and a vertebrate host. In both hosts the parasite develops into various 
morphologically and functionally distinct forms and infects and grows within very different 
cell types and tissues to complete the life cycle. A prerequisite for these complex 
environmental adaptations and phenotypic changes are molecular mechanisms acting on 
the chromatin, the highly organized structure that compacts the DNA through its interaction 
with various proteins and RNA. These so-called epigenetic mechanisms mediate the 
composition and compaction of the chromatin and hence influence essential biological 
processes including gene transcription, the process, in which DNA is transcribes into RNA, 
the template for subsequent protein synthesis.  
In this thesis, I aim to contribute to a better understanding of epigenetic regulatory 
mechanisms as well as transcriptional gene regulation in malaria parasites. In chapter 1, I 
introduce malaria parasites and the disease they cause as well as chromatin-regulatory 
mechanisms in eukaryotic organisms. An overview about the different components of the 
epigenetic machinery in malaria parasites as well as key Plasmodium-specific examples of 
epigenetic regulation are provided in chapter 2. One of these epigenetic components, the 
histone variant PfH3.3, is characterized in chapter 3, where we uncovered its genome-wide 
localization to GC-rich regions as well as its potential role in the process of antigenic 
variation in the human-infecting species P. falciparum. Chapter 4 focuses on the 
heterochromatic mark HP1, which we profiled in different Plasmodium species, strains and 
stages to provide a detailed catalog of heritably silenced genes. In addition, we revealed 
conserved and specialized features of HP1-mediated gene silencing across the genus 
Plasmodium, explored variantly silenced genes across different strains and unveiled a major 
role for HP1-mediated gene silencing in the process of sexual differentiation. In chapter 5 
we unveiled the initial regulatory events that lead to sexual commitment in P. falciparum, 
namely the activation of the master transcription factor PfAP2-G. We showed that binding 
of the nuclear protein PfGDV1 to the heterochromatic mark PfHP1 at the pfap2-g locus 
counteracts HP1-mediated silencing and induces gametocyte conversion. The expression of 
PfGDV1 is regulated by its own antisense RNA. Chapter 6 addresses the transcriptional 
regulatory network in P. falciparum during blood stage development. Here, we revealed cis-
regulatory elements in a genome-wide scale and investigated their role in relation to 
transcription. We identified ‘stage-specific’ novel and previously identified (Plasmodium) 
motifs and uncovered yet unknown cis-trans regulatory interactions. In Chapter 7, I discuss 
our findings and how they contribute to a better understanding of the biology of malaria 
parasites. 
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SAMENVATTING 
 
Malaria is één van de meest dodelijke infectieziekten en is verantwoordelijk voor bijna een 
half miljoen mensenlevens per jaar, ondanks verwoede preventie- en eliminatiepogingen. 
De ziekte wordt veroorzaakt door eencellige parasieten van het geslacht Plasmodium. De 
levenscyclus van deze parasieten vindt deels plaats in een muggenvector en deels in een 
gewervelde gastheer. In beide gastheren ontwikkelt de parasiet zich in morfologisch en 
functioneel verschillende vormen, en infecteert en groeit hij in verschillende celtypen en 
weefsels. Om zich aan te passen aan deze veranderende omgeving maakt de parasiet onder 
andere gebruik van moleculaire mechanismen die werken op het chromatine, een zeer 
georganiseerde structuur die DNA verpakt door zijn interactie met verschillende eiwitten 
en RNA. Deze zogenoemde epigenetische mechanismen mediëren de samenstelling en 
verpakking van het chromatine en beïnvloeden zo essentiële biologische processen 
waaronder transcriptie, het proces waarin DNA wordt overgeschreven tot RNA, een 
blauwdruk voor de navolgende eiwitsynthese. 
In deze scriptie is het mijn doel bij te dragen aan een beter begrip van de epigenetische 
regulatie mechanismen alsmede van transcriptionele genregulatie in malariaparasieten. In 
hoofdstuk 1 introduceer ik de malariaparasieten en de ziekte die zij veroorzaken, evenals 
de chromatine-gereguleerde mechanismen in eukaryoten. Een overzicht van de 
verschillende componenten in de epigenetische machinerie van malariaparasieten als wel 
enkele belangrijke Plasmodium specifieke voorbeelden van epigenetische regulatie worden 
besproken in hoofdstuk 2. Één van deze componenten, histon variant PfH3.3, wordt 
gekarakteriseerd in hoofdstuk 3, waar we zijn genoomwijde lokalisatie in GC-rijke gebieden 
als wel zijn potentiële rol in het proces van antigene variatie in de mens-infecterende soort 
P. falciparum aan het licht brengen. Hoofdstuk 4 focust op de heterochromatine markering 
HP1, die wij hebben geprofileerd in verschillende P. falciparum soorten, -stammen en -
stadia, om een gedetailleerd overzicht te maken van genen waarvan de 
transcriptierepressie erfelijk wordt doorgegeven. Daarnaast hebben wij geconserveerde en 
gespecialiseerde kenmerken van HP1-gemedieerde repressie over het gehele geslacht 
Plasmodium aangetoond, genen onderzocht die tussen verschillende stammen verschillen 
in hun repressie of activatie staan en een belangrijke rol voor HP-1 gemedieerde transcriptie 
repressie in het proces van seksuele differentiatie aangetoond. In hoofdstuk 5 onthullen we 
de initiële regulatoire gebeurtenissen die ervoor zorgen dat aseksuele P. falciparum 
parasieten gaan differentiëren naar seksuele stadia, namelijk de activatie van de 
transcriptiefactor PfAP2-G. We tonen aan dat de binding van het nucleaire eiwit PfGDV1 
aan de heterochromatine marker PfHP1 op de pfap2-g locus HP-1 gemedieerde repressie 
tegenwerkt en gametocyte conversie induceert. De expressie van PfGDV1 is gereguleerd 
door zijn eigen antisense RNA. In hoofdstuk 6 bespreken we het transcriptionele regulatoire 
netwerk in P. falciparum tijdens de bloedstadium ontwikkeling. Hier onthullen we cis-
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regulatoire elementen op een genoomwijde schaal en onderzoeken we hun rol in relatie tot 
transcriptie. We hebben stadium specifieke nieuwe en eerder aangetoonde (Plasmodium) 
motieven geïdentificeerd en nog onbekende cis-trans regulatoire interacties ontdekt. In 
hoofdstuk 7 bediscussieer ik onze bevindingen en hoe zij bijdragen aan een beter begrip 
van de biologie van de malariaparasieten. 
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